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SUMMARY
The phenomenon of species differences in drug metabolism and 
toxicity is in many instances dependent on the ability of the liver 
to handle the drug in question* This problem is particularly important 
when attempting to extrapolate metabolism and toxicity data from 
laboratory animal species to man. In an effort to establish test 
systems that would enable this extrapolation to be predicted more 
reliably and accurately two different but inter-linked approaches 
were adopted*
Firstly* isolated fractions of adult human liver were investigated. 
The obtention of small amounts of fresh biopsy tissue and of larger 
samples of post-mortem material necessitated a thorough assessment of 
the techniques suitable for speedy* small-scale analysis of microsomal 
drug metabolizing system components together with a study into the 
storage and post-mortem stabilities of this system* By use of these 
techniques large species differences in the ability of microsomes to bind 
drugs were noted which appeared to be related to differences in 
metabolism.
The second approach used was that of tissue culture of adult rat 
hepatocytes. Once again a thorough examination of the available methods 
of liver culture had to be made end based on these findings a suitable 
culture system was devised. The cells present in culture were 
subjected to a battery of tests designed to show liver-specific 
functions* These tests proved that the epitheliocytes present in 
monolayer culture were in fact functional adult rat hepatocytes* a 
situation which appears to have been rarely, if ever, achieved previously*
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GLOSSARY OF TERMS
♦Acid* Microsomes
bs
B.S.S.
CO
EGTA
G,r,
G—5—P
IP
MEM
MFO
NADH
NAOP
NADPH
♦Normal* Microsomes 
0.0,
^450 
P.A.S.
PBS'A#
P.M.
P.M.S.
Those produced by isoelectric precipitation 
Cytochrome bg
Balanced salt solution 
Carbon monoxide
Ethylene glycol—bis-^aminoethylether )N*N-tetra-
acetic acid
Endoplasmic reticulum
Glucose-6-phosphate
Isoelectric precipitation
Binding constant for spectrally-apparent 
microsome-substrate interactions
Minimal essential medium
Mixed function oxidase
Reduced nicotinamide adenine dinucleotide
Oxidised nicotinamide adenine dinucleotide
phosphate
Reduced nicotinamide adenine dinucleotide
phosphate
Those produced by conventional centrifugation 
Optical density 
Cytochrome P^gg 
Periodic-acid schiff
Dulbecco*s phosphate buffered saline lacking 
calcium and magnesium salts
Post Mortem
Post mitochondrial supernatant
S,E#M. - Scanning electron microscopy
TPB - Tetraphenylboron
Other abbreviations are those recommended by the *Biochemical Dournal* 
Chemical formulae are those in general use#
CHAPTER 1# GENERAL INTRODUCTION AND RATIONALE
From ancient civilizations on it has boon common practice to use 
animals on which to test for possible toxic effects the food end drink 
meant for human consumption# Comparatively recently, this use of 
experimental animals has been applied, with some sophistications, to the 
routine pharmacology and toxicity testing of therapeutic agents designed 
for human use. This approach is based on the belief that all animals, 
including man, show essentially similar responses on exposure to a 
particular agent and that the effect observed in experimental animals 
can be extrapolated to the human situation# Whilst this is true in 
many instances, particularly in the early studies on the role of 
chemotherapeutic agents in combating bacterial infection in rats and mice, 
it is almost equally true to say that species differences in the responses 
to administered pharmacodynamic and other agents are so great that any 
extrapolation to man is at best highly tenuous. Furthermore, these 
species differences are highly unpredictable in that the pattern of 
species variation in response to one drug does not necessarily match that 
for any other drug.
It is now widely recognized that in many instances these species 
differences in both pharmacological and. possible toxic responses are 
related to the rates and patterns of metabolism of the drugs themselves 
(see Chapter 2)# It is for this reason that metabolism studies play 
an important role in the testing programme of a new drug, being 
involved in virtually every phase of the programme (Drug Research Board, 1969), 
Even after extensive metabolism studies in experimental animals there still 
exists the one major critical stage in the complete testing schedule, that 
of initial pre-clinical trials in man himself* This step is, in many
respects, very much a step into the unknown but the uncertainty inherent 
in this transition to man could be greatly minimized if an appropriate 
in vitro system be devised which would accurately predict metabolism 
and metabolism-related hepatotoxlcity of the drug in man#
The liver is the major organ responsible for the metabolism of 
drugs and other onutricnts within the mammalian body (see Chapter 2), 
Because of this* and also due to the fact that the liver is the first 
major internal organ to receive a drug after administration* the liver 
often shows adverse reactions to the drug prior to the more obvious 
grosser clinical irregularities* It is for these reasons that human 
liver preparations could prove the most appropriate vitro system 
with which to monitor the probable jün vivo metabolism of anutrients 
in man# This in turn would load to a safer and more rational approach 
to the problem of pre-clinical and clinical trials In man*
It was with this rationale in mind that the present study was 
initiated* Early on it became apparent that two approaches might 
prove the most worthwhile to investigate further* These approaches 
were based on the use of isolated adult human liver fractions and of 
tissue culture techniques*
As the isolated fractions would be obtained from either small 
amounts of surgical or needle biopsy samples or from much larger amounts 
of post-mortem material it was considered necessary
a) to assess the existing assay procedures for enzyme analysis with 
a view to scaling them down for the small samples, and
b) to investigate the feasibility of storing, and rapidly isolating*
the fractions from the much larger samples*
Tissue culture of adult human liver was an attractive alternative
in that hepatotoxlcity studies as well as metabolism studies could be
meaningfully carried out using such a technique# However, a survey 
of the current literature on the tissue culture of adult mammalian 
liver revealed adiversity of methods in use which in itself implied 
a high degree of dissatisfaction as to the applicability and usefulness 
of each technique (see Chapter 6), This necessitated a survey of 
some of the more useful techniques in order to ascertain the most 
applicable to the present study, during which rat liver was employed as 
a model for human liver.
DRUG METABOLISM STUDIES
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CHAPTER 2* INTRODUCTION
Characteristics of the Hepatic Mixed Function Oxidase
There exists within the mammalian liver an enzyme system 
which has a major responsibility for the oxidative metabolism 
of various drugs, anutrients, environmental pollutants etc., 
collectively termed xenobiotics. At the subcellular level 
this oxidative metabolism of xenobiotics is localized in the 
endoplasmic reticulum (Mueller and Miller, 1959) and has an 
absolute requirement for both NADPH and oxygen. This dual 
requirement for both a reducing agent and an oxidizing agent has 
led to this system being termed a "mixed function oxidase" (MFO)
(Mason, 1957).
Several excellent reviews on the hepatic MFO system have 
been written (Gillette, 1956, 1971; Estabrook et al. 1971|
Monnering, 1971; Remmer, 1972) and only a brief description 
of the system will be described here* The essential components 
of this system, and their interrelationships, are shown in Fig. 2.1. 
Although metabolism by the MFO system is manifested by a number 
of seemingly different reactions - aromatic and aliphatic 
hydroxylation, N-, 0- and S- dealkylation, S- oxidation and 
deamination (Gillette, 1966) — it has been shown (Brodie et al. 1950) 
that all these reactions can be viewed as hydroxylation processes.
At the heart of the MFO system is the terminal oxidase 
cytochrome so-called because of the wavelength maximum at
450 nm. of the reduced form in the presence of carbon monoxide 
(Omura and Sato, 1964). It has been calculated (Estabrook et el. 1971)
12
that cytochrome P^gg is the major cytochrome species existing 
within the liver, and is also present, in lessor amounts, in the 
adrenals (Lewis and Bryan, 1971), placenta (Ouchau et al# 1973), 
lung (Gram, 1973), kidney (Bakobsson and Cinti, 1973), testis 
(Menard and Purvis, 1973), small intestine (Lehrmann et al. 1973) 
and skin (Alveres et al» 1973)*
The first stage in the cycle (Fig* 2*1) is the interaction 
of the lipid-soluble substrate (S«H) with the ferric form of 
P^cQ (Rannoring, 1971)*
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Fig. 2.1. The Hepatic Mixed Function Oxidase System (from Remmer, 1972)
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These interactions are of two major general types, type I and 
type II (Remmer et al, 1966; Imai and Sato, 1965), although a 
third, minor, type, designated reverse type I, has also been 
described (Schenkman et al« 1972)# These type I and type II 
interactions appear as alterations in the absolute spectrum of 
oxidized (see Remmer, 1972) which when observed as difference
spectra yield plots characteristic of the two classes (Schenkman 
et 1967) (Fig, 2,2),
Type I compounds give a difference spectrum withlkmax. at 
385 - 390 nm, and a Amin, at 418 — 427 nm,; the A max, and Amin, 
given by type II compounds are 425 ~ 435 nm, and 390 - 405 nm, 
respectively. Type I spectra are produced by the majority of 
substrates of the MFO system and are caused by changes in P^gg due 
to the formation of the enzyme-substrate complex, probably involving 
an association with components of the e,r* membrane (see Mannering, 
1971), Type II spectra, on the other hand, are produced by 
various basic nitrogen-containing compounds (such as aniline) 
which bind to the sixth ligand of the haem iron (Mannering, 1971),
The reverse type I spectrum has been shown to be due to the 
removal of endogenous bound material (Schenkman et al, 1972), An 
important observation that arose from studies involving difference 
spectra was that in many instances the spectral dissociation constants 
(Kg) derived from the changes in optical density at different 
concentrations of certain drugs bore a direct relationship to the 
Michaelis constants obtained for the metabolism of the same drugs 
(Remmer et al, 1966; Imai and Sato, 1965; Mannering, 1971),
Indeed, it has been postulated that the spectral changes are in fact 
visible representations of the Michaelis complexes (Gillette, 1969),
15
Once formed the ferric-substrate complex can accept an 
electron to give the ferrous-substrate complex which in turn 
can interact with carbon monoxide to give the characteristic 
absorbance band at 450 nm, of the reduced P^gg - CO compound; 
reduction by dithionite is necessary for a full expression 
of the reducible P„^ gg in vitro. This electron donation can only 
come from NADPH (and not from NADH) via NADPH-cytochrome c reductase 
(Estabrook et al# 1971), a term synonymous with NADPH-cytochrome 
P^cg reductase (Masters et al, 1973). This single electron 
donation is presumed to require the presence of an unknown 
non-haem iron intermediate ("X"),
The ferrous-substrate complex can then interact with 
oxygen (Baron et al. 1973) and pick up an electron donated 
by either NADH or NADPH, giving rise to an "active oxygen" 
intermediate. This electron transfer from either NADH or NADPH 
is believed to flow via cytochrome bg, the other cytochrome 
present in the e.r* and which is quantitatively the second most 
prominent cytochrome in the liver (Estabrook et al* 1971:
Baron et al. 1973| Sesame et al. 1973).
Subsequent to the formation of the "active oxygen" intermediate 
the bound substrate is hydroxylated and then released, returning 
the P.gQ to its original ferric state*
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Fig 2*2. Difference Spectra of Substrate Interactions with 
Cytochrome P450 (From Schenkman 2È 21» 1967)*,
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2m In Vitro Metabolism of Xenobiotics by the Human 
Hepatic MFO System
There are now a large number of reports concerning the 
presence in human liver, foetal and adult, of various components 
of the microsomal MFO system* Thus, cytochrome bg and P^ gg> 
NADPH-cytochrome c (P^gg) reductase activity and metabolism of 
type I and type II compounds have all been shown to be present 
in adult human liver, whether the specimens be biopsy or post-mortem 
material* The present (December 1973) state of the literature 
on this subject is briefly summarized in Table 2#1.
The ethical problems associated with the obtention of 
surgical or needle biopsies from normal undiseased human adults 
are quite clearly immense and because of this a large number of 
the studies mentioned in Table 2.1 have had to be performed 
using post-mortem material* Consequently, caution should be 
excercized when attempting to extrapolate results from the 
in vitro post-mortem state to the state appertaining in vivo* 
Comparison of the levels of P^gg in liver samples from fresh 
biopsy specimens (Ackermann, 1970, 1972; Alvares et al* 1969;
Black et al* 1973; Darby et al* 1973; Pelkonen et al* 1973; 
Thorgeirsson and Davies, 1971) and from post-mortem specimens 
(Darby et al* 1970; Kamataki et al* 1973; Nelson et al* 1971) 
reveals a markedly lower level in the letter specimens, no doubt 
reflecting the autolytic changes that occur post-mortem* Results 
obtained from needle biopsy material can also be questioned due 
to the large amounts of contaminating capsular tissue which 
is invariably found in such specimens, as well as in surgical
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biopsies although to e lesser extent (Schmidt and Schmidt, 1970)*
The pattern that emerges from the studies of the MFO system in 
human hepatic biopsy tissue (see Table 2*1) is that the levels 
of all the components of this system are lower than those found
in rat hepatic tissue* This Is true for cytochromes bg and
P^gQ and for type I and type II metabolism* Furthermore, 
marked individual differences in the levels of P^gg and type I 
and type II metabolism in human liver biopsies have also been 
noted (Pelkonen et el* 1973)* Whether these individual variations 
were genetically-linked or were caused by prior medication was not 
established*
The MFO system of adult human liver is similar in many 
respects to that of rat liver. 1) It has an absolute 
requirement for an NADPH-generating system (Ackermann, 1970;
Gold and Ziegler, 1973; Kuntzman et al* 1966)*
2) Antibody to porcine NADPH-cytochrome c reductase has been
shown to inhibit human hepatic NADPH-cytochrome c reductase, 
NADPH-cytochrome P^gg reductase and aminopyrine N-demethylation 
(Masters et al* 1971; Nelson et al* 1971) thus verifying that a 
common flavoprotein Is involved in the MFO system of human and 
animal livers* 3) Induction of the human hepatic MFO system 
by both barbiturates (Black et al* 1973; Gold and Ziegler, 1973) 
and by ethanol (Rubin et al. 1970) has been reported* One point 
of difference between the adult human and rat hepatic MFO system 
lies in their differing sensitivity to the inhibitor SKF 525-A 
(Ackermann, 1970)* SKF 525-A inhibited aminopyrine N-demethylation 
in man only at a concentration eight times greater than in rat
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Table 2*1. Demonstration of the Presence of Components of
the MFO System in Human Liver - Literature Survey
Source of 
Material
Ackermann (1970)
Ackermann (1972)
Ackermann and 
Heinrich (1970)
Alvares et al (1969)
Bahr et al (1971)
Black ^  al (1973)
Coccia and 
Westerfeld (1967)
Creaven and 
Williams (1963)
Darby et al (1970)
Darby et ^  (1972)
Aminopyrine N-demethylase 
Codeine O-demethylsse 
NADPH-cytochrome c reductase 
Cytochrome bg and P^gg
Ethylmorphine N-demethylase 
Aniline 4-hydroxylase 
Cytochrome P^gg
N-monomethyl-^-nitroaniiine
N-demethylase
4-nitroanisolo O-demathylase 
NADPH-cytochrome c reductase
Cytochromos bg and P^gg
Benzpyrene hydroxylase
Nortriptyline hydroxylase 
Desmathylimipramine hydroxylase
Cytochrome P^gg
Various pathways of chlorpromazine 
metabolism
Biphenyl hydroxylase 
Coumarin hydroxylase
Codeine O-demethylase 
Hexobarbital hydroxylase 
Aniline 4-hydroxylase 
NADPH-cytochrome c reductase 
Cytochrome P^gg
Tolbutamide hydroxylase
Biopsy
Biopsy
Biopsy
Biopsy
P.M.
Biopsy
P.M.
P.M,
P.M.
Biopsy and 
P.M.
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Author(s) Component
Source of 
Material
Darby and 
Grundy (1973)
Deckert and 
Remmer (1972)
Doshi et (1972) 
Enomoto and 
Sato (1967)
Gold and 
Ziegler (1973)
Kamataki jet al 
(1973)
Kitagawa and 
Kamataki (1971)
Korten and 
Van Dyke (1971)
Kuntzman e^ al 
(1966)
Masters et el
(1971)
Nelson jat al
(1971)
Ozols (1972)
Tolbutamide hydroxylase 
NADPH-cytochrome c reductase 
Cytochrome
Aminopyrine N-demethylase 
Aniline 4-hydroxylase
Pentobarbital hydroxylase 
2-Acetylaminofluorene N—hydroxylase
2-Acetylaminofluorene 7-hydroxylase
Aminopyrine N-demethylase
Aminopyrine N-demethylase 
Hexobarbital hydroxylase 
Aniline 4-hydroxylase 
NADPH-cytochrome c reductase 
Cytochrome
Aminopyrine N-demethylase 
Aniline 4-hydroxylase
Aminopyrine N-demethylase 
Aniline 4-hydroxylase
Benzpyrene hydroxylase 
Pentobarbital hydroxylase 
Acetophenetidin 0-dealkylase
3-methyl-4-monomethylamino- 
azobenzene N-demethylase
Aminopyrine N-demethylase
Aminopyrine N-demethylase 
NADPH-cytochrome c reductase 
Cytochrome P^gg
Cytochrome bg
Biopsy
Biopsy
Biopsy
P.M.
Biopsy
P.M.
P.M,
Biopsy
P.M.
P.M.
P.M.
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Author(s). Component
Source of 
Material
Pelkonen (1973) 
Pelkonen al 
1973
Rubin ^  al (1970)
Saggars et al
(1970)
Schoene jet al
(1972)
Strother (1970)
(1972)
Thorgeirsson 
and Davies
(1971)
Uiau ot al (1972)
Aminopyrine N-demethylase 
Aniline 4-hydroxylase 
Benzpyrene hydroxylase 
NADPH-cytochrome c reductase 
Cytochrome P^gg
Hexobarbital oxidase
Pentobarbital hydroxylase 
Benzpyrene hydroxylase
Quinine 2-hydroxylase 
Aniline 4-hydroxylase 
Cytochrome P^gg
Aminopyrine N-demethylase
4—nitroanisole O-demethylase 
NADPH-cytochrome c reductase 
Cytochrome P^gg
Various pathways of methylcarbamate 
metabolism
Ethylmorphine N-demethylase 
NADPH-cytochrome c reductase 
Cytochrome P^gg
Prazepam N-demethylase
Biopsy
Biopsy
P.M.
Biopsy
Biopsy
Biopsy
P.M.
22
liver to obtain a comparable degree of inhibition. Furthermore* 
codeine O-demethylation in human microsomes was not inhibited 
up to a concentration of SKF 525-A of O.SmM* Similar results 
have been shown for the inhibition by warfarin on aniline 
hydroxylase (Deckert and Remmer* 1972) there being no species 
difference with its effect on aminopyrine N-demethylation.
Activity of the human hepatic MFO system does not appear to 
be preferentially influenced by a specific disease process 
(Gold and Ziegler), 1973) but is markedly decreased upon severe 
liver damage (Doshi et 1972; Gold and Ziegler* 1973;
Schoene et al. 1972). Interestingly* activity of NADPH-cytochrome 
c reductase does not decrease during severe liver damage whereas 
the levels of and of N- and 0- déméthylation do (Schoene
et 1972).
The one component of the adult human hepatic MFO system 
that has received little attention is that of the spectrally-apparent 
substrate-P^gp interactions. Whilst aniline has been shown to be 
a type II compound with human and rat hepatic microsomes (Pelkonen* 
1973; Kamataki et al. 1971* 1973; Ackermann* 1972)* hexobarbital 
and aminopyrine* both type I in the rat* have been described as 
being either typo I (Pelkonen, 1973) or typo II (Kamataki et al.
1971* 1973) in man* Desmathylimipramine has boon stated to be a 
weak type I compound in man (Rone et al. 1971) whilst SKF 525-A has 
been described as being type II (Kamataki et al. 1971); both these 
substrates are type I in the rat* Warfarin produces a modified 
type II spectrum in both rat and human liver microsomes (Deckert 
and Remmer* 1972).
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Various components of the MFO system have also been found in 
foetal human liver microsomes (Ackermann et al. 1972; Pelkonen, 
1973a; Yaffe et al, 1970). It is extremely interesting to 
note that foetuses from other animal species do not possess on 
active hepatic microsomal MFO system (see Pelkonen 1973a). 
Activity of the MFO system was lower in human foetal microsomes 
when compared to adult levels (Pelkonen et al, 1973) but could 
be induced by treatment of the mothers with phenobarbitonc 
(Pelkonen et al. 1973a).
3. Factors Influencing Activity of the Hepatic MFO 
:em
A number of factors ore known which can modify the functional 
ability of the liver to metabolize xenobiotics and these factors 
can be broadly classified into three groups — genetic, 
physiological end environmental. Within the context of the 
present work the most important factor is that of species 
variation* Gillette (1971) has pointed out that variations 
and alterations in the hepatic MFO system brought about by 
those factors cannot be universally related to any specific 
component of the system but may arise from alterations in any 
of the components.
A. Genetic Factors: Species and Strain Variations
It is well known that the duration of therapeutic action and 
toxicological response of many drugs and other xenobiotics is 
species dependent* For example, there is a marked species
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difference in the hexobarbitel-induced sleeping time for mouse* 
rabbit* rat and dog (Quinn et al# 1958), A similar species 
variation has been found for the carcinogenicity of 2-acetyl- 
aminofluorene (see Parke, 1968), the guinea pig and lemming 
being refractory whilst the mouse, rabbit, hamster and dog are 
susceptible. Furthermore, there is great unpredictability in 
the patterns of species differences when comparing one compound 
with another*
In the testing of new drugs and other selectively-toxic 
chemicals for use in man,studies of the toxicity and 
pharmacological activity are usually carried out in two or 
three mammalian species, and from these limited data predictions 
are made for man. As illustrated above the extent of species 
variation is such that these extrapolations to man cannot be 
made with any degree of certainty. As yet no species has been 
found which shows toxicological and pharmacological responses 
to all compounds similar to those in man and even the use of 
non-human primates has not been found to be satisfactory 
(Weiner et al, 1968),
In the past fifteen years it has become increasingly apparent 
that these species variations in the effects of drugs and 
carcinogens are frequently due to differences in the rate of 
metabolism of the compounds themselves. Thus the species 
variation in sleeping time has been shown to be due to differences 
in the rate of metabolism of hexobsrbital to its inactive products 
(Quinn et al, 1958), and the species variation in the 
carcinogenicity of 2-acetylaminofluorene is related to the
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proportion of tho two metabolites, N-hydroxy and 7-hydroxy-2- 
acetylaminofluorene, produced in the liver (see Parke, 1968)*
Tho N-hydroxy derivative is carcinogenic whereas the other is 
not*
By virtue of their relatively complex chemical structure 
the vast majority of Xenoblotics have the potential for metabolism 
by apparently independent different routes# It is thus not 
surprising that species differences in the pattern of metabolite 
formation have been frequently noted* An excellent example is 
the metabolism of amphetamine (Oring et al* 1966) (Fig# 2.3)#
Aromatic hydroxylation is the major route of metabolism in rat, 
whereas in man, dog and rabbit the major route is oxidative 
deamination* A further example is that of phenacetin* In
man phenacetin is metabolized by 0-dealkylation to yield 
jg-acetamidophonol, itself an analgesic, but in dog it is 
metabolized by deacetylotion to give £-phenitidine and 
subsequently, by O-dealkylation, jg^ ominophenol, both of which 
are toxic and cause methaemoglobinaemia (Nery, 1971) (Fig# 2*4)#
Although most of the studies mentioned above were carried out by 
analysis of various body fluids following in vivo xenobiotic 
administration, a great number of studies have been made under 
in vitro conditions using microsomal fractions# Thus, species 
variations in the activity of the hepatic MFO system have been 
noted with hexobarbitone (Quinn et al* 1958), 2-acetylaminofluorene, 
coumarin, biphenyl (Parke, 1968), pentobarbital, benzpyrene, 
phenacetin (Kuntzman et al* 1956), codeine (Ackermann, 1970), 
methylcarbamates (Strother, 1972) and tolbutamide (Derby et al# 1972)#
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Work by Davies ^  ^  (1969) and Flynn ^  (1972) has shown 
that these species differences in the rates of metabolism by the 
hepatic MFO system cannot be attributed to variations in the 
level of NADPH-cytochrome c reductase and are not entirely due 
to differences in the magnitude of the substrate-induced binding 
spectrum. Flynn ^  ^  (1972) have observed that prolonged storage 
of microsomes with amlnopyrine or aniline resulted in atypical 
type I or type II spectra which had maximum absorption at different 
wavelengths in various species. This observation implies that 
subtle differences in the state of cytochrome may exist in 
various species. The role that differences in cytochrome P^gg 
content may play as determinants in species variation has not been 
resolved. Davies et ^  (1969) state that it is not a determinant 
whilst Flynn et al (1972) state that it is, even though they could 
show no great difference in the P^gg level in the various species* 
The one parameter that does appear to be a determinant is the 
NADPH-cytochrome P^gg reductase level. Although they suggested 
that the quantity of this enzyme is in general the most important 
factor involved in determining overall drug oxidation activity, they 
concluded that it could not account for all the observed species 
variation (Flynn ^  al. 1972).
Strain variations in the hepatic metabolism of drugs have 
been reported for rats (Quinn et al. 1958; Siegert et al. 1964), 
rabbits (Cram et al. 1965) and mice (Uesell, 1968), and the strain 
variations in the extent of metabolism of 2-naphthylamine in mice 
has been correlated with the incidence of chemical carcinogenesis 
(Dewhurst, 1963a).
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Fig 2,3. Pathways for the Metabolism of Amphetamine
CH^CHNH
ring
hydroxylation
_p--hy dr oxy amphetamine
amphetamine
oxidative
deamination
COOH
(2) benzoic acidoxidationCHLCOCH
benzylmethyIketone
reduction
l-phenylpropan-2-ol
Fig 2.4. Pathways for the Metabolism of Phenacetin
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B« Physiological Factors
This class encompasses ago, sex, diurnal, hormonal (including 
pregnancy), nutritional and disease factors♦
The levels of all the components of the hepatic MFO system 
so far studied change with age* For a short period following 
birth they are very low in the mouse, guinea pig, rabbit, rat, 
pig and man (Oondorf et al* 1958| Foots and Devereux, 1972; 
riacleod et al, 1972; Basu et al* 1971; Short and Stith, 1973; 
Pelkonen, 1973), After birth there is a rapid rise in the capability 
of the newborn to metabolize drugs during which the levels of all the 
parameters of the hepatic MFO system also rapidly increase*
A large number of hormones influence activity of the hepatic 
MFO system. Thus, thyroid hormone, adrenal hormones, insulin,
ACTH and growth hormones have all been shown to exert such an 
influence (Parke, 1968; Kato and Takanashi, 1968; Pfeiffer et el* 
1972; Wilson, 1973), The sex differences in microsomal drug 
metabolism that are observed in rats are also hormonal-linked 
(Uuinn e_t al, 1958; Macleod et al. 1972), os are the effects 
of diurnal variation (Radzialouski and Bousquet, 1968; Oori et al# 
1971; Burke et al, 1972) and pregnancy (Parke, 1968),
The nutritional state of an animal can influence its capabilities 
to metabolize drugs by the hepatic MFO system. Fasting, starvation,
•H- ++
protein deficiency, low dietary levels of Fe and Ca and ascorbic 
acid deficiency in guinea pigs have all boon shown to have an 
influence in this respect (Bock et al* 1973; Gram et al* 1970;
McLean and McLean, 1965; Becking, 1972; Dingell ct al, 1956;
Chadwick et al, 1973), Also, various components of the diet, whether
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natural or synthetic, may also influence the hepatic MFO system*
These include cedrene (Hashimoto et al, 1972), caffeine (Lombrozo 
and Mitoma, 1970), and flauones (Cutroneo et al» 1972), es well as 
various environmental contaminants such as DDT and polychlorinated 
biphenyls (Pouts, 1970; Litterst et al, 1972)#
Damage to the liver leads to an impairment in its ability to 
metabolize drugs (Breen et al, 1973)» In vitro experiments in 
animals have shown that cholestasis leads to an impairment of the 
MFO system (Schaffner et al# 1971) and it is thought that accumulation 
of bile acids which block the active site of the appropriate enzyme 
may explain this (Dank, 1973)» Infection of mice with murine 
hepatitis virus also reduces activity of the MFO system (Kato et al# 
1963). Similar in vitro results have been reported in man
(Ooshi et al» 1972; Gold and Ziegler, 1973; Schoene et al» 1972)#
Rate with abdominal carcinosarcomas, intramuscular transplants 
and breast tumours show impaired activity of the hepatic MFO system 
(Kato et al, 1963; Khandekar et al, 1972; Brown et al, 1971) 
whilst this activity is severely impaired or even absent in 
hepatomas (Brown et al. 1971)# Liver regeneration following partial 
hepatectomy is accompanied by a fall in activity of the MFO system 
which returns to its original value once the rapid cellular 
proliferation is complete (Henderson and Kersten, 1970)#
C# Environmental Factors
Stress conditions such as cold and noise lead to a rapid rise 
in activity of the hepatic MFO system (inscoe and Axelrod, 1960; 
Dewhurst, 1963; Fuller et al# 1972)# This rise is probably due 
to a rapid induction of the system and is under the control of the 
pituitary-adrenal axis (Oriever and Bousquet, 1965)#
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A characteristic property of the hepatic MFO system is its 
ready in vivo susceptibility by a wide range of foreign compounds 
to which man maybe potentially exposed, including drugs, pesticides 
and polycyclic hydrocarbons (Remmer, 1973). The most widely studied 
inducers are phenobarbitone and the polycyclic hydrocarbons such as
3—methylcholanthrene (3-MC). These two compounds appear to exert 
their inducing effects by different mechanisms. For example, 
phenobarbitone induction enhances almost all of the reactions 
catalysed by whereas 3-MC induces relatively few pathways.
These differential inductive effects are also apparent on the 
components of the hepatic MFO system including P^gps NADPH-cytcchrome 
c (P^5q) reductase and type I and type II spectral changes. The 
selective induction by 3-MC is accompanied by the appearance of a 
different form of P^gg termed the formation of which probably
accounts for the relatively selective induction of drug metabolizing 
enzymes by 3-MC. Whether the represents the formation of a
new haemoprotoin or is merely a different allosteric form of 
the existing P^gg has not been fully resolved. For a more 
comprehensive review on enzyme indication see Gillette(1971),
Remmer (1973), Conney ejk al, 1973).
In addition to their role os inducers of the hepatic MFO system 
phenobarbitone and 3-MC hove also been shown, amongst other things, 
to induce the level of serum hemopexin, the haem-binding 
p.-glycoprotein (Smibert et al. 1972), to inhibit the activity of 
ribosomal and microsomal ribonucleases (techner and Pousada, 1971; 
Louis-Ferdinand and Fuller, 1972; Pousada and Lechner, 1972; Smith 
et el. 1972), and to increase bile flow and bile salt excretion 
(Paumqartner et al. 1971; Redinger and Small, 1973).
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Moreover, inducers of the hepatic MFO system possess the
following additional characteristics
a) They increase the microsomal conjugation of bilirubin with 
uridine diphosphoglucuronic acid and hence decrease the serum 
level of free bilirubin (Cstz end Yaffo, 1968).
b) They increase the excretion of glutathione-conjugated 
bromsulphophthalein (BSP) (Fujimoto et al* 1965; Klaasen and 
Plaa, 1968).
c) They increase the microsomal 6|9-hydroxylation of cortisol and 
subsequent excretion of this product (Conney et al. 1965).
d) They increase the excretion of 0-glucaric acid in ascorbic 
acid—requiring animals (Hunter et al. 1973).
Evidence that phenobarbitone and other inducers of the hepatic
MFO system behave similarly in man emerges from several sourcess-
1) Analysis of the plasma half-lives of various drugs has 
revealed that phenobarbitone, tricyclic antidepressants, 
diphenylhydantoin and ethanol, all known inducers in the rat, 
also induce drug metabolism in man (Levi et al. 1968; 0*Malley 
et al. 1973; Hausen ot el, 1971; l/esell et al. 1971).
2) Phenobarbitone treatment decreases the free bilirubin levels 
in the serum of jaundiced infants (see Cao et al. 1973).
3) The excretion of BSP is more rapid in patients receiving 
phenobarbitone (Gogl, 1971),
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4) Diphenylhydantoin, tricyclic antidepressants and phenobarbitone 
all increase the excretion of ^g-hydroxycortisol in humans 
(Conney et al. 1965; D*Malley et al, 1973; Choi et al. 1973)#
5) Anticonvulsant drugs and phenobarbitone increase the urinary
excretion of D-glucaric acid (Hunter et al# 1971)*
6) A few authors have also shown induction of the human hepatic
MFO system in liver samples obtained from patients on alcohol
and tricyclic antidepressants (Rubin et al, 1970; Mezey and Tobon, 
1971; Black et al, 1973; Gold and Ziegler, 1973),
Inhibition of the hepatic MFO system by competition of substrates 
and by other means can also occur end although the inhibition patterns 
are complex it does appear that SKF 525-A and mstyrapone, the two 
most commonly used inhibitors, act by competing with the substrate 
for the active site of the enzyme (Anders and Mannering, 1966; Roots 
and Hildebrandt, 1973)* Moreover it also appears that, at least in 
some cases, metabolism of the inhibitor by the MFO system is a 
prerequisite for its action (Schenkman et al* 1972; Parli et al,
1973)* The administration of steroids, antibiotics, CCl^, lead, 
methylmercury and other hepatotoxins have all been shown to inhibit 
hepatic microsomal drug metabolism (Ouchau and Fouts, 1966; Dixon and 
Fouts, 1962; Peters and Fouts, 1969; Archakov and Karuzina, 1973;
De Matteis, 1973; Sweeney et al. 1973; Alvaros et al. 1972).
Similar inhibition by oral contraceptives and antibiotics has been 
noted in humans (0*Malley et al. 1972; Christenson and Skovsted, 1969).
In the light of the numerous, previously described, genetic 
and environmental factors capable of altering hepatic microsomal
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drug metabolizing activity in experimental animals it comes as 
no surprise that humans display large, if not extreme, individual 
differences due no doubt to a complex interrelationship of these 
genetic and environmental factors (l/esell, 1972).
Isolation of Hepatic Endoplasmic Reticulum Fragments for 
In Vitro Drug Metabolism Studies
When the liver is homogenized the endoplasmic reticulum 
fragments, the fragments collectively being termed the microsomal 
fraction of the resulting homogenate. Classically this microsomal 
fraction is harvested by the method of Schneider and Hogoboom 
(1950) involving a scheme of differential centrifugation* Using 
this approach the homogenate is first centrifuged at 10,000 £ for 
10 - 20 minutes to remove intact cells, erythrocytes, nuclei and 
mitochondria# The supernatant resulting from this preliminary 
centrifugation is then subjected to a spin at 105,000 £  for 
60 minutes* The supernatant (cytosol) is discarded, the pellet 
being the microsomal fraction# For many studies of vitro drug 
metabolism this fraction is too impure and has to be purified by a 
further centrifugation at 105,000 £  for 60 minutes#
From this brief description two major disadvantages to the use 
of differential centrifugation as a means of isolating microsomes 
are apparent* Firstly, it can take up to 4 hours from the time 
of obtaining the liver to the stage where a microsomal suspension 
is ready for use; this is particularly disadvantageous when the 
liver specimen itself has been left for some time before processing, 
as may occur with human biopsy and autopsy samples. Secondly, this 
technique involves the use of costly high-speed centrifugation 
equipment#
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Unfortunately, until recently no alternative technique has been 
available which overcomes these two disadvantages. In the last six 
years, however, three different techniques have been described for 
the rapid isolation of hepatic microsomes obviating the use of high-speed 
centrifugation. All of these techniques use as a starting point the 
10,000 £ post-mitochondrial supernatant described above.
The first such technique is the use of gel filtration involving 
Sepharose 28 (Staron and Kaniuga, 1971; Tangen et al. 1973).
Comparable levels of NADPH-cytochrome c reductase and aminopyrine 
M-demethylase activity have been found in microsomal fractions prepared 
by conventional centrifugation and gel filtration (Tangen et al. 1973). 
However, certain disadvantages do exist with this technique*
1) The yield of microsomal protein and cytochrome P^gg is lower 
in microsomes prepared by gel filtration (Tangen et al. 1973).
2) It takes approx. 1 hour to obtain a usable microsomal fraction 
when timed from the commencement of the gel filtration. This 
preparation time is obviously greatly increased when more than 
one sample is being processed.
3) When more than one sample is processed the high cost of precision 
columns, fraction collectors and monitors becomes prohibitive.
Another recently described technique for the rapid isolation of 
hepatic microsomes is that of Ca’^-induced aggregation (Kamath et al.
1971). Later reports by Kamath and co-workers (Kamath and Narayan,
1971; Kamath and Rubin, 1972) have shown that Ca’^-aggregated 
microsomes contain levels of in vitro drug metabolizing activity, 
when measured as type I and type II metabolism and
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cytochrome content,-comparable to those in microsomes prepared 
conventionally, a finding confirmed by Kupfer and Levin (1972), 
Schenkman and Cinti (1972), Cinti £t al (1972) and Baker et al 
(1973)# It has also been shown that Ca*^-induced aggregation 
leads to microsomes typical with regard to their inducibility 
by phénobarbital (Kupfer and Levin, 1972) and their ability to 
bind substrates of the MFO system (Cinti jet al, 1972; Baker et al# 
1973). Once again, this technique has its own disadvantages:-
1) If the original method of Kamath ot al_ (1971) is used a large 
dilution of the PMS has to be made, hence leading to unwieldy 
volumes for the subsequent centrifugation#
2) If, on the other hand, the modified method of Cinti et al
(1972) is considered, a spin of 27,000£ for 15 minutes has 
to be used, which together with the run-up, run-down and 
washing times, constitutes a lengthy high-speed centrifugation 
step#
3) One report (Schenkman and Cinti, 1972) has observed that Ca*^ -^ 
aggregated microsomes lose their ribosomes, although it should 
be noted that other reports (Kamath et al. 1972; Baker et al# 
1973) have refuted this claim#
The other recent technique for the rapid isolation of 
microsomal fractions is that of isoelectric precipitation, by which 
the pH of PMS is lowered to 5.0-5.4 and the aggregated microsomes 
harvested by brief centrifugation (Karler and Turkanis, 1968; 
Mitchard, 1969), As early as 1946 Claude was able to show that 
aggregation occurred at acid pH, end suggested that this isoelectric
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precipitation represented a membrane phenomenon common to all 
membranous intracellular components# This pH-dependent aggregation 
of hepatic microsomes was later confirmed by Leone and Redstone 
(1962)# Karler and Turkanis (1968) and Mitchard (1969) have 
recently shown that microsomes prepared by isoelectric precipitation 
have levels of hexobarbital oxidase and benzamphetamine N-demethylase 
activity comparable to those present in conventionally-prepared 
microsomes# Unfortunately, no further work on the use of 
acid-precipitated microsomes in studying in vitro MFD acitivity was, 
or has since been, mentioned*
In light of the apparent speed and simplicity of.operation it 
was felt that this technique could prove a valuable alternative to 
conventional centrifugation in studies of hepatic MFO activity 
in vitro. Accordingly, microsomes prepared by isoelectric 
precipitation were thoroughly studied for their ability to exhibit 
characteristics of the MFO system in vitro, both in rat liver and, 
as far as possible, in human liver.
5. Stability of the Hepatic MFO System — Storage and Post Mortem 
Characteristics
A number of workers have commented on the storage characteristics 
of the hepatic MFO system as a factor influencing their results.
Thus Clark (1957) has stated that freezing of 10,000 £ supernatant 
of rat liver homogenate does not inactivate pethidine N-demethylation 
over "several days" whilst Pederson and Aust (1970) have stated 
that storage at —15°C under N- and in the presence of 50^ glycerol 
has no effect on aminopyrine déméthylation in rat liver microsomal 
suspensions, although no time limit for the storage was specified*
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Similarly, storage of rat or pig hepatic microsomes, either 
as pellets or the intact liver, at -18°C for 1 - 4  days has no 
effect on the in vitro metabolism of imipramino (Gigon and Bickel,
1971)# Maintenance of a microsomal suspension in buffer at -5°C 
for 7 days largely destroys the type I spectral interaction but
not that of type II (Shoeman et al* 1969), whilst storage at 4°C for 
24 hours brings about a reduction in the magnitude of the type I 
interaction without greatly changing the (Kutt et al# 1970).
Storage of the microsomal suspensions at -15 C for 18 days brings 
about no loss of activity with respect to aniline hydroxylation, 
aminopyrine déméthylation and binding affinity (Deckert and Hemmer,
1972). Generally similar findings have been observed in respect 
to the storage of human biopsy liver samples (Black et al. 1973;
Gold and Ziegler, 1973) although contamination of microsomes by 
haemoglobin after overnight storage of frozen solid human liver 
samples has been reported (Alvares et al. 1969).
A short-term study into the aging in vitro (90 hours at 1°C 
under N^ ) of hepatic microsomal suspensions has been reported by 
Hewick and Fouts (1970). The decreases in the aniline type II 
difference spectra paralleled the loss of total haem and of cytochrome
content whilst the type I spectra wore less stable to aging 
in vitro than the previously mentioned components. The decreases 
in type I and type II metabolism were loosely correlated with the 
decreases in the magnitude of the binding spectra of the appropriate 
substrate.
Few authors have, however, investigated either the optimal 
storage conditions or the causes for the decay changes that occur on 
storage. Early work by Leadbeater and Davies (1964) showed that
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storage for 30 days at —40°C was most successful with 10,000 £
supernatant, freeze-dried 10,000 £  supernatant or microsomal
0suspension being less successful. Storage at 0 C was not
recommended as all enzyme activity was lost within 7 days.
Furthermore, the stability varied according to the enzyme parameters
being studied, a finding echoed by tevin jst £l (1969) who also
observed that where storage of microsomes for more than one day is 
absolutely necessary they should be stored as pellets overlaid with 
buffer at -15°C rather than as a suspension or freeze-dried powder. 
Similar findings with regard to cytochrome content have
recently been reported by Wade £t aj^  (1972) and Burke (1973).
Gram et £l (1965), Dacobson et £l (1973) and Archakov and 
Karuzina (1973) have postulated that the inactivation of the microsomal 
MFO system that occurs during incubation at 37°C in the presence 
of an NADPH-generating system is due to peroxidative destruction 
of microsomal lipids which are known to be essential for the full 
realization of this MFO system. Studies by Burke (1973) have 
revealed that the degradative changes that occur on storage of 
hamster hepatic microsomes are also accompanied by increases in 
lipid peroxidation,as measured by malonaldehyde production. Thus, 
it can be postulated that it is the peroxidative damage to the 
microsomal membrane lipids that is intimately involved in the storage 
decay in activity of the MFO system.
Lipid peroxidation is the reaction of oxidative deterioration 
of polyunsaturated lipids. Microsomal membranes contain relatively 
large amounts of polyunsaturated fatty acids in their phospholipids 
and some of the most powerful catalysts that initiate lipid peroxidation, 
namely haemoproteins, are in close molecular proximity to these 
polyunsaturated lipids (Tsppel, 1973)*
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Indeed, it does appear that the system responsible for lipid
peroxidation in microsomal membranes is, or is intimately allied with,
the MFO system itself (see Fig. 2*5). Both NADPH-cytochrome c 
reductase and NADPH- cytochrome bg reductase have been shown to 
be involved in the initial propagation of lipid peroxidation in 
microsomal membranes (Aust et al* 1972; Pederson et al. 1973;
Bidlack et al, 1973) by converting molecular oxygen to an active 
intermediate, probably a superoxide, (a), (Pederson and Aust, 1972). 
The superoxide then reacts with the polyunsaturated membrane lipids 
so producing semistable lipid peroxides, (b), which then commence 
a chain reaction of lipid peroxidation on adjacent lipids, (c), 
(Tappel, 1973). Furthermore, these two enzymes also possess a
peroxidative activity, (d), by which the lipid peroxides are
converted to other radicals which are themselves capable of 
propagating lipid peroxidation within the cyclic system, (e),
(Hrycay and 0*Brien, 1973; Bidlack et al. 1973). The cumulative 
effects of this lipid peroxidation cycle include the loss of 
polyunsaturated lipids and protein from the membrane, loss of 
cytochrome P^gg which is paralleled by decreased activity of the 
MFO system and, finally, ultrastructural changes to the membrane 
itself (Bidlack and Tappel, 1973; Hogbero et al. 1973).
In addition, inactivation of cytochrome P^g^ by both carbon 
tetrachloride and ollylisopropylacetamide may be associated with 
their ability to stimulate microsomal lipid peroxidation (Archakov 
and Karuzina, 1973; Schacter et al, 1973). Interestingly, there 
is little loss of cytochrome bg on storage of microsomal fractions 
(U/ade et al, 1972; Hewick end Fouts, 1970) and neither is there any
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Fig 2,5. Tentative Pathway of Lipid Peroxidation in Hepatic Microsomes
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appreciable loss of cytochrome bg on stimulation of lipid 
peroxidation in vitro (Schacter et al. 1973),
The post-mortem stability of the hepatic MFO system has been 
little studied. An early report by Creaven and Williams (1953) 
indicated that leaving rat carcasses at room temperature for up to 
2 hours reduced the biphenyl 4-hydroxylase level to 50/S that of the 
fresh sample. Most of this fall-off occurred in the first hour 
and if the liver samples obtained after 2 hours were then placed in the 
deep freeze for 24 hours the enzyme activity remained at the 50/= 
level. Similar experiments with rabbit livers showed that the 
loss in enzyme activity was no more than 10/= in the first hour and 
only about 15 - 20y= in three hours, this latter value being 
maintained if the liver was then stored for 24 hours in the deep 
freeze. These latter findings were later confirmed by Leadbeater 
and Davies (1964) who further showed that only 15 - 40^ = of the 
original level of enzyme activity remained after 24 hours ijj, situ 
storage post-mortem but that after this time the rate of inactivation 
was very much lower.
Recent work by Macleod jst ^  (1973) has shown that in situ 
storage post-mortem of rabbit livers under conditions approximating 
to those at human autopsy led to decreases in the levels of type I and 
typo II metabolism, NADPH-cytochrome c (P^gg) reductase and cytochrome 
P^gg in the order of 50 - 80?i=, In livers removed immediately after 
death and kept in ice for the same period of time (4*5 hours) the 
levels of these components remained stable. These findings are in 
agreement with those of Oondorf and Donahue (1970), Macleod et al
(1973) cams to the conclusion that slow cooling of the liver with
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coincidental autolysis was the major cause 6or this post-mortem 
decay. The possibility exists that those autolytic changes may 
well be lipid peroxidative in nature.
For obvious reasons no direct study has been made of the 
post-mortem characteristics of the human hepatic MFO system but 
some useful facts on this topic may be gleaned from one or two 
relevant papers* Thus, Kitagawa and Kamataki (1971) have measured 
type I and type II metabolism in human livers obtained post-mortem 
and then placed at 24°C for various periods of time* By 
extrapolating back from these results they endeavoured to assess 
the levels of metabolism in the living state. This approach did 
not prove very successful due to the widely differing individual 
decay rates. Darby et al (1973) hove reported that the Vmax*
and values for [ureyl- Cj—tolbutamide metabolism were the same^^ c]-t
in human biopsy and post-mortem material obtained less than 4 hours 
after death. This finding implies that no significant autolytic 
alteration in the human hepatic microsomal MFO system is present 
up to 4 hours subsequent to death,
6* Metabolism of Xenobiotics in Perfused Liver* Isolated Cells 
and Tissue Culture Systems
The systems of liver perfusion, isolated cells and tissue cultures 
are potentially a much closer approximation to the state ^  vivo 
than is the use of isolated liver fractions, large because the cell 
architecture is, in these systems, essentially unchanged. However, 
for various technical reasons much less work has been done on the 
application of these systems in studies of MFO activity#
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Metabolism of drugs in perfused liver systems has been reported 
for a number of compounds including benzpyrene (Ouchau et al# 1965), 
chlorpromszine (Cordelli et al* 1969), Imipramine (Cordelli et al. 
1969; Bickel and Minder, 1970), phenylbutazone, antipyrine and 
nortriptyline (von Bahr et al* 1970), Unfortunately, certain 
problems of technique do exist which are serious drawbacks when 
considering the validity of the liver perfusion system. These 
drawbacks include the possible interference from hormones and 
vasoactive factors in the circulating blood (particularly if the 
blood is heterologous), the problem of adequate gas exchange, the 
short time (less than 8 hours) during which each preparation is 
viable, and the difficulty in setting up more than one perfusion at 
a time (see Bartosek et al. 1973), These problems do not arise 
when using cell culture systems and consequently a system of 
cultured adult normal mammalian liver could potentially be the most 
appropriate vitro method with which to study hepatic MFO activity. 
As far as the author is aware no work has been reported on the 
metabolism of xenobiotics in cultures of normal adult mammalian 
liver. Nonetheless, a large number of such studies have been 
performed with other cell systems. Thus Henderson and Dewaide 
(1969), Holtzman ejb ^  (1972) and Cantrell and Bresnick (1972) have 
all reported drug metabolism in freshly isolated hepetocytes,
Cantrell and Bresnick (1972) also finding inducible drug metabolism 
in non-parenchymal cells. Cultures of human embryonic lung have 
been shown to metabolize carbaryl (Baron and Locke, 1970) and 
dimethoate (North and Menzer, 1972), the metabolite pattern of the 
former being similar to that found in the intact animal (Borough,
1970), The metabolic profile of dimethoate varied according to
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the cell-line studied (North and Menzer, 1972). A cloned line 
of hepatoma cells conjugates both jgj-aminophenol and ^ nitrophenol 
with glucuronic acid (Dybing, 1972) while primary cultures of 
chick embryo liver demethylate both aminopyrine (Poland and Kappas,
1971) and chlorcyclizine (Poland and Kappas, 1973). Organ cultures 
of chick and rat embryonic liver are capable of conjugating 
O|-aminophenol (Dutton, 1973).
A lot of work has been carried out into the metabolism of 
polycyclic hydrocarbons by cells in culture especially with regard 
to their carcinogenic potential (Gelboin and tilaibol, 1971). A 
large number of different culture systems have been used including 
human lymphocytes (Kellerman et al, 1973), mouse embryo (Sims, 1970), 
monkey kidney, human foetal lung (Diamond, 1971) and many others 
(Diamond, 1971; Huberman et al* 1971; Huberman and Sachs, 1973),
By using such a wide spectrum of culture systems it has been found 
that in general the susceptibility of cells in culture to the 
cytotoxic effects of the hydrocarbon Is related to the amount of 
water-soluble metabolites produced from the hydrocarbon by the cells 
themselves (Huberman et al. 1971; Diamond, 1971; Gelboin and 
Weibel, 1971).
The enzyme largely responsible for the oxidative metabolism of 
the polycyclic hydrocarbons, aryl hydrocarbon hydroxylase, has been 
studied in great detail in foetal rodent cell and organ culture.
Thus, aryl hydrocarbon hydroxylase activity in foetal rot liver 
explants has been shown to be inducible by 3-MC (Burki et al. 1971), 
flavones (Cutroneo et al. 1972) and phénobarbital (Cutroneo and 
Bresnick, 1973), similar findings having also been described for 
foetal rodent liver cells in short-term culture (Gielen and Nebert,
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1971 a, b, c, 1972), Indeed much of the present knowledge 
regarding the early responses of cells to microsomal enzyme inducers 
and the fate of the inducer has been derived from this work of Nebert 
end co-workers (Nebert and Bausserman, 1970 a, b; Gielen and Nebert, 
1971 a, b, 1972),
Nebert (1973) has suggested that foetal coll cultures, not 
necessarily from foetal liver, may prove useful in predicting toxic 
damage due to drugs in the intaCt foetus ijn utero, although the 
importance of metabolic transformation of the drug by the mother 
must also be studied. As Holtzman et al (1972) have pointed out the 
embryonic liver cells grow rapidly and are relatively undifferentiated, 
having little endoplasmic reticulum. For this reason they may be a 
poor model with which to study drug metabolism in the relatively 
stable adult hepatocyte. Consequently, adult mammalian liver 
cells in culture offer a much better model with which to study 
the mechanisms and patterns of drug metabolism and hepatotoxicity 
in the intact adult animal even though the procedures for obtaining 
such cultures are more difficult and unreliable.
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CHAPTER 3, MATERIALS AND METHODS
MATERIALS
1. Animals and Phenobarbitone Pretreatment
Male rats of the Wistar/Albino strain were used throughout 
this work; their weights varied from 150 - 350 g, and thoy were 
bred and maintained in the University Animal House, All animals 
were allowed free access to food and water, the feed being Spiller’s 
No, 1 Laboratory Diet, ’Sterolit* (Engelhard, New 3ersey) was used 
as bedding to eliminate any possible interference from enzyme induction 
caused by wood shavings (Fujii et al, 1968),
Pretreatment with phenobarbitone was administered for 12 days 
prior to sacrifice, in tho form of a 0,1% (W/V) solution of 
phenobarbitone sodium in the drinking water,
!« Chemicals and Instruments
The suppliers of certain chemicals mentioned in this work are 
listed in the Appendix* All other chemicals and solvents used were 
of the highest grade obtainable. Before use, biphenyl was purified 
by recrystalization (twice) from 96% ethanol, SKF 525-A 
(2-diBthylaminoethyl-2,2-diphenylvalerate HCl) was a gift from the 
Smith, Kline and French Laboratories Ltd. (Welwyn Garden City) and 
imipramine-HCl was a gift from Biorex Ltd.
pH measurements were made using an EIL pH meter, model 7030,
For low speed centrifugation an MSE Minor bench centrifuge and Mistral 
6L were used, whereas for high speed centrifugation an MSE High Speed 
18 and Superspeed SO were employed; all centrifugations were carried
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out at 4°C# Spectrophotometers used comprised the Pye-Unicam 
SP 1800 and Perkin Elmer 356 for high resolution measurements and 
the Pyo Unicam SP 500 and 600 and Cecil CE 272 for routine measurement 
of colour production. When small scale enzyme assays were used, 
optical measurements were made using the micro-cell carriage and 
optical system modification on the Pye-Unicam SP 500.
Enzyme essays were carried out at 37°C in a shaking water bath 
(Mickle Engineering Co., Gomshall, Surrey) the tubes being shaken 
at a speed of 75 oscillations/minute. Sample mixing was achieved 
by use of a ’Whirlimixer* and extraction procedures involved the 
use of a rotary shaker built in the department*
METHODS,
A, Preparation of Liver Fractions 
Preparation of Liver Homogenate
Rats were killed between 9,00 a,m* and 11,00 a,m, so as to 
minimize any differences caused by diurnal variation in drug 
metabolism (Burke et al, 1972), The animals were killed by 
cervical dislocation and the livers rapidly removed into cold (4°C) 
1,15% (w/v) KCl* After removal of excess blood and mesentery, the 
liver was weighed in 10 ml. KCl solution and this was followed 
by rough sciosor-mincing. The contents of the beaker were then 
transferred to a cold Potter-Elvejhem homogenizer and homogenized by 
3 up-and-down strokes of the Teflon plunger operated by an electric 
drill at max, speed. The homogenate was diluted with KCl solution 
such that 1 ml* of homogenate contained the equivalent of 250 mg, 
liver, (From the mincing stage onwards all operations were carried 
out at 4°C),
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Human liver specimens^ due to their more fibrous nature* were 
homogenized in a different manner* After transfer to the 
Potter-Elvejhem homogenizer the mince was first subjected to three 
15 second bursts at max, speed with a *Polytron* homogenizer 
(Northern Media Supply Ltd.) followed by homogenization and dilution 
as outlined above.
2» Preparation of Post Mitochondrial Supernatant (PMS)
The 25% (w/v) homogenate, obtained as outlined above* was 
transferred to a 50 ml. polypropylene centrifuge tube and centrifuged
at 10,000 J2, av. for 20 minutes (11,000 r.p.m** 8 x 50 ml.rotor, High
Speed 18 centrifuge). As recommended by Bjorntorp e^ ^  (1965), 
human liver homogenates were centrifuged at 12,000 ^  av# for 
20 minutes (14,000 r.p.m., 10 % 10 ml,rotor, Superspeed 50 centrifuge) 
so as to minimize lysosomal contamination in the ensuing microsomal 
fraction. The supernatant derived from these spins is designated 
the ’post mitochondrial supernatant* (PMS). . „
3, Preparation of ’Normal* Microsomes
The resulting PMS was transferred to a 10 ml. polypropylene 
centrifuge tube and centrifuged at 105,000 ^  av. for 60 minutes
(40,000 r.p.m., 10 x 10 ml# rotor, Superspeed 50 centrifuge). After
this time the supernatant was discarded and the pellet washed by 
resuspension in 1.15% (w/v) KCl using a single complete stroke of 
the glass-Teflon homogenizer and further centrifugation at 105,000 ^  a.v, 
for 60 minutes. The pellet was finally resuspendod in 0.1M phosphate 
buffer pH 7*4: glycerol (4:1 v/v), to a final concentration of 250 mg. 
liver equivalent per ml. of microsomal suspension.
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4# Preparation of ^ cid’ Microsomes
To an aliquot of the PMS was added sufficient 0.2M acetate 
buffer pH 4,0 to lower the pH to 5*4* In early experiments a 
pH meter was used to monitor the pH changes; however, in later 
experiments it was found that 0,075 ml* of the acetate buffer 
per ml* of PMS was sufficient to lower the pH to 5*4* In all 
the experiments (approx* 100 PMS samples) the pH of the PMS, 
using unbuffered 1*15% (w/v) KCl as the homogenizing medium, 
lay in the range 6*70 ~ 6*85* This same pH range was found in 
the limited number of human liver PMS tested*
The aggregated microsomes were collected by centrifugation (see 
Chap, 4) and the pellet was washed by resuspension in 1,15% (w/v)
KCl: glycerol (4:1 v/v), readjustment to pH 5*4 if necessary end
recentrifugation* The final pellet was resuspended in 0*1M 
phosphate buffer pH 7,4: glycerol (4:1 v/v), to a final concentration 
of 250 mg* liver equivalent per ml* of microsomal suspension#
In some experiments 0.2M citrate buffer pH 4*0 or 0*1W HCl 
was used in place of the acetate buffer (see Chap, 4),
8* Assay Methods 
1 * Measurement of Protein (Goodwin end Choi* 1970)
This method, originally described for serum proteins, is based 
on the reaction of lysine residues in the protein with trinitrobenzene* 
sulphonic acid (TNBS), which at pH 10*5 and in the presence of 
sulphite results in the formation of a highly coloured complex with 
absorption maximum at 420 nm. This method was chosen in preference
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to that of Lowry et al (1959) due to its ease of operation and 
obeyance of Beer’s Law up to at least 250|u g» protein per ml* 
incubation mixture*
To 0,5 ml* diluted sample (dilutions: homogenate 1/500, PMS
1/200, microsomes 1/50, all in 0*1M sodium tetraborate) was added 
3ml. of a freshly-prepared mixture of equal volumes of 0,05%
(w/v) TNBS, 0.1M sodium tetraborate and 0*05M sodium sulphite 
(the TNBS was stored in the dark at 4°C and the sodium sulphite 
was freshly prepared each day). The contents of each tube 
wore mixed and the tubes placed at 70°C for 15 minutes. After 
cooling, the samples were read at 420 nm* against a standard of 
bovine serum albumin (5Q0^g/ml in 0,1M sodium tetraborate) which had 
been similarly treated*
Extraction and Assay of RNA (Hatcher and Goldstein, 1969)
In this procedure the nucleic acids are precipitated with 
cadmium ions, followed by washing and hydrolysis, the hydrolysate 
then being assayed for RNA by a modified orcinol reaction*
To 1 ml# of the microsomal suspension was added an equal 
volume of 1M cadmium chloride. After mixing, the tubes were placed 
at 37°C for 10 minutes. The precipitate was collected by 
centrifugation and the supernatant discarded. The pellet was 
washed twice in 0*1M cadmium chloride, again followed by standing 
at 37°C for 10 minutes and centrifuging.
3 ml, of 0,1N HCl was then added to the pellet and the tube was 
placed in a boiling-water bath for 20 minutes to achieve complete 
hydrolysis* After cooling, 1 ml, of hydrolysate was transferred to
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another tube, followed by 1 ml* of 4% (w/v) orcinol in ethanol; 
1-butanol (7 ; 3 v/v) and finally 3 ml. of 0*5% (w/v) ferric chloride 
in cone* HCl was added* The tubes were returned to the boiling-water 
bath for a further 30 minutes and after cooling the contents of each 
tube were read at 660 nm. against a similarly-treated standard 
containing lOOjJig* hydrolysed RNA (Torula yeast) per ml* of 
Q*1N HCl.
3. Measurement of Total Haem Levels (Gilbert. 1972)
Two glass cuvettes were set up each containing 1 ml, of 
0.1M NaOH, 1 ml* of 20% (v/v) aq* pyridine and 1 ml* microsomal 
suspension and, after mixing, a base line was recorded between 
490 - 600 nm* 0*03 ml, of 3mM potassium ferricyanide was added 
to the reference cuvette and an equal volume of water and approx,
1 mg, sodium dithionite was added to the test cuvette. The spectrum
was again recorded after mixing and the total haem level determined 
using the extinction coefficient of 32*4 cm mM for the 0,0* 
difference between 557 and 575 nm* (Omura and Sato, 1954),
4* Measurement of Malonaldehyde (Slater and Sawyer. 1972)
To 2 ml* microsomal suspension was added 2 mi* 10% (w/v) TCA and 
after mixing the tubes were left at 4°C for 30 minutes. The tubes 
wore centrifuged to remove the denatured protein and the malonaldehyde 
assayed by adding 2 ml. of 0,67% (w/v) thiobarbituric acid to 2 ml, 
of the deproteinized supernatant and placing in a boiling-water 
bath for 10 minutes. After cooling, the colours produced were 
read at 535 nm, against a similarly-treated malonaldehyde standard
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of 2.5 n mole/mi* in 5% (w/v) TCA# The standard was prepared by 
diluting 1, 1, 3, S-tetraethoxypropane in 5% (w/v) TCA; this 
resulted in the quantitative production of malonaldehyde as the 
bis-diethyl acetal.
5* Measurement of Cytochrome bg and P^gp
Cytochrome bg levels were measured according to Omura and Sato 
(1964)# Briefly, 2 cuvettes were set up each containing 2 ml*
0.1M phosphate buffer pH 7*4 and 1 ml, microsomal suspension# A few 
grains of NAOH (disodium salt) were added to the test cuvette and the 
spectrum recorded between 390 - 500 nm* Cytochrome bg was 
quantitated as the 0*0, difference between 426 nm, (peak) and 410 nm# 
(trough)# In some experiments this 0*0* difference was converted 
to concentration units using the extinction coefficient of 161 cm  ^
mM**^  (Omura and Sato, 1964),
The measurement of cytochrome P^gp was carried out using one of 
2 methods, the method chosen depending on the particular subcellular 
fraction being studied# When rat liver microsomes were under 
investigation the method was essentially that of Omura and Sato (1964) 
and was performed in the same cuvettes as used for the cytochrome bg 
estimation* A few grains of sodium dithionite were added to each 
cuvette and carbon monoxide was bubbled through the contents of the 
test cuvette for 30 seconds. The spectrum was again recorded from 
390 - 500 nm*
The cytochrome P^gp levels of human liver microsomes, rat liver 
homogenate and PMS were measured by the method of Greim as described 
by Schoene et al (1972)* In this assay the contents of both cuvettes
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were bubbled with carbon monoxide for 30 seconds and sodium dithionite 
was added to the test cuvette only; the spectrum between 390 — 500 nm, 
was then recorded. In this way the marked interference by haemoglobin 
in such fractions could be eliminated. It has been reported (Schoene 
et al, 1972) that both methods for cytochrome P^gg estimation give 
identical results.
The cytochrome P^gp level was quantitated as the 0,0, difference 
between 450 - 490 nm, and in some instances the extinction coefficient 
of 91 cmT^  was also used (Omura end Sato, 1964),
Assay for NADPH-Gvtochrome c Reductase Activity 
(williams end Kamin, 1962)
The rate of reduction of cytochrome c was measured in a double­
beam spectrophotometer using an appropriate blank.
Into each of two cuvettes was added 1 ml# of 3 mM potassium 
ferricyanide, 1ml, of cytochrome c solution (1,85 mg/ml), 0,6 ml,
0,1M phosphate buffer pH 7,4 (0,8 ml, in reference cuvette), 0*1 ml, 
of glucose-6-phosphate dehydrogenase solution (10 I,U,/ml) and 0,1 ml, 
microsomal suspension. The reaction was started by the forceful 
addition of 0,2 ml, of an NADPH-generating system (2 ^  mole NADP,
10^mole G-6-P, 10^mole MgClg) into the test cuvette. The increase 
in absorbance at 550 nm, was then recorded and the enzyme activity 
determined from the initial velocity using an extinction coefficient 
for reduced cytochrome c of 27,7 cm  ^mM"'^  (Williams and Kamin,
1962),
This assay procedure was adapted for use in a single cell dual- 
wavelength spectrophotometer (Perkin Elmer 356) thus eliminating the
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need for a reference cuvette, A preliminary experiment involving 
repeat wavelength scans showed 650 nm. to be a suitable reference 
wavelength for this assay (Fig, 3,1), Both procedures gave 
identical results (Fig, 3*2),
Measurement of Ethvlmorohine, Aminopvrine and Imipramine 
N-demethvlase Activity
Ethylmorphine, aminopyrine and imipramine are metabolized in vitro 
to the N-demethylated derivatives, the methyl group being lost as 
formaldehyde which, after trapping with semicarbazide, can be 
measured by the Nash reaction (Nash, 1953),
The incubation system used is outlined below:-
Control Test Standard
Microsomal suspension--------------- <-------- 0,3 ml
0,1M phosphate buffer pH 7,4 0,9 ml 0,9 ml 0,7 ml
2% Semicarbazide buffered to
pH 7,4---------------------------- <-------  0,2 ml--------- — >
Glucose-G-phosphate dehydrogenase 0,2 ml
(10 I.y,/ml)
NADP (lOu mole/ml) ^
0,2 mlG—6—P (50^mole/ml)
MgClg (50^ 4 mole/ml)
Pre-equilibration (2 min, at 37°C)
Substrate (75ptmolo/ml) 0,2 ml 0,2 ml 0,2 ml
/ / sFormaldehyde standard (lu mole/ml) — — 0,2 ml
■5^ denotes added after incubation
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Fig• 3.1. NADPH-Cytochrome c Reductase Activity - Wavelength Scan at 
Various Incubation Times
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The incubation time was 10 min, at 37°C after which time the
reaction was stopped by the addition of 1 ml* 15/S (w/v) ZnSO^*
Substrate and standard were added to appropriate tubes followed
by 1 ml* sat. BaCOH)^*
The tubes were centrifuged at 2,000 r.p.m* for 15 minutes and
to 2 ml. of the supernatant was added 2 ml, of double-strength Nash
reagent (4M aq. ammonium acetate containing 0*4# (v/v) acetyl-acetone)*
oThe tubes were incubated for 40 min, at 37 C and, after cooling, 
the contents of each tube were read at 412 nm*
8, Measurement of Aniline 4-Hydroxylase Activity
The product of this enzymic reaction, 4-aminophenol, can be 
measured by its reaction with phenol in alkaline solution to 
yield a measurable blue colour* The presence of non-microsomal 
fractions in the incubation system in some way interferes with 
this colour reaction and an extraction procedure is required 
to eliminate this problem (Chhabra et al* 1972)*
The incubation system used for this assay is outlined below;*
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Control Tost Standard
Microsomal suspension-------------- <-------  0*5 ml
0*1M phosphate buffer pH 7*4 0.5 ml 0*6 ml 0*4 ml
GlucosB-6-phosphatB dehydrogenase <-------  0*2 ml  >
(10 I.U*/ml)
NADP (10^ mole/ml)^
G-6-P (50^ mole/ml) ^
MgClg (50^mole/ml)
Pre-equilibration (2 min* at 37°C)
0.2 ml
Aniline (40^ mole/ml) 0*5 ml 0*5 ml 0*5 ml
4-Aminophenol standard
(0*5^ mole/ml) - *- 0*2 ml
* denotes added after incubation
Incubation time was 20 min* at 37°C* When microsomes were used as 
the enzyme source the reaction was terminated with 2 ml. 15# (w/v) 
TCA, substrate and standard added os appropriate, and, after 
mixing, the tubes were centrifuged at 2,000 r.p.m, for 15 min* To 
2 ml, of the supernatant was added 2 ml* 1M sodium carbonate and 
2 ml, 0,25 N NaOH containing 5# (w/v) phenol* After mixing, the 
tubes were left for 1 hour prior to reading at 620 nm*
When this enzyme was assayed in the presence of non-microsomal 
material the following procedure was adopted* The enzyme reaction 
was terminated by plunging the tubes into ice-water. Approx Ig* 
solid WaCl was added to each tube and substrate orVd standard added
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OS appropriate, 15 ml. of 1,5# (v/v) iso-amyl alcohol in diethyl 
ethor was addod and the contents of the incubation mixture extracted 
for 30 minutes. The tubes were centrifuged to separate the layers 
and 10 ml. of the other phase was back-extracted with 4 ml. of 
1# (w/v) phenol in 0.5M potassium triphosphate for 30 minutes.
The phases were again separated and 1 hour after commencing the final 
extraction the colours in the aqueous layers were read at 620 nm,
9. Measurement of 4-Chloro N-Methvlanillne N-Demethvlase Activity
In this assay the product, 4-chloraniline, is measured by its 
reaction with 4-dimothylaminobenzaldehyde in acid solution (Kupfer 
and Druggeman, 1969),
The incubation system used is outlined below
Control Test Standard
Microsomal suspension <--------- 0,3 ml----------- >
O.IFi phosphate buffer pH 7,4 1,2 ml 1.2 ml 1.1 ml
Glucase-6-phosphate dehydrogenase <-------- 0,2 ml--- ------- >
(10 I.U,/ml)
NADP (lOju(mole/ml)
G-G-P (50^mole/ml)
MgClg (SO^mole/ml) ,
0.2 ml
Pre-equilibration (2 min. at 37 C)
4-Chloro N-methylaniline
(30|LI mole/ml) 0.1 ml 0,1 ml 0.1 ml
4-Chloraniline (l^ mole/ml) - - 0.1 ml
denotes added after incubation \
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Incubation time was 20 min, at 37°C* after which time the reaction 
was terminated by plunging the tubes into a boiling-water bath 
for 1 min. Substrate and standard were added as appropriate 
followed by 3 ml, 2# (u/v) d-dimethylaminobenzaldehyde in 1N HgSD^, 
The tubes were then centrifuged at 2,000 r,p,m, far 15 minutes and 
left overnight prior to reading at 445 nm.
10, Inhibition of Hepatic MFQ Activity In Vitro
Two inhibitors of microsomal WFO activity were used in this 
work;— SKF 525-A and carbon monoxide, SKF S25-A was used at a 
final concentration of 10 M in the incubation mixture. Carbon 
monoxide was administered to the incubation mixture by gentle 
bubbling from a cylinder for 10 minutes prior to the incubation} 
during the incubation itself the gassed tubs was kept tightly 
stoppered.
11• Observation and Quantitation of Spectrally Apparent Substrate — 
Microsome Interactions
The microsomal suspension was diluted in 0,1M phosphate buffer 
pH 7,4: glycerol (4:1 v/v) to a final concentration of 2 mg, 
protein/ml, 2,5 ml. of this diluted suspension was placed into each 
of 2 cuvettes which were then stoppered with *Suba Seals* (Gallcnkamp), 
These cuvettes were placed in a doublo-beam spectrophotometer and 
a bass-line recorded between 350 - 500 nm. The substrate* 
dissolved either in distilled water or absolute ethanol* was added* 
from a microsyringe, through the *Suba Seal* into the microsomal 
suspension} an equivalent volume of solvent was added to the
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reference cuvette* The spectrum was again recorded. For each
concentration of substrate present in the cuvette the maximal 0*D#
difference (compensated for base-line) between trough and peak
was calculated, A double reciprocal plot of 0,0. difference
against substrate concentration was then drawn and the binding
constant (K ) calculated from the intercept on the abscissa (Fig# 3,2), s
As can be seen this graph is analogous to a Lineweaver-Burk
plot for enzyme-catalysed reactions. Similarly the definition of
K is analogous to that of the Michaelie constant, namely
i< is defined as that concentration of substrate which produces s
half the maximal 0,D, difference for that particular substrate- 
microsome interaction,
12, Analysis of Results
Whenever 3 or more samples were being assessed the results 
are given as mean ^  SEM, Statistical analysis was carried out 
using Student*s t-test. When comparing microsomes prepared by 
normal centrifugation and isoelectric precipitation, a paired-sample 
t-test was adopted (Campbell, 1967),
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Fig, 3.3. Double Reciprocal Plot to Determine Binding Constant.
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CHAPTER 4, RESULTS
A* Scale-Down of Assays for the Measurement of Hepatic Microsomal 
MFO Activity
In the initial period of this investigation it was quickly 
realized that small-scale enzyme assays were essential when dealing 
with small samples of human liver biopsy material end samples of 
cultured liver tissue.
Consequently, various experiments were performed in attempts 
to improve method sensitivity using rat liver and the existing 
spectrophotomotric methods of product measurement. The results 
from these various experiments (Table 4.1) showed that decreasing 
the level of microsomo-containing fraction from 0*3 — 0.5 ml.(approx.
1.5 - 2.5 mg. protein) to 0*1 ml (approx. 0.5 mg. protein) and 
halving the volumes of the other incubation components in a total 
volume of 1 ml. with subsequent halving of volumes for the ensuing 
extractions and colour measurements gave results totally comparable 
to those obtained using the conventional assay systems as described 
in Chapter 3. The overall improvement in sensitivity produced in 
this way was in the order of 3 — 5 fold.
Furthermore, scale-down in the NADPH-cytochrome c reductase assay 
could be achieved by means of the single-cell dual-wavelength 
modification as described in Chapter 3,
It provided impossible, however, to scale-down the cytochrome 
P^gQ estimation without loss of accuracy and sensitivity.
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B. The Isolation of Hepatic Microsomes - A Comparison of Isoelectric 
Precipitation with the Conventional Centrifugation Procedure
1* Effect of Isoelectric Precipitation on Microsomal 
Protein Yield
From preliminary studies it soon became apparent that a major 
difference between IP and conventional centrifugation techniques lay 
in the increased yield of protein found in *acid* microsomes* 
Accordingly, this problem was studied initially using various acid 
précipitants^ the results are shown in Table 4*2* 50 — 60^ extra
protein is found in the ♦acid* preparations which is not accompanied 
by any increase in the *true* microsoms content as measured by the 
recovery of P^gQ* It appears that this increased protein yield is 
independent of the nature of the acid precipitant in that citrate 
buffer or dilute HCl can be used in place of the acetate buffer 
(Table 4*2), but is related to the lowering of the pH to 5*4,
These findings imply that the increased protein content found in 
♦acid* microsomes is non-microsomal and is probably derived from 
proteins normally located in what is termed, in conventional 
centrifugation parlance, the cytosol i.e. the 105,000 g* supernatant# 
This extra protein is non—ribosomal as judged from a comparison of the 
RNA levels in *acid* and 'normal* microsomes (Table 4*3)* This 
extra protein is also not derived from haemoglobin os shown by a lack 
of any appreciable peak at 420 nm. in the spectrum for (Fig* 4*1)*
Also, the protein content of *acid* microsomes approximates to that 
found in unwashed microsomes prepared by normal means (Table 4*4).
2* Centrifugation Requirements of Acid-Precipitated Microsomes 
During the preliminary studies the *acid* microsomes were 
harvested by the use of a bench centrifuge maintained at 4°C operated
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at max. speed (approx. 2,000 av.). The effects of varying the time
of centrifugation at this speed on the resulting pellet composition 
are shown in Table 4.5.
Two facts emerge from these results. Firstly, quantitative 
harvesting of *acid* microsomes is complete after 5 minutes 
centrifugation and, secondly, the *acid' microsomes remain stable 
(as judged by bg and levels) during the centrifugation procedure.
During this centrifugation procedure there was no variation in the 
protein content of the microsomal pellets.
After the completion of this work it was felt desirable to 
obtain a tighter-packed microsomal pellet so as to simplify removal 
of the overlying supernatant, and this was achieved by centrifuging 
the *acid* microsomal suspensions at 10,000 av. for 10 minutes.
All results hence refer to *acid* microsomes harvested in such a 
manner.
All comparative results between *acid* and ’normal’ microsomes 
are on a paired basis i.e. both ’acid’ and ’normal* preparations are 
derived from the same liver.
From these studies a standardized isolation scheme for microsomes 
using IP was adopted and this is outlined below;—
68
P.M#S,
(from livor homogenate (25^ w/v) in 1*15#! (w/v) KCl)
pH lowered to 5,4 with 
acetate buffer (o#2M, pH 4,0)
Discard*— Supernatant
Discard^---
Centrifuge 10*000 £  av, (10 minutes)
V
Pollet
Resuspend In 1*15^ 1 (w/v) 
KCl: glycerol (4:1 v/v)
Re-centrifuge (10,000 ^  av 
10 min#)
Pellet
Resuspend in 0,1 f1 phosphate buffer 
pH 7,4: glycerol (4:1 v/v)
69
3# MFO Capabilities of Hepatic *Acld' Microsomes
Table 4*6 summarizes the results relevant to this study* *Acid* 
microsomes are identical to *normal* microsomes in regard to their 
capability to metabolize both type I (aminopyrine) and type II 
(aniline) drug substrates* Furthermore, the levels of and bg
ore similar in both microsomal preparations* The spectrophotomotric 
appearance of both cytochromes is unaltered by acid treatment (Fig* 4*1),
NADPH-cytochrome c reductase activity ^  vitro is believed to 
reflect NADPH-cytochrome P^^Q reductase activity although the 
absolute levels for these enzymes are greatly different (see Chap. 2)* 
This being so, it is interesting to note that *acid* and *normal* 
microsomes contain equivalent levels of NADPH-cytochrome c reductase 
activity*
Furthermore, pre-treatment of the rats with phenobarfaitone raises 
the hepatic levels of cytochrome bg and P^gg, type I and typo II 
metabolic activity to the same extent in *ocid* microsomes as in 
*normal* microsomes (Table 4*7)* This is more clearly illustrated in 
Table 4.8 in which the percentage increases in the haemoproteins and 
Type I and type II metabolic activity after induction are recorded*
All 4 parameters studied show similar increases in both *normal* and 
*acid* microsomes. The extent of the increases in type I and type II 
metabolism follows that of the cytochrome P^gg more closely than that 
of cytochrome bg.
It is interesting to note that the extra protein present in 
*acid* microsomes from control rat liver mentioned earlier is absent 
in similar preparations derived from phenobarbitone-induced rat liver 
(Table 4*7)* The reasons for this are not known although it may be
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that phenobarbitone induction of rat livor leads to an absolute 
decrease of cytoplasmic protein in addition to its obvious relative 
decrease compared to microsomal protein* Alternatively it may be 
that excess of acid buffer may be present in control *acid* preparations 
which accounts for tho aggregation of cytoplasmic protein* Obviously, 
in induced *acid* preparations this excess of acid buffer is utilized 
in aggregating the extra microsomal protein that is present, so loading 
to a negligible cytoplasmic protein contamination*
4* Observation and Quantitation of Spectrallv-Apoarent
Substrate-Microsome Interactions
A representative substrate for each type of binding class was 
used, namely biphenyl (typo I) and aniline (type II),
The type of binding for each substrate was unaltered when the 
microsomes were prepared by IP from both induced and control rat 
livers, biphenyl remaining type I and aniline remaining type II 
(Fig, 4,2 and 4,3), The magnitude of the 0,D, change at any 
concentration of substrate is slightly less in *acid* microsomes prepared 
from control rat liver than in corresponding *normal* microsomes due 
to their differing protein content, .However, when the difference 
spectrum is redrawn on a g, liver basis the two preparations yield 
identical results (Fig, 4,4),
Table 4*9 shows that the affinity of binding of microsomes for 
the substrate (both type I and type II) as measured by the K is 
unaltered when the microsomes are prepared by IP, If anything, the 
affinity for aniline is greater in *acld* microsomes as compared to 
’normal* microsomes from control and induced rat liver*
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5, Low-Spesd Sedimentation of Microsomes by Means of IP of 
the Post-Nuclear Supernatant of Rat Liver Homogenate
The success of IP on the PMS of rat liver prompted the question*
Gan microsomes be sedimonted at low speed using IP on rat liver 
homogenate? If this were possible it could prove valuable as an 
initial step in a scheme for the clinical analysis of liver function 
in human biopsy material using MFO activity as the organ-specific 
parameter. It was decided to assess this possibility using rat 
liver homogenate which had been ’cleaned up* of nuclei by low-speed 
(goo gi^# av.) centrifugation for 5 minutes at 4°C in a bench 
centrifuge. Acid precipitation was then attempted on this post-nuclear 
homogenate (*acid homogenate*).
From preliminary studies certain problems regarding assay 
conditions were countered. Firstly, bg levels could not be measured 
in crude homogenate or their low-speed-derived fractions due to the 
presence of .a large excess of mitochondrial cytochromes thereby 
completely masking the cytochrome bg difference spectrum.
Also due to this mitochondrial contamination was the greatly 
increased cofactor levels required for optimal activity of both 
aminopyrine N-demethylase and aniline hydroxylase when assayed in 
homogenate, asr shown in Fig. 4.5.
Table 4.10 gives the levels of protein, P^gg and type I and type II 
metabolic activity in various rot hepatic fractions - homogonate,
*acid homogenate*, PMS and *acid* microsomes. These results are 
also shown, in percentage form, in Tables 4.11 and 4.12,
These results clearly show that IP of liver homogenate yields a 
microsomal fraction comparable to other more commonly prepared fractions
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with regard to both its P^gp content and its drug-metabolizing 
capability, thereby making this method of low-speed aggregation 
of hepatic microsomes a suitable alternative in the absence of high-speed 
centrifugation facilities. Indeed, where a crude microsomal fraction 
is adequate for a particular need, the *acid homogenate* fraction, 
due to its probable higher P^_p content and speed of preparation, 
would appear to be a better proposition than the use of the PMS.
C. Storage Characteristics of the Hepatic MFO System
The storage characteristics of the rat hepatic microsomal MFO system 
were compared in 3 systems, vizs-
1. Storage of microsomal fractions
2. Storage of solid liver
3* Storage of the liver in situ subsequent to death
The aims of this study ware two-fold: firstly, to establish the
optimal storage conditions for valuable material such as human biopsy 
and p.m. samples and to study the effect of in situ p.m. autolysis.
The second aim was to utilize these storage characteristics as a 
probe in understanding the complex structural relationships of this 
membrane-bound MFO system.
1 « Storage of Hepatic Microsomal Fractions
In this experiment microsomal fractions were prepared fay
conventional centrifugation and IP and stored as washed pellets and 
suspensions both at 4°C and 020°C. To ensure a sufficient quantity
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of material livers from 24 rats uoro homogonizod and the homogenats 
pooled; thus each point on tho following graphs represents a single 
measurement. The samples stored at -20°C were slow-thawed by placing 
in ice#
At various time intervals the activities of aminopyrine 
N-demethylase, biphenyl 4-hydroxylase, aniline 4-hydroxylase and 
NADPH-cytochrome c reductase were measured together with the 
corresponding levels of and malonaldehyde in each fraction#
The level of malonaldehyde was taken to represent the level of lipid 
peroxidation and hence the state of membrane integrity at any chosen 
time.
The decay curves for the activities of aminopyrine N-domsthylase, 
biphenyl 4- hydroxylase, aniline 4-hydroxylase and NADPH-cytochrome c 
reductase and the level of P^gg ere shown in Fig* 4*6 - 4*10 
respectively, whilst the increase in malonaldehyde levels is shown in
Fig# 4*11* Whilst it is readily accepted that each point, being a 
single measurement, may contain some error, it is nonetheless felt that 
these graphs do enable valid comparisons of decay characteristics of 
the various fractions to be made*
The first observation that can be made from these results is that 
drug-metabolizing activity of stored microsomes is best maintained by 
storage at —20°C irrespective of the method of preparation of, or 
storage state of the microsomes* In general, storage of microsomes 
at -20°C in the form of pellets leads to a more stable preparation than 
microsomes stored as a suspension# This storage state-dependent 
activity is more marked in the case of aminopyrine N-demcthyiaso as 
compared to the other enzymes and P^gg*
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Concomitant with this decay of drug-metabolizing activity on 
storage is an increase in the malonaldehyde levels (Fig, 4*11); 
for each microsomal preparation increase in the malonaldehyde 
content roughly parallels the decrease in enzyme activity and 
content* This inverse relationship of enzyme activity and P^gQ 
content to the level of malonaldehyde is illustrated in Fig# 4,12 — 4,15 
using each fraction of the *normal microsomes* series; where the 
enzyme activity after 162 hours storage is between 0 - 20^ b that of 
the fresh sample (Fig# 4,12 and 4,14) the malonaldehyde level is between 
700 - 1600/O that of the starting value; where the enzyme activity 
after a similar time is between 40 — 90/ithat of the fresh sample 
(Fig, 4,13 and 4.15) the malonaldehyde level is correspondingly low 
(120 - 140/5 that of the starting value). These results indicate 
that membrane integrity plays an important role in determining the 
in vitro efficiency of the hepatic microsomal flFO system#
Another fact to emerge from Fig, 4.6 - 4,11 is that *acid* 
microsomes are more labile than *normal♦ microsomes on storage*
The initial ( 20 hours) decay in enzyme activity and P^gg content is 
more rapid in *ocid* microsomes and, once again, this more rapid 
fall-off is associated with elevated malonaldehyde levels which are 
higher than those in ’normal* microsomes. After these initial 
activity reductions the resulting rates of decay of both ’normal and 
*acid* microsomes are similar for all the parameters studied but, 
due to the more rapid initial fall-off, the final (162 hours) levels 
of enzyme activity and P^ .gg content are lower in ’acid* microsomes#
It would appear that although *acid* microsomes ore initially 
comparable to ’normal* microsomes with regard to their drug metabolizing 
potential the acid treatment itself activates their decay on storage;
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this is substantiated by the approx. 100% extra malonaldehyde present 
in fresh ’acid’ microsomes when compared to ’normal* microsomes 
(Table 4.13),
Another fact to emerge from Fig* 4,12 - 4,15 is that the decay 
in metabolism of biphenyl, a type I substrate, follows that of 
aniline (a type II compound) more closely than that of aminopyrine 
(another type I compound). Furthermore, in the initial stages 
decay in MADPH-cytochrome c reductase follows that of aminopyrine 
N-demethylase more closely than that of aniline 4-hydroxylase whilst 
in the later stages this is reversed, the reductase activity more 
closely following the aniline 4-hydroxylase activity.
2. Storage of Solid Liver
Short term (approx* 1 week) storage of solid liver placed at 
-40°C immediately after excision from the animal maintained the 
activity of the microsomal MFO system at virtually 100% that of fresh 
liver; this is illustrated in Fig, 4,16* Both the type I and type II 
metabolism and the P^gp content were unaffected by this storage and 
the malonaldehyde content also did not appear to alter to any great 
extent*
This short term stability of the microsomal MFO system of stored 
solid liver was confirmed by the results of a much longer term 
experiment (Fig* 4,17), In this experiment, various parameters of 
the MFO system were measured in microsomes isolated from livers 
maintained solid at -40°C for up to 43 days. This was devised as a 
paired experiment in that one half of the liver was measured fresh and 
served as a control for the other half* The results are illustrated
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m  Fig# 4#17#
Under these storage conditions the type I metabolism was 
decidedly the most labile parameter studied, the decay in enzyme 
activity beginning as soon as storage started such that by day 43 only 
11% of the original activity remained# Type II metabolic capability 
was more stable on storage, enzyme activity falling off only after 16 
days* storage and the activity remaining after 43 days* storage 
being 50% the original value# The cytochromes bg and P^gg were both 
more stable than either type I or type II metabolism# Fall off in 
cytochrome levels occurred after 16 days* storage and by 43 days* 
storage these levels had fallen to only 87% and 74% the original 
value for bg and P^gp respectively# Furthermore, once fall-off in 
the levels commenced the rate of decay for each parameter varied 
considerably#
During the storage period it became increasingly difficult to 
obtain a clean separation of the PMS from its sediment, leading to 
a somewhat contaminated PMS; the cause of this inability to form a 
tightly-packed pellet was not resolved. Also occurring during this 
storage period was the emergence of a peak at 420 nm*, which was 
observed when running the P^gp spectrum (Fig# 4#18). This was not 
the degraded form of cytochrome P^ gp, cytochrome P^ g^# do loss in 
P^gP content could be discovered (this was prior to the cytochrome 
P^gP decay i.e# less than 16 days* storage)# This peak, therefore, 
probably represented contamination of the microsomes with haemoglobin 
and made it impossible to decide if the loss of P^gp after 16 days* 
storage could be accounted for by its conversion to P^^g* It is 
probable that the haemoglobin contamination was related to the previously 
mentioned contamination of the PMS#
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3. Post-Mortem Characteristics of the Microsomal 
MFO System of Liver
Macleod et al (1973) have recently shown with rabbit liver that
maintaining the liver situ after death for hours resulted in 
a decrease in the type I and type II metabolism, NAOPH-cytochrome c 
reductase and NAOPH-cytochrome P^^p reductase activities and P^gp 
content of microsomes derived therefrom# The enzyme levels decayed 
to approx, 25% those of fresh tissue and the P^gg content fell to 
approx# 50%# However, the effect of p»m# storage in situ on the 
binding affinity of hepatic microsomes for substrates of the MFO 
system was not studied. For this reason, in addition to determination 
of any possible species differences in p»m# in situ decay, the 
experiment detailed below was performed#
Six rats (80 « 100 g) were killed end 3 were maintained intact 
for 1 hour at room temp# followed by 2 hours at 4°C| these conditions 
approximated to those existing prior to human autopsy# The remaining 
3 rats served as controls in which the livers were immediately removed
and kept at 4°C during the 3 hours# Both sets of livers ware then
processed identically using IP for preparation of the microsomes#
In agreement with the findings of Macleod e_t ^  (1973) was 
the significant fall in P^gp content on in situ storage together with 
a, previously unreported, similar fall in bg content (Table 4#14),
There was also a less marked fall in microsomal protein content, the 
extent of this decrease being approx* one-half that found for the 
cytochromes#
However, during this period of p#m. decay in the microsomal 
cytochrome and protein content there was no effect on the binding
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affinity of the microsomes for both type I and type II compounds, 
as shown in Table 4*15#
Using microsomes from such young rats (80 — 100 g) revealed the 
presence of two binding sites for biphenyl as described by Burke (1973) 
for the hamster; there was no evidence for more than one binding site 
for aniline in these microsomes# In previous experiments using 
microsomes from older animals (250 g) and from phenobarbitone-induced 
animals there was no evidence for this dual-binding phenomenon with 
biphenyl# Jin situ storage p.m. did not significantly alter the 
for either biphenyl-binding site and the ratio low : K high was 
also unaffected#
D# Studies on the Microsomal MFO System of Human Liver 
1# Details of Human Liver Samples Received
Code
No#
Sex Age
(years)
Nature of Sample/ 
Cause of Death
Storage Details
HU F 56 Surgical Biopsy Received Fresh
HL2 F 53 Surgical Biopsy Received Fresh
*
HL3 F mid
30s
P*M#/Salicylate
Poisoning
14 hours at 4°C 
4 hours at —70^ 1 
Thereafter at —
'K-
HL4 M 22 P,M#/Road
Accident
Samples were 
placed at -4D°C
within 1 hour of 
removal from 
body# Thereafter 
at -40°C
* Unfortunately the time that elapsed from death to autopsy was not 
recorded in samples HL3 and HL4#
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Analyses for the presence of salicylate and 4-aminosalicylate 
in samples of HL3 homogenate proved negative (methods used as described 
by l/arley, 1969). Binding studies performed with rat liver microsomes
showed 4-aminosalicylate to be a very weak type II substrate. It is
felt that these two observcrations taken together strongly indicate 
that 4-aminosalicylate, even if present in sample HL3, would not 
interfere with the studies as described below.
2. Applicability of Isoelectric Precipitation to the
Isolation of Human Liver Microsomes
A comparison of protein and cytochrome levels and of 4-chloro 
W-methylaniline N-demethylase activity in human hepatic microsomes 
isolated by both conventional centrifugation and IP is shown in 
Table 4.15. IP of human hepatic microsomes yielded a fraction 
comparable to that isolated by conventional centrifugation with regard 
to its MFO activity*
These results are in accord with those presented earlier for 
rat liver. A point of interest is that the protein content of 
both microsomal fractions is very similar, a point substantiated by 
the results shown in Table 4.17$
This similarity in the protein content of both washed ’normal* 
and ’acid* human hepatic microsomes differs somewhat from the 
situation existing in rat liver (Table 4.4) and may reflect intorspecies 
differences in cytosol protein structure and/or content.
Furthermore, both ’normal* and ’acid* human hepatic microsomes 
contain ’non-P^gg/bg’ haem which is regarded as representing the 
haemoglobin content of such fractions (Table 4.18). It should be
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noted that the concentrations of the various haem moieties had to 
be calculated using extinction coefficients derived from non-human 
species.
The haemoglobin content of ’acid* microsomes roughly corresponds 
to that found in washed ’normal* microsomes, both of which represent 
one-third to one-quarter that found in unwashed ’normal* microsomes. 
Whilst a small part of the decrease in total haem content on washing 
’normal* microsomes is due to a loss in the levels of cytochrome bg 
and P^gQ by far the major bulk is due to a loss in haemoglobin content,
3, Nature of the Human Hepatic Microsomal MFO System In Vitro
(i) Time Dependence of Enzymic Reactions
The time dependence of 4-chloro-N-methylaniline N-demethylase 
and aniline 4-hydroxylase activities are shown in Fig, 4,19, The 
activity of the former enzyme is linear for at least 20 minutes and that 
of the latter for at least 30 minutes,
(ii) Cofactor Dependence of Enzymic Reactions
The dependence of 4-chloro-N-methylaniline N-demethylase 
activity on the concentration of NADP and G-6-P in the incubation 
system is shown in Fig* 4*20, In the absence of exogenously-added 
NADP or G-6-P there was no detectable enzyme activity,
(iii) Effect of Inhibitors of Enzyme Reactions
Carbon monoxide and SKF 525-A, known inhibitors of the 
microsomal MFO system in the rat, were tested for their ability to
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inhibit 4-chloro-N-msthylanilino N-demethylase and aniline 
4-hydroxylase activities in human hepatic microsomes. The 
results of this study are shown in Table 4,19#
The extent of inhibition by CO was similar for both
enzymes studied and was probably not greater than 55% due to
endogenous oxygen and/or substrate remaining bound on the
cytochrome SKF 525-A on the other hand produced no
inhibition whatsoever. Further work carried out in 
conjunction with Prof, K,3, Netter showed that 4-nitroanisole 
0-demsthylase activity in human liver microsomes was totally 
resistant to any inhibitory effect of both SKF 525-A (10*"^  « 
10"*^ M) and motyropono (10~^M),
4, The Microsomal MFO Activity of Human Liver - Levels of 
Certain Parameters
(i) Cytochromes b^  and P450
The presence of haemoglobin in the human hepatic microsomal 
suspensions resulted in a peak at 420 nm, when attempting to 
measure cytochrome P^gg by the usual method of Omura and Sato 
(1964); this is illustrated in Fig, 4,21, This 420 nm, peak 
distorted the peak of cytochrome P^gg eo moving the peak to 
454 - 457 nm. This interference could be eliminated by using 
the modified method as described in Chapter 3^  as seen in Fig, 4,21, 
The presence of cytochrome bg in human hepatic microsomes 
could readily be detected using the normal method of assay 
(Fig# 4,22), The positions of the trough and peak in the
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cytochrome bg spectrum (410 and 426 nm, respectively) were ident­
ical in both rat and human hepatic microsomes.
Furthermore, the addition of an oxidizing agent, potassium
—5
ferricyanido at a final concentration of 10 M, to the control 
cuvette resulted in an apparent increase in the P^gg concentration 
(Fig, 4,23), This apparent increase was of tho order of 20% 
and indicated that there was endogenous reduced P^gg prior to 
in vivo reduction with dithionlte, this endogenous reduced P^gg 
possibly representing an in vivo state. No such effect on addition 
of oxidizing agent was observed for cytochrome bg.
The levels of cytochromes bg and P^gg found in the 2 
samples of human liver studied are listed in Table 4*20, Whilst 
admitting that these 2 results are hardly statistical, it should 
be noted that the levels of cytochrome bg in both samples were 
extremely similar whilst there was a two-fold difference in the 
corresponding levels of P^gg* the lower level of cytochrome P^gg 
being found in the sample with the poorer storage conditions*
These results are broadly in keeping with those observed during 
the various experiments on storage phenomana in rat liver, namely 
that bg has greater stability than P^gg end that preservation of 
P^gQ content is dependent on the storage conditions.
Furthermore, the level of cytochrome bg in human liver 
microsomes lies in tho lower region of the normal range for male 
rat liver microsomes (0.30 - 0,85 0,D,/g, liver) whilst the level 
of cytochrome P^gg in the better preserved sample also lies in the 
lower region of the normal range for male rat liver microsomes 
(0.30 - 0.95 O.O./g, liver).
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(ii) Metabolism of Type I and Type II Compounds
The results for the metabolism of three type I 
compounds - ethylmorphine, aminopyrine and imipramine - fay 
human liver microsomes is shown in Table 4,21. Two of the 
liver samples were fresh i.e. unstored and one was a stored 
sample; following 6 weeks’ storage there was no detectable 
metabolism of these type I compounds by HL3, although there 
was metabolism of typo II compounds and detectable 
cytochromes bg and P^gp
The level of type I metabolism in fresh human liver 
microsomes is approx, 50% that found in adult male rat liver 
microsomes, on e g, liver basis. Human liver microsomes 
metabolized ethylmorphine and aminopyrine via 
N-demethylation at an identical rate whereas the 
N-demethylation of imipramine was only 20% of this rate; 
this difference in rate of N-demethylation is probably 
related to the known multiplicity of metabolic routes 
available for the microsomal metabolism of imipramine 
(Bickel, 1971), Furthermore, aging of the microsomes by 
in situ storage p,m, led to a fall in the type I metabolizing 
potential, which, in the case of HL4, was of the order of 
75 - 80%.
b) Type II Compounds
Metabolism of type II compounds (aniline and 
4-chloro-N-methylaniline) was demonstrable in all the
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samples tested (Table 4,22)• This type II activity was 
more stable than type I metabolism and in one instance was 
demonstrated 42 days subsequent to storage of the sample 
at —40°C, by which time all type I metabolism had been lost# 
These results indicate that the level of aniline 
4-hydroxylase activity in fresh human liver microsomes 
is similar to that found in adult male rat liver microsomes* 
Aging of human liver by in situ storage p.m* decreased the 
aniline 4-hydroxylase activity fay approx# 60%# The level 
of 4-chloro-N-methylaniline N-demethylase activity in stored 
human hepatic microsomes was approx. 10% that found in 
adult male rat liver microsomes.
5. Spectrallv-Apparent Interactions of Substrates with Human Liver 
Microsomes In Vitro
A number of substrates were tested for their ability to elicit 
any spectrslly-apparent response on addition to human liver microsomes; 
where one did occur the interaction was defined (i.e. type I or type II) 
and, if possible, quantified using the binding-affinity constant K # 
Biphenyl, SKF 525-A, naphthalene, 1-naphthol and safrole are all 
type I compounds in the rat. On addition of these substrates to human 
liver microsomes the spoctrally-apparent responses were those 
associated with type I compounds in that at wavelengths below 410 nm. 
the O.D. change was positive with respect to the base-line, and at 
wavelengths above 410 nm. tho O.D. change was negative. Unfortunately, 
due to excessive absorption at both ends of tho spectrum (not found when 
using rat liver microsomes) the typical horizontal S-shape was not
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observed. This Is illustrated in Fig. 4.23 using 1-naphthol as an 
example# The other substrates elicited similarly-shaped responses.
These binding spectra when analysed, using standard wavelengths 
of 390 nm, and 430 nm, gave workable double reciprocal plots from 
which the could be assessed; this is exemplified in Fig# 4,25.
The values for the various substrates are given in Table 4.23, 
together, where possible, with those corresponding for adult male 
rat liver.
Human liver microsomes did not bind type I substrates as avidly 
as did rat liver microsomes. In fact human liver microsomes were 
approx. 5 times weaker in their binding with biphenyl and naphthalene 
and at least 25 times weaker with SKF 525-A. It was of interest to 
notice that SKF 525-A showed evidence of 2 binding sites with 
markedly differing affinities (approx* 20-fold difference).
Human liver microsomes also bound substrates known to be type II
in rat, the type of binding remaining unaltered. The substrates
/
tested comprised aniline, 4,4 -bipyridyl and metyrapone. In this 
instance the binding spectra were identical in shape to those accepted 
as being archetypic for this class, as shown in Fig. 4.26 for
t
4,4 -bipyridyl.
The double reciprocal plot for all 3 substrates showed evidence 
for the existence of 2 binding sites of differing affinity. This is 
shown in Fig. 4.27 using metyrapone as an example. The binding 
affinity constants for the substrates are shown in Table 4.24 
together with the corresponding values for male rat liver.
The presence of 2 binding sites makes the comparison with rat 
liver difficult. Taking into account the low affinity for aniline
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shows that human liver microsomes bind the substrate os readily as 
do rat liver microsomes but that human liver microsomes show greater 
affinity at the high site# The same situation holds true for 
4,/ -bipyridyl but not for metyrapone where there exists a vast 
difference between the binding affinities for this compound in human 
and rat liver microsomes even allowing for the fact that the figure 
quoted for rat liver was derived from pre-induced livers.
Furthermore, human liver microsomes also elicited a spectrally- 
apparent response with butan-l-ol which constituted what has been 
termed a "Reverse Type I" spectrum (Schenkman et al# 1972). This 
reverse type I spectrum is shown in Fig. 4 28 and could be distinguished
•X-
from a type II spectrum by its different wavelength maxima and minima.
In conclusion, these results show that human liver microsomes can 
produce spectrally-apparent interactions with various compounds typical 
of the three classes of binding - type I, type II and reverse type II*
(Table 4.25)
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Table 4,1 * Comparison of Conventional and Scaled-Down Assays for 
the Measurement of Hepatic Microsomal MFO Activity
Parameter
Ethylmorphine N-demethylase  ^(4)
t3Aniline 4-hydroxylase (5)
4-Chloro-N-methyleniline
N-demethylase  ^(4)
Conventional
Assay
19.5 ±  7.1 
1.14 + 0.16
7.5 + 0.9
Scaled-Down
Assay
19.3 4 4.7 
1.16 ±  0.13
7.7 4» 0.6
Values are mean + S.E.M. Figures in brackets indicate number of 
experiments
a ^ moles formaldehyde/g.liver/hr. 
b |u moles 4-aminophenol/g.liver/hr. 
c ju moles 4-chloraniline/g.liver/hr.
Table 4.2. Effect of Isoelectric Precipitation on the Yield of
Microsomal Protein and Cytochrome P450
Microsomes
* Normal *
0.1N HCl
'Acid* 0.2M Citrate Buffer pH 4.0 
0.2M Acetate Buffer pH 4,0
Protein Content
25.5 + 2.2
37.7 ±  2.4 
40.0 ±  3.0
38.4 4- 2.8
(e) P^gQ Content(b)
0.89 ±  0.08 
0.83 + 0*10
N.D.
0.95 4 0.14
Values are mean of 3 rats 4- S.E.M. N.D* — not determined
(a) mg/g.liver (b) D,0,/g.liver
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Table 4,3, RNA Levels in 'Acid* and 'Normal* Microsomal Fractions
Microsomes
'Normal*
'Acid'
RNA Levels (a)
3,47 ±  0.29 
3.50 4* 0.32
Values arc moan of 9 rats + 5.E.M. (a) mg/g.liver
Table 4,4. Protein Content of Unwashed 'Normal*. Washed 'Normal* and 
'Acid* Microsomal Fractions
Microsomes
Unwashed 'Normal* 
Washed 'Normal* 
'Acid*
Protein
Content
27.0 
17.7
25.1
(a)
Values are mean of 2 rats. (a) mg/g.liver
Table 4.5. Influence of Centrifugation Time on the Composition of 
'Acid* Microsomes
Time of Centrifugation (minutes) Cytochrome bg^ ^^  Cytochrome
5
10
20
(Control - 'Normal* Microsomes)
0.34
0.35
0.32
0.38
0.32
0.30
0.33
0.30
- l»ver
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Table 4.6, Parameters of the MFO System in Hepatic Microsomes
Parameter
(a)Cytochrome P.gg
(q )
Cytochrome bg'
Aminopyrine N-Demethylase
(cVAniline 4-Hydroxylase
(b)
NADPH-Cytochrome c Reductase(d)
'Normal*
Microsomes
0.89 ±  0.08
0.83 + 0.08
16.7 + 1.7
0.80 + 0.04
111.9 4 27,3
'Acid*
Microsomes
0.95 4 0.14 
0.81 4 0.16
16.5 4 2.0
0,83 4 0.04
109.7 4 30,2
Results are mean of 3 rats 4 S.E.M.
(a) ' O.D,/g.liver
(b) ^  mole formaldehyde/g.liver/hr.
(c) JA mole 4-aminophenol/g.liver/hr.
(d) jA mole cytochrome c roduced/g.liver/hr.
Table 4.7. Parameters of the MFO System in Hepatic Microsomes 
from Phenobarbitono-Induced and Control Rats
Induced
Parameter
Protein^ °)
'Acid* 
41,9 4 1.9
'Normal*
Control 
'Acid* 'Normal*
42.4 4 3.2 30.9 4 2.4 24.9 4 l.î
(b)Cytochrome bg' ' 1.34 4 0.09 1.39 4 0,05 0,49 4 0.02 0.49 4 0,{
Cytochrome 2.44 4 0.34 2,48 4 0.24 0.63 4 0.04 0,65 4 0.(
^450^)
Aminopyrine 
N-Demethylaoe
Aniline 
4-Hydroxylaso
(c)
(d)
55.5 4 4.5 50.0 4 5.5 12,7 4 1.6 12,9 4 0.(
2.92 4 0,18 2.83 4 0.15 0.79 4 0.03 0.75 4 0
Values are moan of 4 rats 4, S.E.M, The differences in the values between 
control and induced for each fraction were significant (P O.Ol)
(a) mg/g.liver (b) O.D./g.liver
(c) jA mole formaldehyde/g.liver/hr. (d) jA moles 4-aminophenol/g.liver/hr.
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Table 4.8. Percentage Increases In Haernoprotein Content and Type I 
and Type II Metabolic Activity and Hepatic Microsomes 
After Phenobarbitone Induction
Parameter
Cytochrome bg 
Cytochrome P^gg 
Aminopyrine N-Demethylase 
Aniline 4-Hydroxylase
% Increases after Induction 
'Normal* Microsomes 'Acid* Microsomes
184
282
288
278
174
288
321
270
Table 4.9. Binding Constants for the Spectrally—Apparent
Substrate-Induced Hepatic Microsome Interactions
Phenobarbitone
Induction
Microsomes
* Acid * 
'Normal* 
'Acid* 
'Normal*
Biphenyl
1.25 ±  0,09 (3)
1.21 ±  0.01 (3)
0.17 4 0,07 (4)
0.17 4 0,01 (3)
Aniline
5.19 4 0.53 (3)
5,96 4 0.71 (3)
5.03 4 0,20 (4)
5.35 4 0.30 (4)
Values are mean ±  S.E.M. Figures in brackets indicate the number of 
rats used.
91
Table 4.10. Levels of Protein, Cytochrome and Type I and
Type II Metabolic Capacity in Various Rat Hepatic
Microsome—Containing Fractions
Microsome-Containing
Fraction
Cytochrome
Protein^®)
Aminopyrine
N-Demethy—
lasB^ ^^
Aniline
4-Hydroxy-
lase(^^
Homogenate 
'Acid* Homogenate*
254 4 12*7 1.46 4 0,07 
117 4 3.1 1.17 4 0.02
N.D.(G) 
17.1 4 0.5
0.41 4 0.09 
0.89 ^ 0.08
PMS
■ :4;. v^-
170 4 3.7 N.D. 19,2 4 0.5 0.93 4 0.02
'Acid* Microsomes 51 4 3.1 0.88 4 0.03 13.0 4 0.7 0,65 4 0.01
Values are mean of 4 rats 4 S.E.M.
(a) mg/g.liver (b) O.D./g.liver
(c) jA mole formaldehyde/g.liver/hr.
(d) u mole 4-aminophenol/g,liver/hr.
(e) not determined
Table 4,11, Levels of Protein and Cytochrome P. in Various
Fractions of Rat Liver Homogenate* Expressed as a
Percentage of the Homogenate Value
Source of Microsomes Protein Cytochrome P450
*Acid Homogenate* 46 80
PMS 68 —
*Acid* Microsomes 20 60
92
Table 4.12. Type I and Type II Metabolic Activities in Various 
Fractions of Rat Liver Homogenate# Expressed as a 
Percentage of the PMS Value
Source of Microsomes Aminopyrine
N-Demethylase
Aniline
4-Hydroxylase
'Acid Homogenate* 
'Acid* Microsomes
89
68
96
70
Table 4.13. Enzyme Activity. Cytochrome and Malonaldehyde
Content of Fresh 'Acid* and 'Normal* Microsomes
Parameter
Aminopyrine N-Demethylase^^^ 
Biphenyl 4-Hydroxylase^^^ 
Aniline 4-Hydroxylase 
NADPH-Cytochrome c Reductase 
Cytochrome P^gp^®^ 
Malonaldehyde^ )^
(d)
'Normal*
Microsomes
11,6
2.3
0.50
70.1
22
8.1
'Acid*
Microsomes
13.1 
2.8 
0.62
74.6
31
15.1
(a)jut mole formaldehyde/g.liver/hr.
(b) jlA mole 4-hydroxybiphenyl/g,liver/hr.
(c) jLA mole 4-aminophenol/g.liver/hr.
(d)^ mole cytochrome c reduced/g.liver/hr.
(e) nmole/g.liver
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Protein Levels
Source of Microsomes 5
Proteln(b)
Fresh Liver 0.61 4 0.07 0,50 4 0.06 35.3 4 3.5
Aged Liver 0,37 a  0,10* 0.33 4 0.04+ 29.3 4 3,8+
% Decrease 39 34 17
Values are imean of 3 rets 4 S.E.M.
(a) O.D./g.liver (b) mg/g.liver
* P < 0.1025 4 P < 0,01
Table 4.15. Kinetics of the Spectrally—Apparent Druq-Microsome
Interactions: Effects of In Situ Storaqe Post-Mortem
Binding Constants, Kg(X10^M):-
Source of 
Microsomes Aniline Low Affinity
Biphenyl 
High Affinity Low/High
Fresh Liver 3.55 4 0,19 5.11 4 0*24 1,36 4 0.07 3,75
Aged Liver 3,55 4 0.16(NS) 4.60 4 1.06(NS) 1.26 4 0.06(NS) 3,65
Values are mean of 3 rats j; S.E.M. 
N.B. not significant
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Table 4,16, A Comparison of MFO Activity In 'Acid* and 'Normal* Human
Hepatic Microsomes
Parameter
Protein^
Cytochrome
Cytochrome bg^^)
4-Chloro-N-Fiethylaniline
(c)N-Demethylase
’Normal*
Microsomes
21*14 1*09 (4)
0.18 4 0.08 (3)
0.32 4 0.09 (3)
0.31 4 0.02 (2)
'Acid#
Microsomes
20.7 4 0.79
0.20 4 0.08
0.33 4 0.11
0.30 4 0.06
Values are mean j; S.E.M. 
estimations
Figures In brackets indicate number of
(a) mg/g,liver (b) O.D./g.liver
fA wok
(c) 4-chloraniline/g.liver/hr.
Table 4.17. Protein Content of Human Hepatic Microsomes; Effect 
of Isolation Procedure
Source of Microsome; Protein Content (a)
Unwashed 'Normal* 
Washed 'Normal* 
'Acid*
30.9 4 2.5
20.9 ^  4.1 
23,0 4 0.3
Values are mean of 3 determinations 4 S.E.M, (a) mg/g.liver
Table 4.18. Analysis of Haem Content in Human Hepatic MlcroGomes
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Parameter
450
^450 + bg
Total Haem
Total Haem - (P^gg 4 bg)
Unwashed 
* Normal *
2.64
3.26
5,90
11*10
5,20
Washed 
* Normal*
1,66
2.52
4.18
5.50
1.32
'Acid*
1.95
2.97
4.92
6.65
1.73
All results are in units of nmole/g.liver
Table 4.19» Effect of Carbon Monoxide and SKF 525-A on the Microsomal 
MFO Activity of Human Liver
% Inhibition
Parameter
Aniline 4-Hydroxylase
4-Chloro-N-Methylaniline
N-Demethylase
CO
62
65
SKF 525-A (10 M) 
0
Not Tested
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Table 4.20, Microsomal Cytochrome Content of Human Liver
Sample No.
HL3
HL4
Cytochrome bg(a)
0.478
0.461
Cytochrome (a)
0.177
0.345
(a) O.D./g.liver
Table 4.21. Microsomal Metabolism of Type I Compounds by 
Human Liver
Sample No.
HL1
HL2
HL4
Substrate
Ethylmorphine
Ethylmorphine
Ethylmorphine
Aminopyrine
Imipramine
N-Demethylating
Activity^ )^
9.80
6*50
1.77
1,79 
0.36
(a) jA mole formaldehyde/g.liver/hr.
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Table 4«22« Microsomal Metabolism of Typo II Compounds by Human Liver
Sample No. Aniline
4-Hydroxylase(a)
4-Chloro-N-Methylaniline
N-Domethylase^b)
HL2
HL3
HL4
1.090
0.430
0.345
Not Determined 
0.360 
0.265
(a) |>i mole 4-aminophenol/g.liver/hr
(b) jLA mole 4-chloraniline/g.liver/hr.
Table 4.23. Binding Affinity Constants for the Interaction of Type I 
Substrates with Human Liver Microsomes
Substrate
Biphenyl
Naphthalene 
SKF 525-A 
1-Naphthol
K. (Human) (X10*M)
6.67 (HL3)(a)
7.14 (HL4) 
11.0 (HL4)
53.3; 1.59 (HL3) 
4.88 (HL4)
Kg (Rat) (XIO^M)
1.25 + 0.19(b)
2.60 4 0.19
0.067^^)
(b)
(a) Figures in brackets indicate sample number
(b) Values are mean of 3 rats 4 S.E.M,
(c) Mannering (1971).
Table 4.24. Binding Affinity Constants for the Interaction of 
Type II Compounds with Human Liver Microsomes
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Kg (X10 M)s-
Human
Substrate High Low
Affinity Affinity Low/High
Aniline 1.00 5.00 (HL4)(^) 5.0
4,4*-Bipyridyl 0,20 1.54 (HL4) 7.0
Metyrapone 0.86 5.00 (HL3) 5.8
Rat
5.19 4 0.53(b)
0.315 + 0.009 
0.0067(c)
(b)
(a) Figures in brackets indicate sample number.
(b) Values are mean of 3 rats 4 S.E.M.
(c) Phenobarbitone-induced liver, Liebman et al (1967).
Table 4.25» Wavelength Maxima and Minima for Type II and Reverse 
Type I Spectra Induced in Human Liver Microsomes
Substrate
4;4*-Bipyridyl
Aniline
Metyrapone
Butan-l-ol
Spectrum
Type II
Type II
Type II
Reverse 
Type I
Minima (nm.) 
393 - 395 
390 - 395 
392 - 395 
385 - 390
Maxima (nm.) 
420 - 425
422 - 427
423 - 426 
420
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Fig. 4,1. — Microsomal Cytochrome Levels - Comparison of ’Acid* and ’Normal* 
Microsomes
4-0 * 3 —I
P-450
+ 0.2 -
+ 0.1 —
0 -
-0.1 J
O.D. Change
4 ’Normal’ Microsomes
I------  ^ 'Acid* Microsomes
390 410 430 450 470
Wavelength (nm)
490
The reducedroxidised spectrum of NADH-reducible cytochrome is illustrated 
on the left whilst the CO-induced difference spectrum of dithionite-reduced 
cytochrome is illustrated on the right.
The amount of microsomal fraction used corresponded to 250 mg wet weight 
liver equivalent.
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Fig. 4.2. Spectrally Apparent Interactions of Biphenyl with ’Acid' and 
’Normal' Microsomes from Control and Phenobarbitone-Induced 
Rat Liver.
0.040 -
0.030 -
0.020 -
0.0 10-
0-
-0.010-
- 0. 020-
-0.030-
-0 .040.
O.D.
Change
Normal Microsomes 
Control Liver
j-—  — j Acid Microsomes 
Control Liver
Biphenyl Cone : 0.20 mM.
i Normal Microsomes 
Induced Liver
4 Acid Microsomes 
Induced Liver
350
T
390 430 470 510 wavelength (nm)
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Fig. 4.3, Spectrally Apparent Interactions of Aniline with ’Acid* and ’Normal* 
Microsomes from Control and Phenobarbitone-Induced Rat Livers
O.D.
Change
0.020 -
0.010  -
0 -
4 Normal Microsomes 
Control Liver
0.010  -
0.020 -
0.030 — J
Acid Microsomes
Control Liver
Aniline Cone : 0.80 mM
i Normal Microsomes 
Induced Liver
I------ j Acid Microsomes
Induced Liver
r
350
— T"
390 430 470
Wavelength (nm)
510
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Fio. 4,4« Spectrally-Apparent Interactions of Biphenyl and Aniline with 
’Acid' and 'Normal' Microsomes from Control
Rat Liver (Redrawn on a g:liver basis)
0.25 ^
O.D.
Change
0 -
0.25 -
Biphenyl Cone : 0.20 mM
Aniline Cone 0.80 mM
'Normal' Microsomes
4  'Acid' Microsomes
— !---------- 1—
430 . 470
Wavelength (nm)
350
I
390 510
Each graph represents the binding spectrum for microsomes equivalent to 
1 g wet weight of liver.
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Fig. 4.5. ' Cofactor Dependence of Aminopyrine N-Oemethylase and
Aniline 4-Hydroxylase Activities as Assayed in Rat 
Liver Homogenate
O.D.
at
412 nm.
0.30 -1
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a) Aminopyrine N-Demethylase
0,10
Optimal Levels for Microsomal Fractions 
b) Aniline 4-Hydroxylase
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"T-
10 15
“1 NADP (umole/tube) 
20
G-5-P at 25|u. mole/tube
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—r
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I
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1 G-6-P ^mole/tube)
100
NADP at 10 jumole/tube
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Fig. 4,6.- 4.10. Storage of Hepatic Microsomal Fractions;
Time-Dependent Decay Curves for Various 
Parameters of the MFO System
Fig. 4.11. Storage of Hepatic Microsomal Fractions:
Time-Dependent Increase in Malonaldehyde 
Levels
Key
A  4°C., Pellet
A -20°C., Pellet
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Fig. 4.8. Aniline 4-Hydroxylase
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Fig. 4.9. NADPH-Cytochrome c Reductase
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Fig. 4.11. Malonaldehyde
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Fig. 4.12 - 4.15. Effect of Different Forms of Storage on the MFO
and Malonaldehyde Content of Hepatic Microsomal 
Fractions -
Key
A  Aminopyrine N-Demethylase
A  Biphenyl 4— Hydroxylase
E3 Aniline 4-Hydroxylase
□ NADPH-Cytochrome c Reductase
©  Cytochrome
 --- Malonaldehyde
Left-Hand Ordinate; Levels of Certain Components of the MFO
System as % that of Fresh Sample
Right-Hand Ordinate: Malonaldehyde level as ^ that of Fresh
Sample
Abscissa ; Hours of Storage
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Fig. 4.16. Microsomal MFO Activity and Malonaldehyde Content in Rat 
Liver Maintained Solid at -40°C.
a, Aminopyrine N-Demethylase b. Aniline 4-Hydroxylase
1 0 -
1 . 0  -
0,5 _ n
Ï) I'
c. Cytochrome P450
d. Malonaldehyde
30-1
15-
2 0  - I
10  -
a
4
1, Fresh Sample
2, 18 hours storage
3, 66 hours storage
4, 162 hours storage
Ordinates ; a, ^  mole formaldehyde/g,liver/hr.
b,jw mole 4-aminophenol/g.liver/hr.
c, nmole/g,liver
d, nmole/g,liver
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Fiq. 4.17. Level's of Certain Components of the MFO System in 
Microsomes Isolated From Livers Maintained Solid 
for Varying Periods at -40 C,
Original
Level
100
80 J
40
20
3020
Days of Storage
A  Cytochrome
A  Cytochrome 
0  Aniline 4-Hydroxylase
O  Aminopyrine N-Demethylase
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Fio. 4.18. Emergence of 420 nm. Peak After Storage of Solid Liver 
at —40°C for 15 Days,
0.3 -
O.D.
0.2 -
0.1
0 -J
\ /
-1
510390 430 470
Wavelength (nm)
j Fresh Microsomes
“ 1 Microsomes Isolated from Liver
Stored Solid at ~40°C for 16 Days
The two preparations were paired i.e. derived from the same 
liver and in both cases the above traces were obtained from 
microsomes equivalent to 250 mg* wet weight liver.
119
Fiq. 4.19. lime Dependence of Enzymic Reactions in Human Hepatic
Microsomes
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Fiq. 4.20. Cofactor Dependence of 4-Chloro-N-Methylaniline 
N-Demethylase Activity in Human Liver Microsomes
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Fig. 4.21 y Cytochrome Spectrum of Human Hepatic Microsomes
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Fig. 4.22. Presence of Cytochrome in Human Hepatic Microsomes
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Fig. 4.23. Apparent Increase in Cytochrome Content of Human
Liver Microsomes After Addition of Oxidizing Agent to 
Control Cuvette.
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Fig. 4.24. Spectrally-Apparent Interaction of Human Liver Microsomea 
with 1— Naphthol
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Fia. 4.25, Double Reciprocal Plot to Calculate K_ for the Interaction
" ' ", s ■ .
of Human Liver Microsomes with 1-Naphthol
(N
O
CO
o
oo
CM
OOo
o
CM
o
JZ
4-)
JO
CL
126
Fig. 4.26, Spectrally-Apparent Interaction of Human Liver Flicrosomas
■ ■ I  ■
with 4,4 -Bipyridyl
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Fig. 4.27. Double Reciprocal Plot to Calculate the K for the
Interaction of Human Liver Microsomes with Metyrapone
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Fig. 4.28. Spectrally-Apparent Interaction of Human Liver 
Microsomes with Butan-1-ol*
128
+0.01
O.D.
- 0.01
\
/I 
/ /
I /" \ \
\ \ \
l/ ' 'v '•
/I: \
\
\
/ I
/ // 
//
Vol. of Butan-1—ol Added; 1. 10pl
2. 20^A
3. 30^1
\ i
I I
' V /
\ /
fi
il
I
350 390 430 Itq "?10
Wavelength (nm.).
129
CHAPTER 5. CONTENTS
1« Scale-Down of Assays for Components of the Hepatic 130
Microsomal MFD System
2. Isolation of Hepatic Microsomes by Isoelectric 133
Precipitation
3* Storage Characteristics of the Hepatic Microsomal 136
MFO System
4e Post-Mortem Storage Characteristics of the Hepatic 139
Microsomal MFO System
5® The MFO System in Human Liver Microsomes 141
130
CHAPTER 5. DISCUSSION
1# Scale-Down of Assays for Components of the Hepatic 
Microsomal MFO System
As mentioned earlier (see Chap® 2) the liver has a major 
responsibility for the metabolism of the various xenobiotics to 
which the mammalian body may be exposed. Such a specialized ability 
could in principle prove extremely valuable as a laboratory tool in 
the clinical diagnosis of liver function in man. Indeed, a few
workers have demonstrated a relationship between the degree of 
severity of liver damage and the level of hepatic MFO activity 
(see Chap, 2), One could, in principle, use in vivo metabolism of 
a drug as a method of assessing liver function but difficulties 
exist due to the complexity of the vivo system - the drug or its 
metabolite might undergo non-hepatic metabolism, etc, - and 
consequently the use of liver samples appears to be a more valid 
proposition* Unfortunately, a major problem in the use of MFO 
activity as a measure of liver function in man has been the obvious 
difficulty in obtaining appropriate samples. It is ethically 
unreasonable to submit a patient to surgery simply for the purpose 
of obtaining a liver specimen for subsequent analysis. This has 
meant that needle biopsy samples of human liver have had to be 
considered for this purpose, Needle biopsy specimens are approx,
30 - 50 mg, in weight, part of which has invariably to be used for 
histological analysis. Since 75 - 150 mg, of liver is required for 
a conventional study of MFO activity, small scale assay procedures 
have to be adopted when attempting to measure MFO activity in the 
remaining 15-25 mg, of sample.
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A number of methods exist for the micro-scale assay of hepatic 
MFO activity, these being based largely on radioactivity techniques 
(Kuntzman et al, 1967| Gang et al, 1972| Hayakawa and Udenfriend,
1973; Poland and Nebert, 1973; Kupfer and Rosenfeld, 1973) although 
micro-scale spectrophotometry techniques have also been used (Schoene 
et el, 1972), Enzymes measured by these techniques include 
pentobarbital and hexobarbital hydroxylase (Kuntzman et al, 1967;
Kupfer and Rosenfeld, 1973), aniline hydroxylase (Gang et al, 1972), 
benzpyrene hydroxylase (Hayakawa and Udenfriend, 1973) and aminopyrine 
and jD_-nitroanisole dealkylation (Poland and Nebert, 1973; Schoene 
et al, 1972), Whilst these techniques do use very small amounts of 
tissue (1 - 25 mg. liver wet weight) they do suffer from the major 
disadvantages that there is an absolute need for costly ready-made 
or specially-manufactured equipment, coupled with the cost and 
difficulty in obtaining radioactively-labelled substrates.
We have found that reduction of the total volume of assay 
medium together with a concomitant reduction in the volume of 
microsomal fraction, and the use of a spectrophotometer capable of 
accepting micro cells (as outlined in Chap. 4) has proved successful 
for scaling-down the assays for aminopyrine or ethylmorphine 
N-demethylaso; aniline hydroxylase and 4-chloro-N-methylaniline 
N-demethylase, By these means the equivalent of 25 mg, wet weight 
of liver can be used for each enzyme assay as opposed to tho 75 — 150 mg, 
normally used (Table 4,1), Although these assays were not assessed 
on needle biopsies of human liver they were used on surgical biopsy 
samples (HL1 and HL2), The results obtained for these samples 
(Tables 4,21 and 4,22) agree very well with the values quoted by other
132
workers using similar samples and ’normal* assays (Ackermann, 1972; 
Deckert and Rammer, 1972), thus implying the applicability of these 
micro-scale assays to the human situation* It is probable that 
less than 25 mg, liver equivalent could be used in these assays if 
the incubation time is increased accordingly and a protein stabilizing 
agent, such as serum albumin (Dacobson et al, 1972), is added to the 
assay medium.
The applicability of these assays to homogenates of rat or human 
liver was not tested although problems to this approach are apparent. 
Firstly, there is an increased requirement for the cofactors G-6-P 
and NADP within the assay medium (Fig, 4,5 and 4,6) which probably 
reflects involvement of the contaminating mitochondria (Bachmann et al,
1970) and of hydrolytic enzymes. Secondly, the presence of large 
amounts of protein in the homogenate makes it impossible to accurately 
measure formaldehyde production as assayed by the conventional Nash 
reaction due to turbidity of the coloured solution. This could 
possibly be greatly minimized by either high-speed centrifugation 
(Ziegler D,M,, personal communication) or, more simply, by extraction 
of the coloured complex into an organic solvent (Hasegawa, 1963),
No such difficulty exists in the aniline hydroxylase assay although 
it does appear that an inhibitor of this enzyme is present in rat liver 
homogenate (Table 4,10),
Scale-down of the cytochrome P^^g assay system either by diluting 
the microsomal suspension or by using micro-cuvettes did not prove 
successful. As the microsomal suspension was diluted so the apparent 
concentration of P^^q per g, of liver decreased, - finding also 
observed by Wade ojt ^  (1972) who considered this to be related to 
some form of membrane-aggregation effect*
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2. Isolation of Hepatic Microsomes by Isoelectric Precipitation
In certain situations, e.g, where precise localization of 
metabolism is required or in substrate binding studies, isolated 
microsomal systems have to be used in place of either homogenates 
or PMS* We have shown that isolation of hepatic e,r. fragments 
by isoelectric precipitation yielded a microsomal fraction comparable, 
on a g, liver basis, in activity of the MFO system to that obtained 
by conventional high-speed centrifugation techniques, whether these 
fractions be obtained from normal or induced rat liver (Tables 4,6 
and 4,7), Similar findings with regard to type I metabolism only 
have been reported by Karler and Turkanis (1968) and Mitchard (1969), 
The precipitate formed after addition of acid buffer to a PMS could be 
harvested by low-speed centrifugation for short periods, maximum 
sedimentation occurring after 5 minutes centrifugation at approx,
2,000 2, 8V, (Table 4,5),
The major difference between *acid* and ’normal* microsomes 
lay in their differing protein content, there being 50 — 60^ extra 
protein in the ’acid* preparations (Table 4.2). This difference 
has also been noted by Karler and Turkanis (1968) as well as by 
Takesu and Omura (1970), It is believed that this additional protein 
is derived from what is termed the ’cytosol* fraction of the liver 
homogenate. These cytosol proteins show minimum solubility at pH 4-5 
Leone and Redstone, 1962) and would be expected to co-sediment with 
the microsomes prepared by isoelectric precipitation. Further 
evidence for this belief comes from a number of results;
1) The additional protein can be precipitated when the acetate
buffer is replaced by either dilute HCl or by citrate buffer
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(Table 4,2), implying that it is the lowering of the pH and 
not the effect of the acetate per se which is responsible;
2) The extra protein is non-ribosomal in origin as judged by 
the yields of RNA (Table 4,3);
3) It is not derived from haemoglobin contamination as assessed 
by a lack of any appreciable peek at 420 nm. in the spectrum 
of (Fig. 4,1);
4) The protein content of ’add* microsomes is similar to that 
of unwashed ’normal* microsomes, washing of which results in 
the removal of trapped soluble cytosol proteins (Table 4.4).
This difference in protein content between *acid* and ’normal* 
microsomes is not observed when using livers obtained from 
phonobarbitone-induced animals (Table 4.7). The reason for this 
is obscure although it may reflect a relative or absolute decrease 
in the level of cytosol protein on phenoberbitone induction.
It is clear from these studies that both acid pH and the presence 
of acetate ions exert no short-term deterious effect on tho functional 
state of the MFO system in hepatic microsomes, Karler and Turkanis 
(1968) were able to show that hexobarbital metabolism stayed at a 
normal level even if the pH went as low as 4,6 during the IP stage 
although it has been reported (Betz et al. 1973) that exposure of 
hepatic microsomes to pH 5,0 for 40 minutes leads to a fall in the 
levels of bg, P^^q end NADPH-cytochrome c reductase activity. The 
final concentration of acetate present when the pH is lowered to
5,4 is of the order of 0.02M. Incubation of hepatic microsomes
with sodium acetate at pH 8,0 for 10 minutes produces no loss of ^450*
even if the acetate concentration is 2M or greater (Imai and Sato, 1967).
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As indicated earlier, the overall rate of drug metabolism 
(as measured by the levels of type I and type II metabolism), the 
rate of reduction (as assessed by the level of NADPH-cytochrome
c reductase) and the level of P^gg itself are exactly comparable in 
’acid* and ’normal’ microsomes. In addition, the affinity of 
’acid’ microsomes for substrates of the MFO system is strikingly 
similar to that for ’normal* microsomes (Table 4,9), This is true 
for control and induced livers. If anything, the affinity for 
aniline is greater in the ’acid* microsomes although this is not 
reflected as differences in the level of aniline hydroxylase activity. 
Furthermore, the type of binding is unaltered by the acid treatment 
(Fig, 4,2 and 4,3),
Thus at all stages of the MFO system so far studied - substrate 
binding, cytochrome P^gp reduction and overall rate of metabolism - 
hepatic microsomes prepared by IP are at total parity with those 
prepared by conventional techniques. This technique of isoelectric 
precipitation offers distinct advantages in respect to its speed 
and its obviation for the need of a costly high-speed centrifuge®
These results concerning IP, which were obtained using rat liver 
microsomes, have been further confirmed in two samples of human p,m, 
liver* Once again, the levels of P^ gpj bg and enzyme activity were 
comparable in ’normal’ and ’acid* microsomes whilst the protein levels 
were, surprisingly, also similar (Table 4,16). In this instance, 
the protein level of ’acid* microsomes more closely approached that 
of washed ’normal* microsomes as opposed to unwashed ’normal’ 
microsomes (Table 4,17), The extra protein present in unwashed 
’normal* microsomes could be attributed, at least in part, to the
haemoglobin contaminating the samples. This study has conclusively
136
shown that isoelectric precipitation is indeed a highly feasible 
and attractive alternative to high-speed centrifugation when 
studying human liver microsomes for their drug-metabolizing potential,
IP can also be successfully employed to achieve a microsome-rich 
fraction from rat liver homogenate cleared of nuclei and cellular 
debris which is distinct from a PMS (Table 4*10), The preparation 
of a ’pure* microsomal fraction via a PMS results in the loss of 40^ 
of the P^gp present in the homogenate (Table 4.11 and Schoene et el, 
1972), this value being reduced to only 20/o in the,’acid* homogenate. 
The level of type I and type II metabolism in ’acid’ homogenates is
approx, 90% and 95% respectively that of PMS fractions derived from the
same livers; the corresponding figure for microsomes derived from 
these PMS fractions is 70^ (Table 4,12). By use of this scheme of 
IP on liver homogenate it is possible to achieve a microsome-rich 
fraction requiring the use of a common bench centrifuge only.
These microsome-rich fractions appear a suitable tool with which to 
assess the functional ability of the liver to metabolize various drugs 
without the disadvantages (discussed earlier) of using the 
homogenate proper,
3, Storage Characteristics of the Hepatic Microsomal.MFO System
Whilst it is advisable to measure MFO activity as soon as 
possible after preparing microsomal fractions situations do arise 
where this is not possible. In these circumstances it would bo 
obviously advantageous to know the best method of storing microsomes, 
either as the solid unprocessed tissue or as isolated fractions. This
has been studied in the present work.
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Although the short-term stability of hepatic microsomes 
prepared by IP appears to be very high they are more susceptible to 
the loss in MFO activity associated with storage, this being reflected 
in the high level of malonaldehyde present even in fresh samples 
(Table 4.13). In general, activity of the hepatic MFO system in 
isolated fractions is best maintained if the samples are stored at 
-20°C in the form of microsomal pellets (Fig, 4,7 - 4,11), These 
findings are broadly in agreement with those of Leadbeater and 
Davies (1964), Levin et al, (1969) and Wade et al, (1972), Also, 
the ’normal* microsomes remain more stable at —20°C than do their 
’acid* counterparts (Fig, 4,7 - 4,11); with storage of both 
microsome preparations at 4°C the decay is more rapid and so 
meaningful comparisons between the various preparations cannot be 
made. The storage decay curves with time for two enzymes responsible 
for the metabolism of type I substrates, aminopyrine N-demethylase 
and biphenyl 4-hydroxylase, in *normal* microsomes at -20°C show 
discernible differences (Fig. 4,13 and 4,15) which may possibly 
indicate the presence of more than one terminal oxidase within the 
MFO system (Levin et al, 1969),
Concomitant with the time- and storage-dependent decay in the 
levels of various parameters of the MFO system is a time- and 
storage-dependent increase in the malonaldehyde content (Fig, 4,12 - 
4,15), The level of malonaldehyde is generally regarded as a 
sensitive index for lipid peroxidation (Tappel, 1973) and so one can 
deduce that the storage dependent decay in activity of the MFO system 
is associated with peroxidation of the lipid present in the microsomal 
membrane. This provides further evidence for the vital role played
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by microsomal membrane lipid in maintaining the correct structural 
and lipophilic features of the MFO system (Estabrook et al, 1971)*
Thus it is probably not specific degradation of the MFO system per se 
within the microsomal membrane which leads to its decay on storage 
but rather it is degradation of the microsomal membrane which leads 
to inactivation of the MFO system*
This poses the problem as to what initiates this membrane 
degradation# This is probably the MFO system itself via its role 
as a peroxide-generating system as outlined in Chap* 2, The finding 
of Deckert and Remmer (1972) that rat liver microsomal suspensions 
could be maintained for 20 days at -20°C with no loss in activity 
(which is in disagreement to the findings presented above and the 
work of Wade et al* 1972) can be ascribed to the presence within the 
suspending system of EDTA, a known inhibitor of lipid peroxidation 
(Bidlack et al, 1973)# This use of EDTA has its limitations in that 
it might interfere in the subsequent assays performed on the 
suspensions#
Our work has shown that if storage of a valuable sample is 
necessary it is best achieved by storing the solid liver specimen 
itself and not by storing the isolated microsomal fraction# An 
experiment carried out in parallel with that on storage of isolated 
microsomes showed there to be no decrease in the levels of aminopyrine 
N-demethylase, aniline 4-hydroxylase activity and P^gQ content, and 
no increase in the level of malonaldehyde if liver was stored solid 
at -40°C for up to one week (Fig# 4.16)# This was confirmed in a 
further experiment which also showed that during 6 weeks’ storage fall 
off in activity did occur although the rate of decay varied according
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to the parameter under study, type I metabolism being the most labile 
and bg the most stable (Fig* 4,18)* Once again, the loss in MFO 
activity in these samples is probably linked to a membrane lipid 
peroxidation effect, the greater short-term stability of these 
solid-stored samples (cf. isolated microsomes) reflecting the 
protective effect of intracellular compartmentalization and integrity 
of the endoplasmic reticulum. It is also possible that lipid 
peroxidative damage of lysosomal membranes could lead to the release 
of hydrolases (Tappel, 1973) which in turn could directly inactivate 
the microsomal MFO system (Betz et al, 1973),
4, Post-Mortem Storage Characteristics of the Hepatic Microsomal 
MFO System
In studies of the human hepatic microsomal MFO system it is
usually very difficult to obtain fresh normal samples and recourse
has often been made to the use of p.m. material. However, the 
«
autolytic changes that occur p.m. are a major drawback to this 
approach and it is well known that p,m« storage of liver in situ 
results in a decrease in the levels of type I and type II
metabolism, P^gg reduction and of protein content (Oondorf and 
Donahue, 1970; Macleod et al. 1973). These results have been 
confirmed with regard to P^gg and protein content, together with a
previously unreported fall in bg content (Table 4.14), However
during this period of p.m. decrease in cytochrome and protein content, 
there is no corresponding decrease in the bindihg affinity of the 
microsomes (on a mg, protein basis) either for dniline or biphenyl 
(Table 4.15). It is feasible to assume that the overall metabolism
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of type I and type II compounds, being dependent on the levels 
and/or activities of various components in the MFO system, would be 
expected to show greater susceptibility to p.m. changes compared 
with the comparatively simple reaction of microsome-substrote binding. 
Based on these findings it is probable that analysis of substrate 
interactions with microsomes derived from post-mortem and/or stored 
liver samples could provide a more rational extrapolation to the 
functional in vivo compared to, say, the measurement of metabolism 
or cytochrome content.
It is apparent from these proceeding studies that extrapolation 
from MFO activity in stored and/or p.m. liver to that existing in 
vivo is, with the possible exception of analysis of microsome-substrate 
interactions, of somewhat doubtful value. Yet for obvious reasons 
this extrapolatory approach has had to bo employed in many instances 
when investigating the MFO system in human liver (see Table 2,1),
Whilst the use of p.m. human liver may not prove valid for 
quantitative studies on microsomal drug metabolism it is, nevertheless, 
a perfectly acceptable tool with which to study qualitative patterns 
of microsomal drug metabolism, and has been so used to assess 
pathways of chlorpromazine metabolism (Coccia and Westerfeld, 1957) 
and the relative proportion of N- and 7- hydroxylation of 
2-acetylaminofluorene (Enomoto and Sato, 1957), It is most likely 
that this qualitative attitude to the use of p.m. human liver in drug 
metabolism studies could prove to bo of great value in the pro-clinical 
testing of potential drugs in that, although absolute values for 
metabolism could not be given, the relative proportions of metabolite® 
produced could be assessed and compared with the patterns obtained
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from laboratory animal species jjn vivo and vitro. This system
would obviously entail an awareness as to the possible 
storage-dependent differential decay in activities of the enzymes 
responsible for the various pathways of metabolism and could 
involve the use of a marker of storage decay such as malonaldehyde 
production,
5, The MFO System in Human Liver Microsomes
Only four samples of human liver were available for our study 
and these ranged from fresh biopsy samples to p,m, specimens 
subjected to long periods of storage# It is important that the 
history of each sample be known with regard to the method of its 
obtention, the storage conditions and the medical state of the 
donor; these wore obtained as complete as was possible. Due to 
this paucity in the number of samples only preliminary findings 
can be reported.
In agreement with other workers is the finding that human 
liver microsomes do contain cytochromes and bg (Table 4,20;
Alvares et al, 1969; Ackerman, 1970; Black et al, 1973; Nelson 
et al, 1971; Schoene et al, 1972), The presence of largo amounts 
of haemoglobin necessitate the use of a modified assay for P^gg 
as described by Schoene ^  ^  (1972) (Fig, 4,21), It has been 
reported that storage of solid human liver in a frozen state 
overnight leads to haemoglobin contamination of the ensuing fraction 
(Alvares et al, 1969), One interesting observation is the possibility 
that up to 20/s of P^gg may bo in the reduced state within the human 
liver in vivo (Fig, 4,23),
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The levels of P^gg in our study are much lower in the p.m. 
liver samples (1.9 — 3.8 nmole/g.liver) when compared to those 
reported for fresh biopsy samples (approx. 12 nmole/g.liver) (Black 
et al. 1973; Schoene et al. 1972; Thorgeirsson and Davies, 1971) 
whilst the levels of fag in the fresh and p.m. samples are comparable 
(approx. 3 nmole/g.liver) (Ackermann, 1970). This no doubt reflects 
the greater storage stability of bg as observed in our previous 
studies for rat liver.
Human liver microsomes are capable of metabolizing a number of 
compounds known to be either type I or type II in the rat (Tables 4.21 
and 4.22). Metabolism of type I compounds in fresh biopsy samples 
of human liver is at a level (6.5 - lO^moles product/g.liver/hr. ) 
one third to one half that present in malo rat liver microsomas; 
similar relationships have been reported by Ackermann (1970),
Darby ^  (1972) and Pelkonen ^  ^  (1973), Metabolism of
aniline on the other hand is at a level equal to that found in male 
rat liver microsomes (1^ mole product/g.liver/hr.). Comparison of 
enzyme activities for both type I and type II compounds in fresh 
biopsy and stored p.m. human liver samples reveals the decrease 
brought about by the post-mortem and storage conditions, (Tables 4.21 
and 4,22).
A few studies have shown that metabolism of various substrates 
by human liver microsomes is mediated by a typical MFO system 
(Ackerman and Heinrich, 1970; Kuntzman et al, 1965; Masters et al, 
1971). This has been confirmed in these studies with regard to 
time and cofactor dependency for the déméthylation of 4-chloro-N-rnethyl- 
aniline (Fig, 4,19 and 4.20) and the susceptibility of aniline 
hydroxylase and 4-chloro-N-methylaniline N-demethylase to inhibition
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by CO (Table 4*19)* One striking difference, however, between 
human and rat liver microsomes lies in the resistance of human 
liver microsomes to any inhibition by either SKF 525-A or metyrapone, 
even when the concentration of SKF 525-A is increased by a factor 
of 10 over the level effective in the rat. This difference in 
sensitivity to inhibition by SKF 525-A has also been noted by 
Ackermann (1970)# This aspect will be discussed further.
The present study has shown that human liver microsomes will 
bind substrates of the MFO system in a manner similar to that 
observed for rat liver microsomes# Thus, biphenyl, naphthalene,
SKF 525-A and 1—naphthol are type I substrates in human and rat liver 
microsomes (Table 4*23; Fig, 4,24; Mannering, 1971; von Bahr et al.
1971) whilst aniline, metyrapone and 4,4^-bipyridyl are type II in 
both species (Table 4.24; Fig# 4,25). In addition, butan-1-ol 
has been shown to give a typical reverse type I spectrum on addition 
to human liver microsomes (Fig, 4.20; Table 4,25). Kamataki et al, 
(1971; 1973) have reported that addition of high concentrations of
hexobarbital, aminopyrine and SKF 525-A to suspensions of adult human 
liver microsomes yielded characteristic type II spectra whilst 
Pelkonen (1973) has shown that these compounds elicit type I spectra. 
This discrepancy between the results of Kamataki et al (1971; 1973)
on the one hand and those of the present study and of Pelkonen (1973) 
on the other can possibly be allied with the known alteration in the 
class of binding which occurs with certain compounds (hexobarbital, 
aminopyrine, imipramine, didemothylimipramine and (+) -amphetamine) as
their concentration in the sample cuvette is increased (Kamataki et al,
/
1973b; Anders 1972; Hoffstrom and Orrenius, 1973; von Bahr and 
Orrenius, 1971), However, no evidence for this transition from
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type I to type II spectra was observed in the present study*
As discussed earlier the binding affinity of hepatic microsomes 
is much less affected by p.m., and probably storage, changes than 
are the levels of or overall drug metabolizing capability*
Based on this it is reasonable to assume that the K values
G
obtained for the p.m. human liver microsomes would bear more relation 
to those obtained for fresh samples than would the levels of overall 
drug matabolizing activity. Consequently, analysis of the K 
values obtained from these p.m. human liver microsomes could prove 
extremely valuable in elucidating the differences in MFO activity 
between human liver microsomes and those derived from the various 
laboratory animal species. It has been argued that values are 
linked to the Michaelis constants for various substrates (see Chap. 2)* 
The present findings support this contention. Thus, the low rate of 
metabolism of type I compounds in man appears to be related to the 
lower affinity of human liver microsomes for the substrate (see 
biphenyl and naphthalene in Table 4.23) as well as to the lower 
P^gg content, whilst the similar level of aniline hydroxylase activity 
in human and rat hepatic microsomes is paralleled by near parity in 
their values for aniline (Table 4*24). In this context, the level 
of aniline used for the enzyme assays (10 mM) lies within the range 
for which the low affinity value applies. Evidence for two
binding sites was obtained for all three typo II substrates and tho 
similarities in the values for the low K^;high ratio strongly 
suggest that these two binding sites are common to all three substrates. 
There was no evidence for two binding sites for these compounds in male 
rat liver microsomes. Furthermore, the previously-noted resistance 
of the MFO system in human liver microsomes to inhibition by either
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SKF 525-A or metyrapone is palpably associated with a very much 
lowered affinity of human liver microsomes for these inhibitors 
(Table 4.23 and 4.24)* The reasons for these species differences 
in substrate-microsome affinities are at present unknown although 
differences in the structure of which lead to alterations in
the charge density end/or lipophilicity of the relevant molecule, 
are probably involved.
These studies have revealed three major conclusions. Firstly, 
techniques exist by which small samples of human liver can be 
processed and assayed for their drug metabolizing potential, analysis 
of which could prove a useful tool in the diagnosis of liver-specific 
disease situations. Secondly, stored p.m. human liver cannot be 
used for quantitative studies on drug metabolism. They could, 
however, with reservation be profitably used for qualitative studies 
into the patterns of drug metabolism and these patterns compared with 
those found when using fresh animal liver microsomes* Finally, 
analysis of drug-microsome interactions using p.m. human liver and 
fresh animal liver could prove valuable in assessing the relative 
rates of hepatic drug metabolism in man and laboratory animal species. 
This is of further importance due to the difficulty in obtaining a 
regular supply of fresh human liver suitable for direct drug metabolism 
studies.
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CHAPTER 6. INTRODUCTION
1* Rationale
The mammalian liver is a complex and heterogeneous organ, both 
morphologically and functionally* It is this functional heterogeneity 
that makes mammalian liver the ideal organ with which to study various 
metabolic processes, their control and their interrelationships*
These metabolic processes, including those concerned with the 
transformation of xenobiotics, can be studied at four levels of 
tissue organization viz* whole animal, isolated liver, isolated 
liver cells and isolated subcellular fractions* In the field of 
drug metabolism it is only the two extremes of this organizational 
spectrum that- have been used to any great degree* The reasons for 
this are not hard to find; both systems are relatively easy to use 
and, in the case of the whole animal, gives a true picture of the 
overall state of metabolism. The use of isolated liver preparations 
either as the perfused organ or the isolated cells offers distinct 
advantages when examining in detail the role of the liver in drug 
metabolism and obviously represent a truer approximation to the ^  vivo 
state than do the subcellular fractions. The major limitation to 
the use of perfused liver in such metabolic investigations is the short 
length of time (loss than 10 hours) during which the preparation 
remains Viable; there is potentially no such limitation in the case 
of cultured cells. Thus, this system of cultured liver cells would 
appear ideal for studies into the metabolism of xenobiotics and also, 
possibly more important, into drug-induced hepatotoxicity and the role 
of metabolism therein.
Furthermore, obvious ethical difficulties exist to using human 
volunteers and perfused post-mortem human liver as systems for 
studying metabolism and possible hepatotoxicity of novel compounds 
developed by the pharmaceutical industries* Once again, the most 
feasible system for these preliminary clinical trials is prospectively 
that of cultured human liver*
In spite of these considerations there are no published reports 
as to the use of cultured adult mammalian liver in examining the 
metabolism of xenobiotics (although foetal cultures and 
freshly-isolated cell systems have been used for this purpose - 
see Chap. 2). The reasons for this lay in the recognized difficulty 
in obtaining cultures suitable for such a purpose* Foetal liver 
can be cultured quite successfully (see later) although these cells 
are unsuitable for most drug metabolism studies due to their known 
state of immaturity with regard to the microsomal MFO system (see 
Chap* 2). Many culture systems whilst being successful in a number 
of respects are unsuitable for metabolism and toxicity studies due 
to their difficulty and scale of operation* This is discussed 
elsewhere. Firstly, however it is appropriate to give a brief 
description of the mammalian liver and also of the factors which 
may possibly affect its successful culture,
2, Brief Description of the Anatomy and Histology of Mammalian Liver
In the adult the liver is supplied by blood from two sources. 
The principal afferent blood vessel, supplying 90^ of the blood, is 
the portal vein* It collects the blood from the viscera of the
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digestive tract end enters the liver at the porta together with the 
hepatic artery. As the portal vein enters the liver it branches 
up into a series of vessels which supply a capillary bed in the 
liver tissue, from which the blood drains into the hepatic veins 
which discharge into the inferior vena cava. The minor source 
of blood supply (10/0 is by way of the hepatic artery a relatively 
small vessel which delivers oxygenated blood from the dorsal aorta 
and supplies the interlobular connective tissue and its contained 
structures and helps to nourish the parenchyma of the gland,
b. Liver Lobules
The mammalian liver is comprised of small polygonal areas 
each of which represents an architectural unit or lobule, 0,7 mm, 
to 2 mm, in diameter. The lobule is a polygonal prism which in 
cross section has 5 — 7 sides. Running through the centre of the 
lobule, in its long axis, is the central vein, while at the 
periphery are the branches of the portal (interlobular) vein, the 
interlobular bile ducts, branches of the hepatic artery and the 
lymphatics which form a network about the portal vein and its 
branches (Fig, 6*1),
c« Hepatic Sinusoids
The cords of liver cells are separated one from another by the 
hepatic sinusoids* These are irregular blood spaces which pursue 
a radial course in the lobule and connect the interlobular portal veins 
with the intralobular central veins. They also receive blood from 
the branches of the hepatic artery. The lining of the sinusoids is
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Fig. 6.1. Idealized Transverse Section of Mammalian liver to Show 
Lobule Structure
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Each portal canbl transmits a branch of the hepatic portal vein, 
hepatic artery, bile duct and lymphatic vessels.
Fig. 6.2, Intralobular Structure of Mammalian Liver
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composed of an irregular alternation of 2 kinds of cells* These 
are the undifferentiated lining cells and the fixed macrophages — 
the stellate cells of von Kupffer - both types being part of the 
reticulo-endothelial system (Fig* 6*2),
d. Hepatic Cells
The liver cells (hepatocytes) are arranged regularly in cords 
which form columns extending radially from the central vein to the 
periphery of the lobule* The cords may branch slightly and anastomose 
with nearby cords, but in spite of this their general direction is 
perpendicular to that of the central vein. Between those cords are 
the sinusoids (Fig* 6,2).
The liver cells are polygonal in shape and have 6 or more 
surfaces* Most hepatocytes have one large, round nucleus, although 
binucleated cells are quite common; a recent study has estimated 
that binucleated cells comprise about 30^ of hepatocytes in adult 
rats and that large numbers appear shortly after weaning (Wheatley, 
1972), The nucleus is quite vesicular; it has a smooth membrane and 
one or more very prominent nucleoli and a few small chromatin dots.
The cytoplasm of the hepatocyte presents an extremely variable 
appearance which reflects to some degree the functional state of the 
cell. Both glycogen and fat inclusions can be readily demonstrated 
The cytoplasm also contains mitochondria of variable appearance, a 
Golgi net and vacuoles*
In spite of the multitude of functions which hepatocytes perform, 
there is a marked similarity in all of them* This is at variance 
with what is seen in other organs, in which highly specialized functions
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are carried on by cells which morphologically are highly differentiated* 
It seems that all the hepatocytes are equally endowed with the same 
functional properties, but that their active participation in these 
processes under normal conditions depends on the location of the cell 
in the lobule*
e. Bile Canaliculi
In adult man the liver cell cords in cross section consist of 
two adjacent cells between which runs a thin bile canaliculus 
which is a condensation of the membrane of the hepatocytes* Those 
bile canaliculi, after pursuing a tortuous route, eventually join 
up with the interlobular bile ducts*
f• Connective Tissue
The liver lobules are partially separated by very thin strands 
of dense connective tissue termed periportal connective tissue#
This is a part of Glisson*s capsule, the dense connective tissue 
sheathing the intrahepatic portions of the portal vein, bile duct and 
hepatic artery, and is also continuous with the thin layer of 
connective tissue covering the liver# In man the outlines of the 
lobules are usually indistinct because the connective tissue partitions 
between them are poorly developed* In the pig, polar bear and 
racoon, on the other hand, each lobule is completely surrounded by 
a layer of connective tissue and the lobulation is obvious* The 
periportal connective tissue continues directly into the dense network 
of intralobular reticular fibres which surrounds the sinusoids and 
supports the liver parenchyma*
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3# Some Characteristics of Mammalian Liver of Possible Importance 
to its Successful Culture
Connective tissue is found wherever there is a need for support 
of other tissues and is composed of two phases, the cellular and the 
extracellular* The proportion of these two phases governs the 
type of connective tissue.
Dense connective tissue occurs where strength is more important 
than looseness (e,g* as organ capsules, support for skin, muscle 
fascios and tendons) and has an abundance of the extracellular phase 
with a few cells* The predominant cells are fibroblasts which 
synthesize and secrete the collagen fibres which, together with the 
ground substance of mucopolysaccharides, constitute the extracellular 
phase*
Loose connective tissue is found where exchange of metabolites and 
fluids between an epithelial layer and the vascular system is 
desirable* Although the major cell type is again the fibroblast 
various other cell types are also observed including macrophages, the 
lymphoid cells, eosinophils, most cells and plasma cells* The 
extracellular phase consists of three types of fibres viz*, 
collagenous, elastic and reticular* The reticular fibres are 
collagenous in form but with smaller diameter than the mature collagen 
fibre. This reticular connective tissue is foupd in the interior of 
most organs*
Basement membranes form another extracellular material of rather 
amorphous structure and are considered to be a supporting structure,
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mostly for epithelia and vascular channels. They are composed of 
reticular fibres and a ground substance*
As mentioned earlier* the periportal connective tissue and 
Glisson*s capsule account for the bulk of the dense connective 
tissue found in the liver* Basement membranes surround the blood 
vessels and lymphatic channels found in the portal tracts and the 
epithelium of the bile ducts and ductdles also rests on a basement 
membrane. Within the liver lobules the only connective tissues 
present are the reticular fibres which surround the sinusoids* 
although the space between the endothelial cells and the hepatocytes, 
the space of Disse, contains protein-bound mucopolysaccharides 
(Rubin and Hutterer* 1967)*
In man, the infant liver contains less than one-half of the 
collagen content of the adult liver* This has been taken to indicate 
that in normal growth the parenchymal cells proliferate much more 
rapidly than do the stromal cells (Rubin and Hutterer, 1967). A 
similar situation has been found in rat liver where the hepatic 
collagen content was related to both age and diet (Oeyl et el* 1971)* 
The ground substance of hepatic connective tissue has been shown 
to be largely a mixture of chondroitin sulphates A and C together with 
some hyaluronic acid (Rubin and Hutterer, 1967)*
This brief discussion on connective tissue and its presence in 
mammalian liver highlights some points extremely relevant to the 
successful isolation of, and hence culture of, hepatocytes* These 
points are summarized below*
i) Connective tissue is the only tissue which supports the liver 
whether this connective tissue be surrounding the blood vessels or 
the liver itself, or whether it be the fine reticular fibres which
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support the hepatocytes*
11) The vast bulk of the hepatic connective tissue is extralobular 
with only the reticular fibres being intralobular#
ill) In both the dense and reticular connective tissue the 
outstandingly predominant extracellular fibre is collagenous whilst 
the ground substance is virtually all chondroitin sulphates A and C#
Two conclusions can be drawn from these points# Firstly* 
successful isolation of liver cells should be possible by use of a 
system which breaks down the collagen/chondroitin sulphate phase of 
the connective tissue# Secondly* it should be theoretically easier to 
isolate and culture* foetal or newborn liver cells than adult 
hepatocytes#
The Ca^-free collagenase/hyaluronidase system which breaks down 
collagenous structures has been proposed by Howard and Pesch (1968),
This couples the specific action of Clostridial collagenase with that 
of testicular hyaluronidase* an enzyme effective against hyaluronic 
acid and chondroitin sulphates A and C, The dissociating medium is 
free of Ca"^ * presumably to minimize the possibility of Ca*^-induced 
re-aggregation of the dissociated cells (Moscona et al, 1965),
The Clostridial enzyme progressively removes small fragments from the 
terminal carboxy end (Evanson* 1971); for activity the enzyme 
requires a P-R-R^ structure where P represents proline or hydroxyproline* 
the actual break occurring between R and (Bangs, 1966), Testicular 
hyaluronidase by itself has no action on collagen (Bangs, 1966),
The use of this enzyme system will be discussed elsewhere.
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The mammalian pancreas contains an enzyme* termed a collagen 
mucoproteinase* which is able to exert a collagenase effect provided 
the substrate is adequately disintegrated (Banga, 1966), although 
Evanson (1971) has stated that this mammalian collagenase is strongly 
inhibited by a potent serum factor. Other more general proteases, such 
as trypsin, appear to be essentially inactive against collagen* Banga 
(1966) has given evidence that only associated accessory substances 
are removed during tryptic digestion, whereas the collagen protein 
is not attacked*
b* The Cell Types of Mammalian Liver
Mammalian liver contains a large number of cell types in 
addition to the hepatocytes; these cell types are listed in 
Table 6*1.
It should not be imagined that these non-parenchymal cell 
types represent an insignificant figure in the total cell population 
of the liver. Gates e^ (1951) computed that approx, 16% of 
the cells in human liver were non-parenchymal while in rats this 
figure approached AQ% (Daoust, 1958). A breakdown of these 
results is shown in Table 6.2*
This multitypic conglomeration of cells in mammalian liver 
leads to one of the most serious and continual problems in liver 
culture, namely, the appearance of either more than one cell-type or 
of a single undesired cell-type, leading in both cases to a suppression 
in the growth of the desired cell-type, the hepatocyte.
TablQ 6.1. The Cell Types of Mammalian Liver
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Tissue
Parenchyma
Reticulo-Endothelial
Bile Duct 
Connective Tissue
Blood
Blood Vessel 
Walls
Cell Classes 
Hepatocytes
Littoral (Kupffer cells 
and indifferentiated 
lining cells)
Bile Duct Epithelium
Fibroblasts
Macrophages
Erythrocytes 
Leucocytes 
Lymphocytes 
Monocytes 
Plasma Cells
Fibroblasts 
Pavement Epithelium
Site
Intralobular
Intralobular
Interlobular
Interlobular
Inter— and Intra­
lobular
Inter— end Intra­
lobular
Table 6.2. Distribution of Cell Types in Mammalian Liver 
(from Daoust* 1958; Gates et al* 1961)
Cell Type
Parenchymal 
Littoral 
Bile Duct 
Connective Tissue 
Blood Vessel Walls
Rats (%)
60.6
33,4
2,0
2.2
1,8
Man (%)
84.2
14.7
0.6
0,2
0,3
159
c. The Hepatic Cell Cycle and its Regulation
The cell cycle of hepatocytes Is identical to that of other* 
cells and has four phases, the pre-DNA-synthesis stage (G )^, the 
DMA synthesis stage (S), post-DNA-synthesis stage (G^ ) and a mitotic 
stage (M) (Lehmiller, 1971), This cycle is outlined in Fig# 6,3,
Fig, 6,3, The Hepatic Cell Cycle
M
Proliferation Kinetics in normal adult hepatocytes ere unusual 
in that few cells continuously cycle through S and M phases although 
cells can be readily stimulated to rapidly cycle through those phases. 
To account for these characteristics, a phase has been postulated 
(Baserga, 1968), While in this phase the cells are considered to be 
outside the replicative cycle in a typo of "siding" from which they 
can be recalled by appropriate stimuli.
The growth fraction (the proportion of hepatocytes that are 
involved in the replicative cycle) declines markedly as rats age.
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From a level of about 36/a on the first day after birth it declines 
to 4>o « 6% in rats 6 - 8  weeks old (see Grisham, 1973); the 
corresponding proportion of mitoses is 3,8% and 0*6% respectively 
(Buetow, 1971)# This discrepancy between the proportion of cells in 
the replicative cycle and the proportion actually undergoing mitoses 
can partially be explained by the gradual appearance of tetraploid and 
octaploid nuclei over this time (Wiest, 1973), Furthermore, the 
duration of the cell cycle appears to lengthen shortly after birth, 
reaching constant values at 3 weeks (see Grisham, 1973)* This is 
illustrated in Table 6,3.
Table 6.3, Phases of the Hepatic Cell Cycle in Intact Livers of 
Maturing Rats (from Grisham, 1973).
Age Phase Time (hours) Total Generation
"l S M Time (hours)
1 Day 5.0 7.0 1,5 0.3 13.8
3 Weeks 9.0 9.0 1.8 1,7 21.5
8 Weeks and older 9.0 9.0 1,8 1.7 21.5
Once formed, rat hepatocytes have a "life-span" or turnover 
time of 400 - 450 days, the mouse hepatocytes having a turnover time 
of 480 - 620 days whilst the littoral cells of mouse have a turnover 
time of 160 days; these figures should be compared to the turnover 
times for mouse duodenal epithelium and erythrocytes which are 3 and 
1 - 2  days respectively (Cameron, 1971).
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The regulation of hepatic cell proliferation is poorly 
understood although a number of hypotheses have been proposed#
Bullough and Laurence (1967) have proposed the chalone concept to 
explain the regulatic of hepatic cell proliferation, a chalone being 
a tissue-specific mitotic inhibitor produced by the cell type on which 
it acts# A liver-specific chalone has been isolated by Bullough 
and Laurence (1967)# On the other hand, various investigators have 
suggested the existence of humoral regulator factors of hepatic 
cell proliferation# Glinos (1967) has postulated such a humoral 
regulator whose site of synthesis is the liver itself thereby enabling 
a feedback control system to be established* One of these factors 
appears to be associated with the plasma proteins although this is 
not the only factor involved (Glinos, 1967)# In agreement with this 
proposal is the finding by Onda and Voshikaua (1973) of an hepatocyte- 
specific mitotic inhibitor in normal rat plasma which may be present in 
the-globulin fraction* A very similar hypothesis has been put 
forward by Grisham (1973)*
It is conceivable that all those above-mentioned points have a 
bearing on the successful cultivation of adult mammalian liver tissue# 
Thus, in explant culture of liver, in which the liver architecture is 
largely unaltered, the proliferation and outgrowth of hepatocytes may be 
very poor due to the maintenance of the normal inhibitor level within 
the expiant despite the fact that the hepatocytes may remain
functionally intact within the expiant until their turnover time expires#
\
In cell cultures, on the other hand, where the cells have firstly been
/  ■ ■ , . separated, the mitotic inhibitor present whether it be intrahepatic or
humoral is likely to be washed out leaving the'cells ready for mitotic
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growth by altering the hepatocyte state from the phase to the 
phase of the replicative cycle,
3, The Isolation of Mammalian Hepatocytes
The isolation of adult mammalian liver cells whether for 
immediate use or for culturing has been attempted by a large number 
of investigators (for review see Muller et al, 1972), although 
many of these studies have paid insufficient attention to the viability 
of the cell suspensions. The most commonly used viability test 
is exclusion of the dye trypan blue, which occurs only with viable 
cells. This is generally regarded as a sensitive index of membrane 
integrity, on which many hepatic functions are dependent. Each 
method of cell isolation falls into one of three overlapping categories, 
namely, mechanical, chemical and enzymic, although this classification
» is somewhat misleading in that every method contains an element of 
mechanical dissociation e.g., the use of a stirring or mixing 
apparatus.
The employment of a wholly mechanical system for the isolation 
of liver cells has occasionally been reported. Thus, Kattenbach (1952), 
Le Page (1953) and Ontko (1967) have described the use of a tissue 
press whilst Bucher ^  ^  (1951) dissociated liver cells by shaking 
liver slices with glass beads. However, it has been much more 
common to use some form of In situ perfusion of the liver in 
conjunction with these mechanical techniques; the perfusing fluid 
commonly contains a metal chelator. An early example of this 
technique is that of Anderson (1953) who perfused a solution of
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sodium citrate through the liver ^  situ prior to dissociation of the 
liver by moans of a modified Potter-Evejhem homogenissr. This 
technique was later modified by Jacob and Bhargava (1962), who 
reported high cell yields, and by Rutter and Brosemer (1961) who used 
a sucrose/sodium citrate mixture for the perfusion* Suzsngar and 
Dickson (1970) have recently examined this system in detail and 
assessed the various perfusion media.
Two interesting variations on this perfusion-mechanical 
dissociation procedure have been reported, Branister and Morton 
(1957) and Dajani and Orten (1959) have described the use of 
polyvinylpyrrolidone as the perfusing medium whilst McLimans (1969) 
has reported the use of a hypertonic, hyperosmolar salt solution as 
perfusing medium.
Whilst most of these perfusion-mechanical dissociation techniques 
produce excellent cell yields (Suzangar and Dickson, 1970), the 
harsh treatment of the homogenization step invariably leads to 
damaged cells and cell membranes. This damage is manifested in 
a number of ways;- lack of aerobic glycolysis and of endogenous 
respiration, impairment of protein and RMA synthesis, leakage of 
enzymes, potassium ions and NAD, and, finally, staining with trypan 
blue (for references see Muller et al, 1972).
The one example of chemical dissociation of liver is the use of 
tetraphenylboron (TPB) as a potassium-chelator, originally suggested 
by Rapaport and Howze (1966). Casanello and Gerschenson (1970) have 
described this use of TPB and have shown that these dissociated cells 
are capable of growth in suspension culture. The viability of cells 
dissociated by this method has been questioned by a number of authors
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on the basis of trypan blue exclusion tests and leakage of enzymes 
(Gallai-Hatchard and Gray, 1971; Rutzky et al* 1971), lack of 
uptake of acetate into cellular lipid (Lipson et al, 1972), lack 
of endogenous oxygen consumption (Suzangar and Dickson, 1970) and low 
potassium content (Murthy and Petering, 1969),
In 1958 Howard and Peach described the first successful 
enzymic digestion of adult mammalian liver into appreciable numbers 
of largely intact cells. This procedure of Howard and Pesch (1968) 
basically involved brief perfusion of the liver in situ with a 
mixture of collagenase and hyaluronidase in Ca*^—free solution, 
slicing the liver and incubating the slices with the Ca*^—free enzyme 
solution. Approx. 5 x 10^ cells per g, liver could be obtained 
with viability score (as judged by trypan blue exclusion,of between 
75 and 95%; the level of endogenous respiration was higher than that 
found in mechanically—isolated cells (Howard and Pesch, 1958). Since 
then the method has been continually modified, largely with the aim 
of increasing cell yield (Berry and Friend, 1969; Capuzzi et al, 1971; 
Ingebretsen and Wagle, 1972), All these modified techniques involve 
the use of a continuous perfusion of the liver vitro in the 
presence of circulating collagenase/hyaluronidase. Various studies 
have shown that these enzymically-prepared adult hepatocytes are 
superior in morphology and functional activity to both mechanically- 
end chemically-prepared cells (Lipson et al. 1972; Gallai-Hatchard and 
Gray, 1971; Murthy and Petering, 1969; Muller et al, 1973) whether the 
cells are isolated from normal liver, regenerating liver or hepatoma 
(Muller et al. 1973), These enzymically-dissociated hepatocytes 
have been reported to be able to synthesize and secrete albumin
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(Weiqand et al, 1971; Cast et al# 1973), the ratio of albumin synthesis 
to total protein synthesis being the same as in intact liver in vivo 
(Weiqand et al, 1971), Furthermore, such cells can synthesize 
glycogen (Seglen, 1973), are responsive to glucagon and epinephrine 
in stimulating glycogenolysis (Wagle and Ingebretsen, 1973; Garrison 
and Haynes, 1973) and are susceptible to the inductive effects of 
glucocorticoid hormone on tryptophan oxygenase (Berg et al, 1972), 
flore recent work (Seglen, 1972; Howard et al, 1973) has shown that 
the presence of Ca*^ in the dissociation medium stimulated the 
enzymic dissociation and also increased the potassium content of 
the dissociated cells (Howard et al, 1973); it should be noted 
that previously Ca*^ was excluded from the dissociation medium (Howard 
and Pesch, 1968), This Ca^  ^—stimulated enzymic dissociation is 
dependent either on a preliminary removal of tissue Ca with a 
chelator (Seglen, 1972) or on the time of addition of the Ca^
(Howard et al. 1973),
In spite of the obviously superior morphological and functional 
qualities of hepatocytes prepared by collagenase/hyaluronidase 
digestion very few authors have commented on the possibility of 
culturing these hepatocytes (see later).
4, Liver Culture : Techniques and Results
The culture of animal tissues can be achieved using a variety 
of techniques which fall into 3 categories viz,,organ culture, explant 
culture and cell culture (Moscona et al, 1965), In organ culture
the organ or a piece of the organ is maintained such that the cellular 
architecture of the organ is unaltered and that peripheral outgrowth
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is discouraged. This is usually achieved by placing the specimen on a 
solid support such as a sponge, grid or raft and allowing sufficient 
medium to just come into contact with the specimen-support interface* 
Explant culture is very similar to organ culture in that small pieces 
of tissue are used but differs from it in that the peripheral outgrowth 
is encouraged and the outgrowing cells, not the expiant, are examined* 
The third system for culturing animal tissue is cell culture in which 
cells isolated from the desired tissue are maintained as independent 
units either by attachment to a support or in suspension culture*
The behaviour of animal cells and tissues in vitro depends very 
largely on the size of the units which are cultured and, according 
to the size selected, the conditions for their culture must be varied* 
All three types of culture system have been applied to mammalian 
liver both foetal and adult, non-human and human in origin*
i) Culture of Foetal Mammalian Liver
a* Non-Human Species
Culture of dissociated foetal mammalian hepatocytes has 
been described by a number of workers (Schapira et al* 1971;
Plas et al* 1973; Lambiotte et al* 1973; Leffert and Paul, 1972; 
Gielen and Nebert, 1971)* It appears to be much easier than 
culture of adult hepatocytes, which is predicted on theoretical 
grounds* The most widely-used dissociating agent is trypsin 
(Schapira et al* 1971; Plas et al, 1973; Lambiotte et al* 1973) 
although collagenase (Leffert and Paul, 1972) and viokase, an 
enzyme mixture (Gielen and Nebert, 1971) have also been used*
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The number of isolated cells actually attaching to the culture 
surface never exceeds 10% that of the initial seeding level 
(Leffert and Paul, 1972; Plas et al, 1973) even when collagen, 
a substratum known to be beneficial to cultured cells (Elsdale 
and Bard, 1972), is used in place of plastic (Plas et al, 1973)*
Two types of cell, fibroblastic and epithelial, were distinguishable 
in these cultures (Plas et al. 1973) although after 4 days in 
culture the extent of fibroblast involvement never exceeded 15%
(Plas ^  al, 1973).
Lambiotte e^ ^  (1973) were able to selectively remove 
the fibroblasts (2-3 days after plating) using a collagenase 
subculturing stage, during which the hepatocytes were almost 
completely selectively replated* Leffert and Paul (1972) 
suppressed growth of non-parenchymal cells by use of a medium 
deficient in arginine although it should be noted that the 
hepatocytes in culture were either non- or at best slow-growing*
This non-growth of cultured hepatocytes in arginine-deficient 
medium may be related to the lack of extracellular arginine; 
this deficiency of arginine has been shown to lead to a decrease 
in the level of ornithine-SSaminotransferase, an important 
enzyme in the urea cycle, over a 24-hour incubation period 
(Strecker and Hammer, 1971). It is possible that such a build-up 
of toxic nitrogenous waste produced as occurs in blockage of the 
urea cycle could inhibit cellular growth.
These cultured hepatocytes have been shown to retain 
liver-specific urea-cycle functions together with synthesis and 
secretion of albumin (Leffert and Paul, 1972) as well as 
benzpyrene hydroxylase activity, both endogenous and inducible
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(Gielen and Nebert, 1971), However, the continual presence of 
cortisol in the medium was required for cultured foetal hepatocytes 
to exhibit glycogen storage function (Plas et al, 1973) and 
formation of bile canaliculi (Lambiotte et al, 1973), Furthermore, 
Schapira et al (1971) have shown that these cells lose a liver- 
specific aldolase on culturing* It is very possible that these 
differences in the ability of foetal hepatocytes in culture to 
retain specific functional activity may be a reflection in some 
way of the use of the different dissociating enzymes for their 
isolation (see above)#
The only reports regarding expiant culture of mammalian 
foetal liver from non-human species appear to be those of 
Sandstrom (1964, 1955, 1966)* Four cell types could be 
distinguished in the explant outgrowth, only one type of which 
resembled true hepatocyte morphology (Sandstrom, 1965). Moreover, 
the predominance of any call type in the culture depended largely 
on the means of culture# The only system of culture in which 
hepatocytes predominated was one wherein the liver explant was 
held firmly compressed between 2 sheets of cellophane just moist 
enough to adhere to each other by capillary force (Sandstrom,
1964, 1965).
Wicks (1968) has described a system, involving a metal grid 
as e support, for the organ culture of foetal rat liver#
Tourian (1973) has shown that such a system maintains the tissue 
in a differentiated state over a 48-hour period, at least with 
regard to its high baseline tyrosine aminotransferase activity 
and the hydrocortisone deducibility of this activity. This
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culture system has been used to study the phenylalanine 
hydroxylase activity (Tourian, 1973) and the inducibility of 
tyrosine aminotransferase (Wicks, 1968) and aryl hydrocarbon 
hydroxylase (Burki et al. 1971) in foetal liver. A system of 
organ culture, similar to that of Wicks (1968) has been described 
by Klein and Weller (1970)* Using this system Eisen ejb ^  (1973) 
have demonstrated the role of insulin in regulating hepatic 
glycogen synthesis# A slightly modified culture system, 
employing a lens paper and metal grid support, has been used 
by Raiha £t ^  (1971) to confirm the finding of Wicks (1968) 
regarding the inducibility of tyrosine aminotransferase.
b# Man
The first report of culture of human foetal liver was that 
of Hillis and Bang (1959) using an expiant culture system in 
collagen-coated roller tubes; collagen was considered essential 
for growth# Cell outgrowth was good but by the tenth day of 
culture cells of mesenchymal origin began to overrun the 
hepatocytes* Further work (Hillis and Bang, 1962) showed 
that more selective growth of hepatocytes could be obtained 
by infrequent medium changes, and that the presence of arginine 
provided a more abundant healthier spread of hepatocyte bands 
and cords# Feldenstein (1963) maintained human foetal hepatic 
cells in culture by allowing cell suspensions (prepared by 
trypsinization) to settle by gravity onto collagen-coated 
polythene discs. Zuckerman et al (1967) using a system involving
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pressure implantation of trypsin-softened human foetal liver 
onto polythene discs, reported fibroblast interference in 
cultures after approx, 10 days culture. Mechanical 
disaggregation and the use of pronase as dissociating agent 
proved unsuitable for the initial preparation of cell clumps.
Lie (1972) in a recent paper has demonstrated the effect of 
portal serum in enhancing hepatocyte outgrowth from human 
foetal liver explants* This effect was specific to portal 
serum, fibroblastic outgrowths being repeatedly observed when 
using peripheral serum,
A recent report regarding the culture of trypsin-dissociated 
human foetal liver is that of Bissell and Tilles (1971), The 
presence of 10% calf serum or 1% human serum in the growth 
medium accelerated the proliferation of the liver cells with 
subsequent rapid loss of characteristic morphology and specific 
functional activity. In the absence of serum the cultured 
liver cells retained their morphology and their function for at least 
4 weeks as evidenced by secretion of serum albumin and storage of 
glycogen and iron although the division rate was very low*
ii) Culture of Adult Mammalian Liver
For the sake of simplicity the term ’adult* in this context refers 
to any period after birth* This distinction is purely arbitrary and, 
as discussed earlier, the liver does not attain its adult morphology 
and functions for some time after birth (3 weeks in the case of the rat).
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a, Non-Human Species
Literature reports regarding culture of adult mammalian 
liver place much less emphasis on the role of organ culture 
techniques and much more emphasis on the cell culture techniques. 
The only reports concerning organ culture of adult liver appear 
to be those of Laufs and Walker (1970) and Campbell and Hales 
(1971), the former employing marmoset liver and the latter 
rat liver. These reports place great stress on the gas atmosphere 
required for optimal survival of the tissues, both agreeing on the 
desirability of an oxygen-enriched atmosphere* Campbell and 
Hales (1971) noted that during the first 6 days of culturing the 
tissue pieces showed a gradual loss in glycogen content, the 
extent of decrease being dependent on the composition of the gas 
overlay.
The first report regarding explant culture of adult liver 
was that of Hillis and Bang (19B9)* Using a culture system 
identical to that used for foetal human liver, they were able to 
observe that adult monkey liver followed the same pattern of 
growth to that of foetal human liver except that the outgrowth 
was more irregular and began somewhat later and at a much slower 
rate* Watanabe (1966), using a system very similar to that of 
Hillis and Bang (1959), reported that outgrowth from expiants 
of newborn (24 hours old) rat liver was essentially identical to 
that described by Hillis and Bang (1959), More recently,
Alexander and Grisham (1970) using a system very similar to that 
of Sandstrom (1965) but invorporating a collagen substratum, have 
reported on the light and electron microscopic appearance of cells
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which grew out from expiants derived from livers of rats 1—5 days 
old. Several types of cells were observed, the most prominent 
being hepatocytes. On the other hand, Rutzky et ^  (1971) 
obtained a fibroblastic cell-line from explants of 
trypsin-treated neonatal rat liver, Rabee £t ^  (1972) 
using a simple culture system (no collagen, large fluid volume) 
could not demonstrate any outgrowth from rat liver explants 
(rats older than three weeks) in culture; only when the rats had 
been pretreated with diethylnitrosamine for 107 days did they 
observe cell proliferation and then only from expiants derived 
from the induced ’preneoplastic* enzyme-deficient nodules,
Douglas et al (1966) attempted to culture explants derived from 
the livers of nine chimpanzees. The outgrowth was exclusively 
fibroblastic and only from the liver of one animal could a 
cell-line be established which eventually transformed itself 
to an epitheloid line.
Because of the difficulties inherent in using explant and 
organ cultures of adult liver a number of investigators have 
concentrated on the use of cell cultures for such tissue. 
Unfortunately, after many years of research there still is no 
widely accepted system for the culture of adult mammalian 
hepatocytes. Consequently, hepatocytes prepared by all three 
isolation methods (mechanical, chemical and enzymic) have been 
claimed to be able to survive in culture although the morphological 
and functional state of some of these cultures must remain in 
question,
McLimans (1969).has reported that mouse hepatocytes isolated
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by perfusion/mechanical dissociation can grow in culture provided 
that a collagen substratum and a thin film of medium overlay is 
used. However, work by Gallai-Hatchard and Jones (1971) has 
shown that hepatocytes prepared by this means are not viable 
on the basis of dye-uptake tests, Dickson (1971) has also 
described the culture of mechanically-disaggregated hepatocytes; 
during the 10-day culture period there was no storage of glycogen 
and the histological appearance of the cultured cells showed 
marked irregularities especially of the nuclei. These results 
are not unexpected in light of previous work, mentioned earlier, 
which conclusively showed that the hepatocytes isolated by 
mechanical disaggregation were damaged even before the culture 
proper was initiated,
Hepatocytes dissociated by treatment with TPB have also been 
maintained in culture (Casanello and Gerschenson, 1970) although, 
once again, this method of dissociation is not recognized as one 
which yields viable cells; it is probable that cultures of this 
type arc derived from clonal growth. Moreover, evidence 
obtained from chromosomal analysis and carcinogenic potential 
(Oshiro 1972) and from enzymic analyses (Walker et al, B72)
strongly indicates that the cells of this established line do not 
resemble normal functional hepatocytes.
The establishment of cultures from trypsin-dissociated liver 
has been reported (Umedo and Saito, 1969; Armato et al, 1972a, b; 
Williams et al, 1971) although the rats used were either newborn 
(Umeda and Saito, 1969; Armato et el, 1972a) or ID-day-old 
(williams et al, 1971), Up to seven cell types have been
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described in such cultures, the predominant types being 
morphologically hepetocyte-like and fibroblastic (Armoto et al« 
1972b), Uilliams ejt al (1973) later demonstrated that 
treatment of these cultures with carcinogens yielded cells which 
on injection into rats produced carcinomas not found after 
injecting untreated cells*
Borek (1972) has described the establishment of a clonal 
line of epithelial-like cells obtained from rat liver by means 
of a trypsin/collagenasB dissociating mixture* Conditions of 
nutritional stress led to neoplastic transformation into 
differentiated hepatoma-like cells* lype (1971) using the 
method of Howard and Posch (1958) for the isolation of hepatocytes 
has reported the establishment of cell lines which appear normal 
with regard to karyology, morphology and growth pattern; 
unfortunately no tests for liver-specific function were tested 
for* lype (1971) also reported that an oxygen-rich atmosphere 
was harmful to the growth of these cells. In a subsequent 
paper, lype ^  ^  (1972) demonstrated organ-specific antigens 
on the surface of cells freshly isolated from normal rat liver 
and from the liver cell lines*
b* Man
Attempts to obtain cell cultures of adult human liver have so 
far not been too successful* Chang (1954) described a cell line 
consisting of epithelial cells derived from normal human liver# 
These cells developed the characteristics of undifferentiated
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neoplastic tissue and it was not suggested that these cells 
represented differentiated hepatic cells, A cell morphology 
similar to that of the Chang cells was observed in a cell-line 
developed by Syverton and McLaren (1957) from a liver biopsy 
of an infant. More recently, Sullman ot ^  (1950) published a 
brief report on the applicability of the method of Zuckerman 
^  ^  (1967) to the culture of adult human liver biopsies; no 
follow-up work has been reported. Two cell-types could be 
distinguished in these cultures, namely hepatocytes and 
fibroblast-like cells.
Explant culture of adult human liver has met with some 
success. Thus, Sandstrom (1973) using a method previously 
described (Sandstrom, 1954) for rat liver was able to show 
outgrowth of hepatocytes from expiants of human liver biopsies, 
there being histochemical evidence for the presence of bile 
canaliculi, A thorough investigation into expiant culture of 
adult human liver has been carried out by Bourel and co-workers 
(Bourel et al, 1968; Lenoir et al, 1968; Le Guilly et al, 1969, 
1971, 1973; Guillouzo ^  £l, 1972). After a lag of 4-5 days cell 
outgrowth commenced, and fibroblasts and macrophages became 
apparent. In the days following, cells resembling hepatocytes 
became noticeable (Bourel et al, 1968), Incorporation of a 
proton-acceptor, e.g, dipyridamole, into the culture medium 
greatly facilitated this growth (Lenoir et al, 1968), Later 
work (Le Guilly et al, 1971; Guillouzo et al, 1972) showed that 
five cell types could be observed and that the type of serum 
protein produced by any culture was determined by the predominating
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cell type. By day 20 of culture all cells had simpler 
ultrastructuros (Guillouzo et al, 1972); dedifferentiation was 
claimed to account for this phenomenon# On the other hand, 
Oemoise et al (1971) proposed on electron microscopy analysis 
that the epithelial cells which outgrew from explants of adult 
human liver biopsy material were mesenchymal rather than 
parenchymal in origin#
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CHAPTER 7. MATERIALS AND METHODS
Materials 
1. Animals
All animals used in this study were male Uistar/Albino rats, 
weight range 60 - 150 g«, which were bred and maintained in the 
University Animal House# The animals were allowed free access 
to food and water, the feed being Spiller*s No# 1 Laboratory Diet#
2# Materials# Media and Chemicals
Culture vessels used were *Falcon* treated-polystyrene flasks 
of area 25 sq$cm#* and in some experiments *Falcon* microtitre 
plates were employed; both were supplied by Scientific Supplies, 
London# The Bolting nylon cloth was obtained from P#A# Simon Ltd#, 
Cheadle Heath, Stockport#
The suppliers of the various media, media supplements and 
chemicals are listed in the Appendix# Sheep portal serum was a 
generous gift from Pfizer Ltd*, Sandwich#
All solutions prepared in the laboratory were sterilized by 
either autoclaving at 15 lb* pressure for 15 minutes in the case of 
salt solutions, or by filtration through a Millipore filter pore size 
0*22^ « All media contained gentamycin (70^g/ml) whilst those media 
based on MEM also contained non-essential amino acids#
Method;
1 « Expiant Culture
Rats were killed by cervical dislocation and the abdomens
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swabbed with 70% (v/v) aq# ethanol prior to removal of the livers, 
which were subsequently placed in PBS * A* containing gentamycin at a 
level of ?0^g*/ml (PBS *A*/gentamycin). The livers were then 
roughly scissor-minced and the mince washed 3 times in PBS *A*/ 
gentamycin. Pieces of liver wore transferred to a Petri dish 
containing a small volume of PBS *A*/gentamycin and finely minced,
3
using a scalpel, to cubes of approx# 1 mm# dimensions# 8-12 of 
these finely-minced pieces in a minimum of fluid were transferred to 
the culture flask and allowed to adhere to the culture surface by 
partial drying at 37°C for one hour# After this time 5 ml# of 
the appropriate medium was added to the flask which was then 
incubated at 37°C# The medium was changed 24 hr, after the 
initiation of the culture and thereafter at 2 day intervals. From
the scissor-mince stage onwards all operations were carried out ' 
under sterile conditions#
2# Cell Culture
A# Cell Dissociation Procedures
The rats were killed and the livers removed os described above#
In some methods the liver was perfused prior to removal from the 
body, the perfusion fluid being introduced via the inferior vena cava# 
Each liver was finely minced and then subjected to one of a variety of 
cell dissociation procedures described below#
i) Method of Jacob end Bharqava (1962)
The liver was perfused with 50 ml# of 0»027M sodium citrate 
in Ca^-froe Locke's B#S#S# until the blanched liver was fully
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distended# The liver was removed and finely minced, and this 
mince was transferred to a glass boiling-tube* 10-12 complete 
strokes of a loose-fitting rubber bung on a handle served to 
completely dissociate the cells# The resulting cell suspension 
was filtered through one layer of Bolting cloth to remove strands 
of connective tissue and clumps of cells# The filtered 
suspension was centrifuged at 100 jg. av for 2 min* to remove 
blood cells and washed twice in PBS *A'/gentamycin# The cells
were finally resuspended in culture medium and, after counting 
and viability assessment (see later), were diluted to 5 x 10 
cells/ml# Two ml# aliquots of this cell suspension were then 
placed into culture flasks and examined microscopically at 
various intervals to check for growth#
ii) Method of McLimans (1969)
In this method the liver was perfused with 50 ml. of an 
alkaline, hyper-osmolar salt solution as described by McLimans 
(1969). The liver was removed and minced, the mince being
placed in this salt solution for 30 minutes at 37°C# This
mince solution was then subjected to 2 complete strokes in the 
homogenizer described above. The filtration, washing and 
initiation of culture was then carried out os outlined above#
iii) Use of Tetraphenylboron (TPS)
The minced liver was subjected to four 30-minute cycles of
dissociation in 3mM TPB in isotonic saline (10 ml), the temperature
obeing maintained at 37 C* After each cycle the supernatants were 
pooled. The centrifugation, washing and initiation of culture was 
carried out as described above.
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iv) Usb of Trypsin# Pangestin and Other General
Froteases
The trypsin, pangestin and protease (from Strep# grisous; 
pronase) were dissolved in PBS *A* at various concentrations 
(0*05/u « 0,50/ (w/v)). The minced livers were subjected to 
enzymic digestion at varying temperatures (room temp, and 37°C), 
varying concentrations of enzyme and various times of digestion 
(30 - 120 min,), including overnight at 4°C followed by 30 
minutes at 37°C, A magnetic stirring bar was used in all 
experiments to aid mixing and dissociation,
v) Use of Collagenase/Hyaluronidase
The minced liver was subjected to enzymic digestion in 
collagenase/hyaluronidase (0,05//0,10/ (w/v)), A variety of 
conditions for the digestion procedure were investigated and 
these included the effect of temperature, overnight digestion in 
the cold and the effect of initial Ga*^—removal and subsequent 
replacement in the enzyme solution.
After much investigation (see Chap. 8) the following 
procedure was adopted. Following removal from the body the liver 
was cut into slices approx, 0,5 — 1 cm. in thickness by means 
of a sharp blade and these slices transferred to a 250 ml, 
conical flask* The contents of the flask wero washed twice 
in PBS *A*/gentamycin at 37°C. in a shaking water bath for 
10 minutes followed by two 10 minute cycles at 37°C in 0,5mM EGTA 
in PBS *A*. After this, the liver pieces wero digested in 10 ml, 
of enzyme solution. The incubation time was 60 minutes at 37°C
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in a shaking water bath (approx, 90 oscillations/min*)| the 
enzyme solution consisted of collagenase/hyaluronidase 
(0,05/^0*10/ (w/v)) in Hank's 8,5,5# containing 5mM Ca^,
At intervals during the incubation the pH of the medium was 
checked and if necessary adjusted to approx, 7,5,
The filtration, washing and initiation of culture were 
carried out as described in i) above,
0, Cell Count and Viability Assessment — Trypan Blue 
Exclusion Test
An aliquot of the cells suspended in culture medium was mixed 
with trypan blue to give a final concentration of 0,14% trypan blue. 
This stained suspension was placed in an improved Neubauer counting 
chamber (Hawskley, England) and examined under the microscope*
Cells considered to be non-viable were those which took up the 
stain into their cytoplasm and nucleus (Howard ot al# 1973), Thus, 
a total cell count and a viable cell count could be performed and 
from these a value for the /-viability could be calculated,
C* Subculturing Procedures
In a few experiments subculturing was attempted and this was 
carried out in one of two ways:-
i) After washing the cell sheet in PBS *A*, 0,25/ /w/v) trypsin in 
PBS *A* was added and left in contact with the cells for 30 seconds 
at room temperature* The bulk of the enzyme solution was decanted 
and the flask placed at 37°C, The cell layer was examined under a 
microscope at various intervals until virtually all the cells had
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become detached* Fresh medium uns then added and, after dispersing 
the cells, the suspension was inoculated into fresh flasks*
ii) After washing, the cells were subjected to a 5 minute treatment
o
with collagenase/hyaluronidase (0.05//0.10/ (w/v)) in PBS *A* at 37 C* 
After this time the cell-containing enzyme solution was removed and 
centrifuged at 100 ^  av* for 2 minutes. The supernatant was discarded 
and the cell pellet suspended in fresh medium which was then placed in 
fresh flasks,
3, Staining Methods
All the staining was performed with the cells fixed in situ on 
the culture surface* Photomicrography was carried out using an 
Olympus PM6 camera and EM AH exposure meter, the camera being 
mounted on an Olympus inverted microscopo*
1) Haematoxylin — Eosin Stain
The cells were fixed in acetic;alcoholsformalin (5;85sl0) 
for 5 minutes following a preliminary rinse in PBS *A*, After 
fixation, the monolayer was rinsed twice with tap-water and 
stained with Harris* haematoxylin for 3 minutes* The stain was 
decanted and replaced by 0,5% (w/v) aq, lithium carbonate for 
5 minutes. After removal of this solution the cells were 
stained with 0*5/ (w/v) alcoholic eosin for 1 minute, after which 
time the stain was discarded and the cell-sheet rinsed twice 
with absolute alcohol. In order to make the preparations 
semi-permanent each flask received a small volume of iso-amyl 
alcohol (approx, 0,3 ml) which covered the monolayer.
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ii) Periodic Acid - Schiff (PAS) Stain for Glycogen
Following fixation in mothanol (10 minutes) the cells were 
subjected to a 10 minute treatment with 1/ (v/v) periodic acid. 
After this time the periodic acid was removed and the coll sheet 
was thoroughly rinsed in 70/ (v/v) etj, ethanol. The cells were 
then stained for 20 minutes with the Schiff stain as described 
by Horobin and Kevill-Davies (1971), After this staining 
the cells were thoroughly rinsed in absolute alcohol prior to 
microscopic examination.
Intracellular PAS positive material was taken as presumptive 
evidence for the presence of glycogen.
iii)
The cells were fixed in buffered neutral formalin and 
stained with oil red 0 for 30 minutes, the flask being kept 
closed during this time. The stain was prepared by diluting 
6 ml, of a stock solution of oil red 0, saturated solution in 
iso-propyl alcohol, with 4 ml, distilled water, leaving for 
10 minutes and filtering; the filtrate was the staining solution. 
After staining, the monolayer was rinsed with 60/ (v/v) aq, 
ethanol and examined microscopically,
4, Scanning Electron Microscopy Studios
For these studies the cells wore cultured on small (12 mm, diameter), 
sterile cover-slips maintained in sterile plastic Petri dishes. At
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various intervals some of these cover-slips were processed for 
scanning electron microscopy*
Following rinsing of the cover-slips, the cells wore fixed 
in situ in cold glutaraldehyde (1/ in 0#1M phosphate buffer pH 7*4) 
for 1 hour# The cover-slips were washed twice in buffer and dehydrated 
sequentially in 25, 50, 75 and 100/ acetone, 30 minutes each# After 
air-drying, the cover-slips were vacuum-coated with palladium and 
then examined in a Cambridge Mark II Stereoscan scanning electron 
microscope#
5# Tests of Functional Differentiation in Cultured 
Hepatocytes
A variety of tests were performed on hepatocytes isolated by 
collagenase/hyaluronidase digestion and maintained in culture for 
3 days in order to assess their state of functional differentiation* 
These tests included the following*
This was qualitatively assessed by the presence of 
intracellular PAS positive material, os determined by the 
PAS stain (see above)*
ii) Urea Production
3 days after initiating the culture the cells received 
fresh medium which 24 hr# later was collected and assayed for
urea by the diacetylmonoxime method as described by Ellis (1971). 
Medium not in contact with cells was used as a control#
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iii) Albumin Production
Following 3 days in culture the monolayer was washed three 
times with PBS *A* and received fresh medium which was free 
of serum so as to prevent cross-reaction with the albumin 
antiserum# Twenty-four hours later the medium was collected 
and assayed for the presence of albumin by Ouchterlony gel 
diffusion using goat anti-rat albumin antiserum#
Visualization of the line of precipitation was carried 
out by staining with araidoschuarz 108 as recommended by Varley 
(1969)#
iv) Histochemical Demonstration of Glucose-6-PhosphatasB 
Activity
Glucose-6-phosphatase activity was assessed in unfixed 
cells using the method of Wachsteln and Msisel (see Culling, 1963)# 
The cells were post-fixed in 10/ formalin# Owing to the 
hypotonicity of the incubation medium the cells assumed a 
rounded appearance and consequently the intracellular localization 
of the enzyme could not bo ascertained#
v) Effect of Insulin and Glucagon on Glucose Metabolism
fresh medium (MEM) containing 0#25^Ci
24 hr# after establishing the culture, the cells received
-glucose per ml;
2 ml. of this radioactive medium was used per flask# In some 
flasks the radioactive medium also contained insulin at a final 
concentration of 200 or 400 ^units/ml# Twenty-four hours 
later the medium was collected and counted for radioactivity#
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These flasks then received non-radioactive medium containing 
200 ng# glucagon per ml# and twenty-four hours later this 
medium was also collected and counted.
For counting, 20^1 of medium was pipetted into scintillation 
vials and 10 ml# scintillator added# The scintillator used 
was toluene-based and contained 0*4/ PPG and 0.01/ POPOP#
vi) Metabolism of 'Imipramine
Twenty-four hours after commencing the culture the cells
14,received 2 ml. of fresh medium containing 0.2^i •imipramine
at an imipramine concentration of O.ImM. The cells were 
cultured for a further 1—2 days after which time the medium was 
assayed for imipramine and its motabolitos using the extraction 
technique and chromatography system of Bickol and Weder (1958). 
Following the chromatography the silica gel was scraped off in 
bands 0.5 cm* width and placed in scintillation vials containing 
1 ml, methanol. The vials were shaken to oluto any material off 
the silica and 10 ml* scintillator added. Scintillator used was 
that outlined above.
Radioactivity counting was performed using a Packard Tricarb # 
Counting efficiency was assessed by internal 
standardization.
Determination of Mitotic Index
Mitotic index was calculated by incubating the colls in the 
presence of colcemid, 0.05^g/ml, for 5 hours# After this time the 
cells were stained with haematoxylin and eosin, and the percentage of 
cells in mitosis was ascertained.
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CHAPTER 8. RESULTS
Two tissue culture systems were chosen with which to investigate the 
feasibility of culturing adult mammalian liver# These systems were expiant 
culture and cell culture, the latter technique also involving an assessment 
of the methods available for the isolation of hepatic cells# The available 
literature (see Chapter 6) indicated that these two systems appeared to be 
the most applicable for the study of culture of adult mammalian liver®
1® Explant Culture of Mammalian Liver
The technique of expiant culture is outlined in Chapter 7# The 
standard medium used throughout these studies was based on MEM with 
Hank's B.S.S#, antibiotics and HEPES as buffer; serum was added at 
a final concentration of 20/# For each experiment 40 - 80 explants 
were cultured, 8 - 12 explants per flask. When using foetal bovine 
or calf serum cell outgrowth was usually observed from approx# 75/ 
of the expiants although the extent of outgrowth varied quite 
considerably from explant to explant#
Outgrowth of cells was invariably apparent 3 days after commencing 
the culture and took the form of isolated cells which were stellate 
in shape (Plate 8#1)* As the growth progressed these cells began 
to assume a typically fibroblastic form with numerous bundles of 
cells (Plate 8.2)# The cells wore consistently mononucleate, the 
cytoplasm was lightly staining and numerous cytoplasmic projections 
could be observed (Plate 8.2)# Throughout this period these cells 
were consistently negative for the PAS stain# The outgrowth appeared 
to have a limiting size above which no further outgrowth occurred 
although "stacked" layers of fibroblasts could be seen (Plate 8#3)«
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This stage was followed by one during which the fibroblast-like cells 
nearest the explant contracted together to produce an arc effect of 
spindles around the expiant (Plato 8.3)* In many instances sheets 
of fibroblastic cells could be observed round explants and mitotic 
figures were frequently observed (Plate 8,3). If at this stage 
the explant was removed and resettled on another area of growth surface 
this sequence of outgrowth could be repeated, even if this transplanting 
was carried out in the same flask in which the original culture was 
initiated* In some instances a few bizarre cells could be seen 
after the fibroblast outgrowth was complete* These took the form of 
giant multinucleate cells containing a large number of vacuoles which 
stained positively for lipid. At no time was any cell-type observed 
which could be identified as epithelial or epithelial-like*
The nature of the substratum had a dramatic effect on this cell 
outgrowth. Treated polystyrene ('Falcon* flasks) was the best 
substratum studied and the foregoing discussion of the cell types was 
based on cultures growing on those flasks. On the other hand, cell 
outgrowth was extremely poor on glass and the deposition of a gelatin 
layer (Moscona et al* 1955) on this glass did not improve this 
situation,
A number of media other than MEM (i.e. L-15, medium 199 end 
McCoy's SA) wore tested for their ability to induce outgrowth of 
epithelial cell types, but of these only L-15 was as successful. 
Furthermore, a number of different sera were also tested (foetal 
bovine, calf and horse serum and sheep portal serum) but no major 
differences in the pattern of coll outgrowth could be detected other than 
for a greater initial cell outgrowth when using the portal serum. Other
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biological media such as chick embryo extract, tryptoss phosphate 
broth and liver digest ultrafiltrate used at concentrations ranging 
from 10 •» 30/ produced no beneficial effect on the pattern of cell 
outgrowth, fibroblasts remaining the only cell type observed*
g
Putrescine used at 0*3 - 2*0 x 10 M increased the outgrowth of 
fibroblastic cells, in agreement with the work of Pohjanpelto 
end Raina (1972) using skin fibroblasts, but did not induce the 
appearance of any epithelial-like cells.
Subculture of the cell outgrowth with trypsin yielded cell-lines 
which were characteristically fibroblastic in appearance*
2 • Isolation of Adult Rat Hepatocytes
A number of systems which have been reported for the isolation of 
rat hepatocytes were investigated with regard to the yield and viability 
of the isolated cells* These techniques were based on perfusion 
(Jacob and Bhargava, 1962; McLimans, 1969), dispersion by chemicals 
(i.e. TPB) and dispersion by enzymes (trypsin, pangestin, pronase, 
subtilisin and collagenase/hyaluronidase). The results of this study 
are shown in Table 8*1*
Perfusion of the liver In situ followed by dispersion of the cells 
in a loose-fitting homogenizer resulted in the release of a large number 
of hepatocytes, particularly if the perfusion medium contained a 
Ca^-chelator (Jacob and Bhargava method) or was hyperosmolar and 
hypertonic (McLimans method). The cell suspension produced by 
the latter method was significantly 'cleaner* than that produced by the 
Jacob and Bhargava method there being much less contamination by 
nuclei and other cell debris and red blood cells*
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However, the viability of these isolated cells, as measured by 
dye uptake, was extremely poor (see Table 8.1) virtually all of the 
cells taking up the dye. In an attempt to improve the viability 
of cells prepared by these methods dispersion of the liver was 
carried out either in glycerol-containing solution (25 - 100% v/v 
glycerol) or in 2M sucrose, both being membrane-protective agents.
None of these modifications, however, proved effective in increasing 
the cell viability.
Incubation of liver pieces with the K^-chelator tetraphenylboron 
also produced large numbers of cells the vast majority of which were 
again non-viable (Table 8.1). These cell preparations were contaminated 
with large numbers of isolated nuclei implying that the dissociation 
step had progressed beyond the coll isolation stage and the TPB had 
started to destroy the newly-isolated cells,
A number of nonspecific proteoses were also tested as possible 
dissociating agents for rat hepatocytes. These proteases included 
trypsin, pangestin (a pancreatic extract) and pronase, and a number 
of different incubation conditions were tried;- varying the level of 
enzyme (0,05/ - 0,25/ w/v), varying the dissociation temperature 
(room temp. 37°C and overnight at 4°C) and sequential treatment with 
two enzymes (trypsin and pangestin). Treatment with these enzymes 
proved singularly unsuccessful, very few cells being released, tho 
cells that were being virtually 100/ non-viable (Table 8.1),
The only system to yield reasonable numbers of viable hepatocytes 
was that of dissociation by collagenase/hyaluronidase as adapted from 
the technique of Howard and Pesch (1968) but omitting the initial 
perfusion stage (Table 0,1). By this technique approx. 1 x 10^ viable 
cells could be obtained from 1 g. liver. It was noticed that this
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yield was decreased somewhat when larger rats were used and was increased 
if the dissociation was carried out at 37°C rather than at 25°C.
Prolonged exposure of the liver tissue to enzymes at 25°C in an 
attempt to improve the viable cell yield should be avoided as this would 
lead to excessive destruction of the fragile newly-isolated cells®
It was also apparent that slicing of the liver was superior to 
chopping into cubes with regard to the final yield and viability of 
cells* These dissociated cells were very susceptible to mechanically- 
induced damage, the cell yield being lower if a magnetic stirrer was 
used in place of a shaking water bath to maintain the liver slices 
in an agitated state. Once again, neither treatment with 
collagenase/hyaluronidase overnight at 4°C, nor the use of a 
secondary sequential enzyme dissociation step (e.g® with trypsin or 
pangestin) raised the viability score or the viable cell yield.
By incorporating a preliminary Ca'^ -^romoval stage with EGTA and
by adding Ca*^  to the enzyme dissociating mixture, as outlined in
Chapter 7, into the collagenase/hyaluronidase dissociation scheme
it was possible to increase both the viability score and total cell
yield (Table 8,1; Modified Collagenase/Hyaluronidase method). The
6average total cell yield was 5,5 x 10 hepatocytes per g. liver of 
which 78/ were viable* This represents a more than 2-fold enhancement 
of the total cell yield coupled with a higher viability score, when 
compared to the method of Howard and Pesch (1968). The cells 
isolated by this modified technique were largely resistant to uptake 
of the dye trypan blue and possessed highly retractile coll membranes 
(Plate 8.4). Red blood cells were also present in these preparations 
together with another cell-type, smaller in size than tho hepatocytes, 
which was presumed to be of fibroblastic origin.
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3# Culture of Freshly Isolated Rat Hepatocytes
The only cell suspensions to show consistent reproducible growth 
in vitro were those which contained a high percentage of viable 
cells. Thus, although isolated areas of living cells could be seen 
using various isolation methods, the culture of cells obtained by 
methods other than collagenase dissociation was on the whole 
unsuccessful* Indeed, it appeared that once attachment of the viable 
cells to the substratum was complete (approx, 4 hours after initiating 
the culture) the continued presence of non-viable cells markedly 
decreased tho number of living cells present 20 hours later (Table 8,2), 
implying a direct toxic effect of the dead cells or their contents on 
the living cells.
The pattern of ija vitro growth was the same whether the colls 
were obtained by the original Howard and Pesch (1958) method, omitting 
the initial perfusion stage, or its present modification employing a 
preliminary Ca -removal and its subsequent replacement, but as the 
latter approach gave higher yields of viable cells this was used in 
all subsequent studies.
The plating efficiency, i.e. the percentage of inoculated viable 
cells that remained viable and attached to the surface 24 hours after 
inoculation, varied considerably between preparations but lay in the 
range 10 - 20%, Similar values were obtained if tho cells were 
cultured in microtitre plates. Once again, the nature of tho 
substratum markedly influenced the appearance of the culture# Thus, 
cell attachment and growth was almost non-existent on ordinary 
glass culture bottles (i.e. 2 oz, medical flat bottlos) although 
growth on glass coverslips was possible albeit on a limited scale
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compared with the treated-polystyrene 'Falcon* flasks.
Three distinct cell—types could be seen 24 hours after initiating 
the culture (Plate 8,5), together with large numbers of dead cells 
which lay over the epithelial colonies (Plate 8.5), The most 
abundant type (60/) was an epitheliocyte, usually highly granular, 
present singly or, more commonly, in groups ranging from 4 — 20 cells in 
number (Plates 8.7 and 8.8), Tho epithelial colls in the groups 
showed a marked polygonality strongly reminiscent of true hepatocytes. 
The cell nuclei were round, large and very apparent and contained one 
or two nucleoli centrally placed; chromatin dots were also apparent.
A number of these epitheliocytes (approx, 20 — 30%) were binucleete and 
use of e metaphase-arresting agent (colcemid, 0,05^g/ml) revealed 
that the epithelial cells had a mitotic index of approx. 2 — 3%, 
Distinct intercellular gaps could often be seen in the cell clusters.
The cell cytoplasm was highly granular and occasionally showed a 
small number of vacuoles which stained positively for lipid. The 
number of cells containing lipid droplets was greater in both medium 
199 and MEM when compared to L-15 which strongly indicated that lipid 
build-up was related to the composition of the medium. The cytoplasm 
stained positively for glycogen although the intensity of staining 
varied from cell to cell. On the basis of their microscopical 
appearance and their functional abilities (to be discussed later) 
these epitheliocytes were designated as hepatocytes in culture.
The second most common cell-type apparent after 1 day in culture 
was a rather bizarre 'foamy* cell (Plate 8,9), These cells were 
always found singly, had a lightly-staining nucleus and cytoplasm, and 
the cytoplasm contained large vacuoles which did not stain for lipid.
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The one remaining cell-type present was fibroblastic in origin 
(Plate 8,10), These cells were small in size and number with spindle 
and stellate forms apparent. The nuclei were elongated and the 
cytoplasm was clear and consistently PAS negative.
After 2 days in culture the areas of epitheliocyts formation had 
increased in size and, especially at the periphery of the culture 
flask, started to assume a sheet-like appearance (Plate 8.11),
Although the proportion of fibroblasts increased during this time 
(Table 8,3) their actual numbers as seen on the culture surface 
appeared to change little.
By day 4 the culture began to take on a different appearance in 
that the fibroblasts began to dominate (Plate 8,12) even though the 
actual cell number decreased (Table 8,3), This led to tho eventual 
encircling of the hapatocyte colonies by the fibroblasts (Plate 8,13) 
which by day 7 was complete and a virtually complete cell monolayer 
composed almost entirely of fibroblasts was obtained (Plate 8,14),
One or two areas of epithelial presence could occasionally be seen 
at this time and it was considered that the sudden increase in the 
rate of fibroblast division utilized the available culture surface 
so rapidly that the hepatocytes with their much lower mitotic rate 
were unable to keep abreast of this sudden fibroblast growth and so 
became, as it were, strangled by the fibroblasts. It is also possible 
that the restraints imposed on the hepatocytes by the fibroblasts 
surrounding them compelled the hepatocytes to assume a fibroblastic 
shape and so lose their observable characteristic epithelial morphology# 
Substantially similar patterns of growth were observed when the 
isolated cells were grown on thin round glass coverslips and examined 
by the scanning electron microscopy. Thus, 3 distinct cell—types could
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again be seen which correspond to those already mentioned* Fibroblasts 
could be readily distinguished by their cylindrical appearance (Plate 
8,15) and the hepatocytes possessed a characteristic polygonal 
appearance (Plate 8*16), The hepatocytes appeared to attach to the 
culture surface by one of two mechanisms. Firstly, the cytoplasm may 
'fuse* with tho culture surface and this is exemplified in Plate 8,16; 
alternatively, where the cytoplasm is raised off the surface, 
attachment could be achieved by means of cytoplasmic processes 
extending down from the mass of cytoplasm (Plate 8,17), The 'foamy* 
cells could also be observed by the scanning electron microscopy and 
the vacuoles observed in light microscopy showed some evidence for 
the presence of structure within or under these vacuoles (Plate 8,17), 
The fibroblast overgrowth of the hepatocyte colonies was 
obviously undesirable and preliminary experiments showed that the 
incorporation of either dexamethasone (final concentration 2 x 10~^M) 
or collagenase (final concentration of 0,05/ w/v) into the medium or 
the use of arginine-free medium were successful in keeping down the 
overgrowth although the fibroblast presence could not be completely 
eliminated. Each method of fibroblast suppression was initiated on or 
before the third day of culture so as to minimize the initial 
fibroblast involvement. By these means it proved possible to 
maintain the hepatocyte dominance in the cultures for up to two weeks 
or, in the case of dexamethasone incorporation, three weeks.
Throughout those periods the hepatocyte morphology appeared to bo 
essentially unchanged although further work on this matter was not 
carried out. No tests on the functional abilities of these long-term 
cultured hepatocytes was carried out.
Subculture of the hepatocytes proved completely unsuccessful®
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Trypsin (0,25^ w/v) and collagenase (0,05^ w/v) ware tested for 
their ability to release cells from the culture surface and whilst the 
fibroblasts could be readily subcultured, the hepatocytes could not# 
This refractory nature of the hepatocytes to the action of proteases 
is well exemplified by the previously noted observation that the 
hepatocytes could be successfully grown in collagenase-containing 
medium#
4# The Functional State of Cultured Hepatocytes
As the granular epithelial cell-type predominated for only the 
first 3 days in culture it was decided to test these cells for 
hepatocyte-specific functions within this time-scale# The following 
functions were detectable in the 3 day culture#
a) Glycogen storage could be detected histochemically in the 
cultured hepatocytes although the extent of storage varied from cell 
to cell# The other two cell-types did not store glycogen#
b) The hepatocytes could be successfully maintained on glucose-free 
medium, the glucose being replaced by galactose# This implied that 
the cells possessed a gluconeogenic function#
c) Experiments (carried out in collaboration with Mr# A. Shabaan) 
showed that glucose uptake by the epitheliocytos was influenced by 
insulin and glucagon, there being a dose-dependent response with insulin 
(dose-dependency with glucagon was not assessed)#
Table 8#4 shows that the glucose uptake into the epitheliocytes 
was markedly enhanced in the presence of insulin, this enhancement
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increasing as the insulin concentration was increased#
Furthermore, the subsequent release of glucose into non-redioactive 
medium in the absence of exogenously-added hormones was greater if 
the cells had been exposed to insulin at the same time as the
-glucose (Table 8*5)# This insulin-enhanced release of glucose 
was further enhanced in the presence of glucagon which strongly 
indicated a glycogenolytic function for glucagon on the epitheliocytes#
d) An experiment (performed in conjunction with Mr# M# Bird) showed 
there to be good histochemlcally-detsctable activity of glucose-5- 
phosphatase, a liver-specific enzyme, in the epithelial cells, although 
by the nature of the method this activity could not be quantitated#
The other two cell-types did not possess histochomically-detoctable 
glucose-6-phosphatase activity#
e) Analysis of the spent medium showed that the epitheliocytes 
produced urea at a rate of approx# 0#2 mg# per flask per day#
f) The cells could be successfully maintained on arginine-free 
medium#
Those last two points strongly indicated a functional urea cycle in 
these presumptive hepatocytes#
g) Secretion of albumin into the medium could be readily detected 
by Ouchterlony gel diffusion, there being lines of identity between 
rat albumin standard and the albumin detected in the culture medium# 
(Plate 8.18)
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h) Finally, extensive metabolism of [^^cj-imipramine by the 
epitheliocytes could be detected (see Fig, 8*1), When medium 
containing jj -imipramine was incubated for 44 hours in the absence 
of cells, no metabolism of the imipramine could be demonstrated 
(Fig, 8,1a). When the same medium was incubated for 20 hours in 
the presence of rat liver epitheliocytes, two metabolites could be 
readily detected (Fig, 8,1b), The use of a reference marker of 
desmethylimipramine and comparison of the obtained values with 
those quoted by Bickel and Weder (1969) strongly indicated that the 
major metabolite produced (28% of the total radioactivity on the thin 
layer plate) was the W-oxide (R^  0,1-0.2), whilst the minor metabolite 
(7%) was the desmethyl derivative (R^  0,3-0,4) (Fig, 8,1b). After 
a further 24 hours incubation the amount of N-oxide produced had risen 
to 39% and that of the desmethyl derivative to 15% (Fig, 8,1c), No 
analysis for possible glucuronida/sulphate conjugates was carried out. 
During the incubation period of 44 hours the imipramine appeared to 
have no toxic effect on the epitheliocytes,
Imipramine is known to undergo complex metabolic transformations in 
the liver ie vivo which leads to the production of large numbers of 
metabolites (Bickel and Weder, 1969), That only two metabolites 
could be detected upon incubation of imipramine with the presumptive 
cultured rat hepatocytes may possibly be due to one or two factors. 
Firstly, each flask received only a low level of radioactivity (200nCi 
per flask) and possibly the level of radioactivity attributable to each 
minor metabolite was too low to be detected. Secondly, the possibility 
exists that many of the minor metabolites as well as some of the 
desmethylimipramine would be conjugated within the liver cells and so 
would not be detectable as the free compounds in the organic extract of 
the medium.
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Table 8.1# Isolation of Adult Rat Hepatocytes — A Comparison of Methods
Method of
*
Number of 
Isolation Experiments
Oacob and Dhargava 6
McLimans 8
Tetraphenylboron 3
Trypsin 15
Pangestin 5
Pronase 2
Collagonase/Hyaluronidase 11
Modified 20
Collagenase/Hyaluronidase
Total Cell Yield 
(X10^/g#llver)
21,4(9.1-31.2)+
22,8(14,3-32,3)
11,8(9.3-13,4)
< 1 
< 1 
<1
2.6(0,3-9.9) 
5,5(2,9-14,0)
Viability
(%)
0
0
0
0
0
0
70(50-09)+
84(70-98)
^ Methods used wore those outlined in Chapter 7
Collagenase/Hyaluronidase - method of Howard and Pesch (1968) but
omitting the initial perfusion
Modified Collagenase/Hyaluronidase method as detailed in Chapter 7 
i.e. initial Ca++-removal and 
subsequent replacement in enzyme 
mixture
+ Results are mean with range in brackets
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Table 8.2. Effect of Dead Cells on the Numbers of Viable Cells 
Existing 24 Hours After Initiating Culture
Viable Hepatocyte Count 
(XloVflaskf
Medium undisturbed 
for 24 hours
Medium changed 4 hours 
after initiating culture
7,2
13.9
* Cells were prepared by the modified collagenase/hyaluronidase method. 
Both flasks received 2 x 10^ viable hepatocytes per flask. Viability 
of initial suspension was 71%
Table 8,3, Monolayer Culture of Rat Liver - Proportion of Cell Types 
at Various Times of Culture
Granular
Culture Epithel- Fibroblast!
Period (days) iocytes (%) (%)
62.4
61,0
9,0
1
7.3
17.1
83.8
98,0
*Foamy* 
Cells (%)
30,3
21,0
7,2
2.0
Total Cell Number 
(XlO^/flask)
1,02
0.76
0.62
0.99
Cells were prepared by the modified collagenase/hyaluronidase method. All
flasks were seeded initially at 2 x 10 viable hepatocytes.
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Table 8.4. Glucose Uptake by Cultured Rat Hepatocytes — Influence 
of Insulin
Level of Insulin 
(^units/ml,medium )
O(Control)
200
400
•Glucose
Remaining in Medium
97,0 4- 0,5
93,0 + 0,5 
91,5 4- 0,5^
*
+ Results are mean of 3 experiments ±  S,E#M,
Significantly different from control (P<0#01)
Table 8,5, Glucose Release from Cultured Rat Hepatocytes — Influence 
of Glucagon
Insulin
Incubation Conditions 
-f Glucagon
14, -Glucose Released
(Control as 100%)
4-
+
100
117
138
+ Insulin concentration 200|w units/ml.medium
^ Glucagon concentration 200 ng/ml,medium
Plate 8.1. Expiant Culture of Adult Rat Liver. Morphological
Appearance After 3 Dave Culture
a) X 100
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b) X 200
The dark masses at the bottom of the plates are the explanted pieces of liver.
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Plate 8,2. Expiant Culture of Adult Rat Liver. Morphological
Appearance After 5 Devs Culture
a) X 100
*
/gf . . .
"  « ■'‘7  •’*
* ■ " g@ee*,7 'S'-'ï" , '
b) X 200
, %
) '(fi- ,
M
4’"*’ ' /' -!
W  ■ "
.
" f#
Plate 8.3. Expiant Culture of Adult Rat Liver. Morphological
Appearance After 8 Days Culture
a) X 100
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Mitotic figures are indicated by arrows
Plate 8.4, Morphological Appearance of freshly-Isolated Adult
Rat Hepatocytes
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X 200
The cells are suspended in trypan blue solution. The 
darkly-staining cells (indicated by arrows) are regarded 
as being non-viable.
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Plate 8.5. Monolayer Culture of Adult Rat Liver - The Three CeXl-Tvpea
Present
X 100
Hepatocytes are indicated by
A fibroblast is shown in the centre (indicated by arrow) 
*Foamy* cells surround this fibroblast
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Plate 8*6# Monolayer Culture of Adult Rat Liver
X 200
The amorphous material overlying the hepatocyte groups are dead 
cells. Tuentyfour hours in culture.
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Plate 8.7$ Monolayer Culture of Adult Rat Liver
X 200
Hepatocyte group after tuentyfour hours culture
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Plate 8.8, Monolayer Culture of Adult Rat Liver
X 400
Hepatocyte group. Binucleation is apparent as are the 
intercellular spaces.
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Plate 8.9. Monolayer Culture of Adult Rat Liver
X 400
’Foamy* cell. Large vacuoles can be observed around 
the cell nucleus.
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Plate 8.10. Monolayer Culture of Adult Rat Liver
X 400
#
Fibroblasts. Shown are the typical stellate and spindle forms.
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Plate 8.11, Monolayer Culture of Adult Rat Liver.
X 200
4
Two-day culture. Sheet-like appearance of hepatocytes.
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Plate 8.12# Monolayer Culture of Adult Rat Liver
X 200
Four day culture* This plate illustrates the emergence of 
fibroblast clusters (in centre).
Plate 8.13. Monolayer Culture of Adult Rat Liver
X 100
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Five day culture. Overgrowth of hepatocyte groups by fibroblasts.
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Plate 8.14, Monolayer Culture of Adult Rat Liver
X 100
f
Seven day culture. Overgrowth by fibroblasts is now complete.
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Plate 8,15, Scanning Electron Microscopy of Adult Rat Liver Cells In
Culture — Fibroblast,
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Plate 8,16, Scanning Electron Microscopy of Adult Rat Liver Cells in
Culture - Hepatocytes
I
-a
The polygonal nature of the cells is very apparent.
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Plate 0.17. Scanning Electron Microscopy of Adult Rat Liver Cells in
Culture - 'Foamy* Cell
The *foamy* cell is at the bottom left-hand of the photograph.
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Plate 8.18# Ouchterlony Gel Diffusion Precipitation Patterns of Albumin 
in Containing Medium
1• Goat anti-rat albumin antiserum 
2, Rat albumin standard
3# Unincubated medium
4. Medium incubated with cells
For method see Chapter 7#
Radioactivity Profile of Thin Layer Chromatograms of Organic
Extracts Obtained from Media Containing L CJ— Imipramine14
Incubated with Rat Liver Epitheliocytes
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a) Medium alone; 44 hr.
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CHAPTER 9é DISCUSSION
1• Expiant Culture
The basis of expiant culture is the attachment of small tissue 
pieces to a suitable substratum and observation of the cells that 
grow out from these explants (Moscona et al« 1955), However, when 
adult rat liver was cultured using the most simple explant technique 
viz, explants attached directly to glass, the results were most 
disappointing in that virtually no outgrowth was observed from any 
of the explants (see Chapter 8), Gelatin and other proteins have 
often been reported to be suitable substrata for cell outgrowth 
studies (see Moscona et el, 1965), largely because these are thought 
to represent a more physiological approach to the problem of cell 
attachment and spreading. In the case of liver expiants the 
deposition of a gelatin layer onto a glass surface did not induce 
any cell outgrowth whatsoever.
Successful reproducible outgrowth of cells from liver explants 
could only be achieved if the explants were attached to polystyrene 
specially treated for tissue culture purposes (i.e. ’Falcon* flasks).
The cells present in these outgrowths were, however, of typical 
fibroblastic appearance (see Chapter 8) and did not stain for glycogen
at any stage in the development of the culture. Using a similar 
technique (i.e. treated polystyrene as substratum) essentially 
identical results have been reported for the explant culture of foetal 
human liver (Lie, 1972), adult human liver (Domoise ejb 1971) and 
adult monkey liver (Douglas et al, 1966).
The overwhelming predominance of fibroblasts in the cell outgrowths 
when using plastic flasks was not influenced by the source of the serum
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present in the medium. Thus, the presence of foetal bovine serum, 
calf serum or horse serum produced no differences in the cell outgrowth 
pattern (see Chapter 8), Lie (1972) has reported that incorporation 
of portal serum into the culture medium led to cell outgrowth of a 
largely hepatocyte nature from explanted human foetal liver, but this 
could not be confirmed using explanted adult rat liver (Chapter 8).
This discrepancy between the foetal and adult situations is perhaps 
related to the much greater repression of cell division by 
tissue-specific mitotic inhibitors which are present to a considerably 
higher extent in the adult animal (see Grisham, 1973)#
It would appear from a survey of the literature that successful 
outgrowths of hepatocytes from explant cultures of adult mammalian 
liver can only be achieved using highly complex culture conditions* 
Thus, Alexander and Grisham (1970) employed a collagen-coated glass 
coverslip covered with a piece of perforated cellophane and encased 
in a Sykes-Moore chamber as a culture vessel and cellulose sponge 
as a medium reservoir. With this system they were able to observe 
the outgrowth of several cell types, including hepatocytes from livers 
of rats 1 — 5 days old. A similar system has been employed by 
Sandstrom (1965), the coverslip being replaced by a second piece of 
cellophane which is unperforated. By this technique foetal rat 
hepatocytes (Sandstrom, 1965) and more recently, adult human 
hepatocytes (Sandstrom, 1973) have been successfully cultured.
Whilst these cultures are of undoubted value in observing 
morphological changes of the cells in response to any given stimulus 
they are of doubtful value in metabolism studies, largely because of 
the difficulty of producing exactly parallel replicate cultures.
226
For these reasons the expiant culture approach was discarded and the 
cell culture aspect was further studied# Before this, however, it 
was necessary to examine what is, perhaps, the most critical step in 
cell culture, namely the initial cell isolation#
2# Isolation of Adult Rat Hepatocytes
A number of workers have shown that collagenase/hyaluronidase 
digestion of rat liver yields a cell suspension superior in viability 
to those produced by mechanical, chemical or other enzymic means 
(Gallai-Hatchard and Gray, 1971; Dezyk and Liberti, 1969; Lipson 
et al# 1972; Muller et al# 1972; Murthy and Petering, 1969)#
This conclusion has been amply confirmed in the present study in 
that collagenase/hyaluronidase treatment was the only system to produce 
cell suspensions of a largely viable nature as judged by trypan blue 
exclusion# Furthermore, maintenance of hepatocytes in culture as 
morphologically viable entities was also only possible when the 
cells were produced by collagenase/hyaluronidase digestion (see 
Chapter 8)# It has been argued by Dickson (Dickson, 1970;
Suzangar and Dickson, 1970) that viable hepatocytes normally take up 
trypan blue, mainly in the nucleus, and that non-viable hepatocytes 
be considered as those which stain uniformly within the cell. If this 
were true all the cells produced by the perfusion techniques and by 
TPB treatment were in fact viable, which should have been reflected by 
reproducible maintenance and growth of these cells vitro. That 
this was not in practice the case strongly argues against this 
contention of Dickson#
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The viability test most commonly used in studies of isolated 
liver cells is that of dye exclusion which is based on the ability 
of the dye to enter only non-viable cells via a damaged plasma 
membrane* This test is purely one of plasma membrane integrity 
and it might be thought that cells with damaged plasma membranes might 
still be viable with regard to various metabolic capabilities*
However, all the available information on the metabolic capabilities 
of mechanically- and chemically-isolated liver cells (as outlined in 
Chapter 6) points to the view that non-viability as measured by dye 
uptake is only one of a number of abnormal aspects of cell morphology 
and function, although whether these arise as a result of the plasma 
membrane damage is as yet unknown* Conversely, maintenance of membrane 
integrity is accompanied by near normality in various metabolic 
parameters (see Chapter 6). Thus, if isolated liver cells are 
required for short term use only (less than, say, 6 hours) the question 
of cell viability is still of extreme importance, especially if a 
comparison to the vivo state is contemplated#
A major drawback to the method of hepatocyte isolation by 
collagenase/hyaluronidase as reported by Howard and Pesch (1958) and 
its subsequent modifications (Berry and Friend, 1959; Capuzzi et al# 
1971; Ingebretsen and Uagle, 1972; Seglen, 1972) has been the 
necessity to use a preliminary perfusion of the liver with the enzyme 
mixture, either in situ or in vitro# This initial perfusion step 
is obviously impractical when using foetal liver or human biopsy 
material# It was found in this present study that reasonable numbers 
of viable cells could be obtained if this perfusion step was omitted 
(see Chapter 8) the yield of viable cells (0,2 - 6#6 x 10^/g.liver) being
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comparable to that reported by Howard and Pesch (1968) (approx#
4 X 10^/g#llver)# Introduction of a Co^^-removal stage prior to 
the enzymic digestion and the presence of Ca"^  ^in the digestion stage 
itself as suggested by Seglen (1972) increased the yield of viable 
cells still further (range 2.2 - 11#0 x 10 /g.liver)#
rt -<
It is generally recognized that Ca plays an important role in 
the maintenance of intercellular contacts in intact tissues (Moscona 
et al, 1965) and it appears to act via a 6a*^-dependent adhesion 
factor (Modjanova and Malenkov, 1973)# It is probable that initial 
washing of the liver pieces with Ca -free buffer containing EGTA 
removes both the Ca"^ and the adhesion factor (Seglen, 1973b), and the 
cellular adherence is reduced sufficiently to facilitate subsequent 
access for the matrix-dissolving enzymes (Moscona et al, 1965). 
CollagenasB itself requires the presence of Ca"^ for maximal activity 
(Seglen, 1972; Howard et al, 1973), ^
3* Culture of Cells Liberated by Collaqenase/Hyaluronidase Digestion 
of Rat Liver
Culture of collegenase/hyaluronidase-digested adult rat liver 
cells yields 3 morphologically distinct cell-types, the relative 
proportions of which alter as the culture progresses (see Chapter 8), 
Twenty-four hours after initiating the culture the major cell-type 
present is a granular epitheliocyte (62^ 1) together with fibroblasts 
(7^ ) and ’foamy* cells (31^ 1), these relative proportions being strongly 
reminiscent of the values quoted for rat liver ^  vivo i#e, parenchymal 
cells reprooenting 60% of the total cell population (Oaoust, 1959), 
During the following days in culture there is a fall in the total cell
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number (arising largely from the loss of the ’foamy* cells) which 
is accompanied by an absolute, as well as relative, increase in the 
fibroblast population. The rate of division of the epitheliocytes 
is much slower than that of the fibroblasts so that by 5 — 7 days 
the fibroblasts completely dominate the culture (see Chapter 0), 
Morphologically, the epitheliocytes are strikingly similar to 
normal hepatocytes in vivo and resemble the granular epitheliocytes 
observed by Alexander and Grisham (1970), Sandstrom (1965) and 
Watanabe (1966), The fibroblasts are believed to be of connective 
tissue origin. Introduction of collagenase into the culture medium 
for 3 days markedly decreased the number of fibroblasts remaining on 
the culture surface, which possibly suggests that these fibroblasts 
are functional in that they secrete, and attach to, collagen fibres* 
The origin of the ’foamy* cells could not be established. The 
morphological appearance of the throe cell-types present in culture 
could be confirmed by the scanning electron microscopy (see Chapter 8) 
and it is possible that use of this technique might prove useful in 
investigating the short-term effects of various carcinogens on the 
surface morphology of cultured cells,
A large number of differing liver—specific functions were tested 
for in the three-day cultures of epitheliocytes (see Chapter 8), 
Firstly, the cells appear to have a normal carbohydrate metabolism. 
They store glycogen, they can grow in medium in which glucose is 
replaced by galactose, and glucose uptake and release by the cells is 
strongly influenced by insulin and glucagon respectively. Those last 
results indicate that the epitheliocytes possess functional hormone 
cell receptor sites and from this it appears that this culture system 
is potentially a very useful tool in the study of liver-hormone
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interactions. The advantages of this technique are that the
concentration of hormone and the period in which it is in contact with
the cells can be critically monitored, and also that the hormone does
not act on organs other than the liver and so lead to misleading results#
Two situations can be readily imagined in which this culture system
could prove a valuable experimental tool:- a) studies into hormone
* /
receptor sites, and b) studies into the role of adenosine 3 : 5 -cyclic
monophosphate as a secondary messenger in mediating many effects of 
hormones acting on the liver.
Secondly, evidence suggests that these epitheliocytes possess a 
functional urea cycle which although not truly liver-specific is 
found in mammals only in liver, brain and kidney (Conn and Stumpf,
1972)# The epitheliocytes can be maintained in culture for at least a 
week in medium which is essentially free of arginine and they produce 
urea at a rate of approx# 0,2 mg# per flask per day#
Furthermore, these cells secrete immunochemically-detectable 
serum albumin into the medium, and they also show intense staining for 
glucose-6-phosphatose, a liver-specific enzyme#
Finally, metabolism of [^^c]-imipramino by those cells has been 
detected (see Chapter 8). The major routes of imiprsmino metabolism 
by the liver in vivo are N-demethylation and N-oxidation (Gigon and 
Bickel, 1971), These routes of metabolism have also been detected in 
this present in vitro study# Imipramine administration in vivo leads 
to the production of numerous minor metabolites, none of which could be 
detected in this study; various technical limitations (see Chapter 8) 
probably account for this discrepancy#
All this information when taken together with the morphological 
appearance of the cells very strongly suggests that these epitheliocytes
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can, with some confidence, be designated ^cultured hepatocytes”*
Whilst certain of these parameters have been used previously 
as markers for adult hepatocyte cultures (Alexander and Grisham, 1970;
Le Guilly et al# 1973) this present study is, as far as is known* the 
only one to combine so many parameters of hepatocyte-specific 
function as a tool in assessing the nature and origin of cultured 
liver cells* The various reports of adult mammalian hepatocyte 
monolayer cultures that have appeared in the literature base their 
justification for designating the cells "hepatocytes" purely on 
morphological appearance (Suliman et el* 1968; Armato et el* 1972a* b; 
lype, 1971) and not on any functional criteria whatsoever# In the cell 
culture situation the use of morphological appearance may not* by 
itself, help in elucidating cell derivation (see Moscona et al, 1955), 
mainly due to difficulties in translating the 3-dimensional structure 
in vivo to an essentially 2-dimensional structure vitro* and it 
is for this reason that functional criteria have to be used both to eluc­
idate cell derivation and the differentiated state of the cells* This 
has been done in the present study and the wide range of hepatocyte- 
specific functions that have been detected in these cultures most 
strongly argue for the existence, in culture, of differentiated 
hepatocytes*
Preliminary experiments have shown that the fibroblast overgrowth 
which is complete by 7 days in culture may be successfully minimized#
In agreement with Leffert and Paul (1972) was the finding that the use 
of an arginine-free medium eliminates the fibroblast presence to a 
largo extent without morphologically affecting the hepatocytes. The 
incorporation of dexamothasone (2 x 10*"^ M) or collagenase (0.05^)
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into the culture medium produced similar findings. This effect 
of collagenase in minimizing fibroblast growth has been utilized 
by Lasfargues (1973) to enable mammary epithelial cells to be 
maintained in culture in the presence of fibroblasts* It should 
be pointed out that as yet these results are based solely on 
morphological patterns and that biochemical tests on the cells 
surviving these treatments has not been attempted*
It proved impossible by the various techniques employed to 
subculture the hepatocytes although the fibroblasts could be readily 
subcultured* It is of interest to note that in keeping with the 
results obtained from the cell isolation experiments, trypsin was 
not successful in detaching the hepatocytes from the substratum in 
a viable state* The lack of effect of collagenase as a subculturing 
agent for the hepatocytes indicates that the attachment and spreading 
of the hepatocytes in culture is by a different mechanism to that 
operating in vivo*
Three different cultures have been developed to satisfy the 
requirements of any particular experiment» The cultures can be 
grown in flasks, these being ideal for analysis of medium contents*
The cells can be grown on coverslips to enable detailed examination 
of the cells to be made, and, finally, the cells can be grown in 
microtitre plates suitable for micro-scale work* In all three 
culture situations the morphological appearance of the hepatocytes is 
identical*
In conclusion, the system described for the culture of differentiated 
rat hepatocytes is potentially a very useful tool with which to study a 
wide range of problems concerned with hepatocytes and their involvement
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in metabolism and toxicity. Examples in which this application of 
hepatocyte cultures could prove useful include the role of covalent 
binding of drugs to macromolecules in toxic hepatic damage, and the 
influence of hormones on hepatic drug metabolism. In both situations 
the effects on the hepatocytes can be studied without the problem of 
possible interference by other organs of the body* Another example 
is the study of the short-term effects of hepatocarcinogens and other 
hepatotoxic agents on the morphology and function of hepatocytes with 
a view to the potential use of hepatocyte cultures as a test in 
determining the possible hepatotoxicity of novel compounds. Obviously, 
this culture system would be totally unsuitable where the toxic effect 
on the liver is directed not to the hepatocytes but to the other 
cellular elements e.g. the bile duct epithelium* In such instances 
the experimental approach would have to be based on an organ culture 
system in which the cellular architecture is maintained i^ vitro »
Furthermore, if this method could bo adapted for use with human 
liver, a paired system of rat and human hepatocyte cultures should 
prove valuable in elucidating species differences in drug metabolism 
and toxicity and should, in turn, lead to a more rational transition 
of drug studies from animals to man* It is perhaps worthwhile at this 
stage to speculate on the feasibility of culturing differentiated 
human hepatocytes* The probability exists that, owing to the greater 
fibrous content of adult human liver, the viable cell yields would be 
lower from human specimens, but the microtitre system which has been 
developed using rat hepatocytes could prove very useful whore the viable 
cell yields from human liver are low, due either to poor dissociation 
or to the size of sample received* This culture system now appears 
to be at a stage where its applicability to human liver could 
profitably be investigated*
APPENDIX
SUPPLIERS OF MEDIA, MEDIA SUPPLEMENTS AND CHEMICALS
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Albumin, Bovine Serum 
Albumin, Rat 
Aminopyrine 
Aniline
Antiserum, Goat Anti-Rat Albumin
4,4^-Bipyridyl
Calf Serum
Chicken Embryo Extract 
4-Chloroaniline 
4-Chloro-N-methylaniline 
Colcemid
Collagenase (Types I and II) 
Cytochrome c (Type II, Horse Heart) 
Dsxamethasone
Ethylmorphine Hydrochloride
Foetal Bovine Serum
Gentamycin
Glucagon
^^ c^j-Glucose
Glucose-6-phosphate, Disodium Salt 
Glucose—SOphosphate Dehydrogenase 
(Type XV, Baker’s Yeast)
Koch-Light
Sigma
Ralph N, Emmanuel 
BDH
Calbiochem
Ralph N. Emmanuel
Biocult
Biocult
Calbiochem
Calbiochem
Calbiochem
Sigma
Sigma
Roussel
May and Baker
Biocult
Biocult
Sigma
Radiochemical Centre, Amersham
P-L Biochemicals
Sigma
Horse Serum
Hyaluronidase (Type II, Ovine Testes)
Biocult
Sigma
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14_ imipramine 
Insulin Hydrochloride 
Liver Digest Ultrafiltrate 
McCoy’s 5A Medium 
Medium 199 with HEPES Buffer 
MEM with Earle’s 8.5.5, without Arginine 
MEM with Hank’s 8.5.5. and HEPES Buffer 
NADH, Disodium Salt 
NADP
Naphthalene
1-Naphthol
Non-Essential Amino Acids 
Phenobarbitone Sodium
Protease (Type Streptomyces grisous) 
Putrescino Dihydrochloride 
Ribonucleic Acid (Torula Yeast)
1,1,3,3-Tetraethoxypropane 
Tetraphenylboron Sodium 
Trinitrobenzenosulphonic Acid 
Trypan Blue
Tryptose Phosphate Broth 
Trypsin (2.5^ , 1:250)
Radiochemical Centre, Amersham 
BDH
Wellcome
Biocult
Biocult
Biocult
Biocult
Koch-Light
P-L Biochemicals
Ralph N. Emmanuel
Ralph N. Emmanuel
Biocult
BDH
Sigma
Sigma
Sigma
Koch-Light
Ralph N. Emmanuel
BDH
Biocult
BDH
Biocult
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